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Following peripheral nerve injury, myelin and Remak Schwann cells up-regulate a 
repair phenotype, controlled by c-Jun, to facilitate axon regeneration. Despite 
activation of this phenotype, nerve regeneration in humans is poor. An important 
factor is the deterioration of the distal nerve stump, a process involving a decrease in 
trophic factors initially up-regulated following injury and a decline in Schwann cell 
numbers, resulting in poor long-term regeneration. Regeneration deficits also 
develop with age - injured nerves in old mice regenerate slowly. I hypothesized that 
in old mice, and during chronic denervation, c-Jun levels are not maintained. This 
predicts that in young mice, c-Jun levels fall during chronic denervation, and that by 
maintaining Schwann cell c-Jun, the deterioration of the distal stump can be 
prevented. Similarly, by enhancing c-Jun levels in old mice, the regeneration deficit 
should be reversed.  
In young mice, Schwann cell c-Jun significantly decreased during chronic 
denervation. Markers of the repair phenotype also declined. A mouse that over-
expressed Schwann cell c-Jun (OE/+) was generated. Following chronic denervation, 
Schwann cells in denervated nerves maintained c-Jun levels. Regeneration was 
assessed by suturing a chronically denervated tibial nerve to a freshly cut common 
peroneal nerve, followed by neuronal backfilling. Improved motor and sensory 
neuron regeneration was observed in OE/+ mice following chronic denervation. In 
old OE/+ mice, the reduced c-Jun levels seen in old wild type mice were corrected. 
Regeneration was assessed by backfilling and old OE/+ nerves maintained the 
regenerative capacity of young animals. These results highlighted c-Jun as a 
pharmaceutical target. Sonic hedgehog is elevated after nerve injury and agonists 
significantly increased c-Jun and trophic factor expression in cultured Schwann cells. 
This work implicates the c-Jun pathway in the regeneration deficit that occurs 
following chronic denervation and with advancing age, and highlights hedgehog 
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1. Introduction  
The peripheral nervous system has a remarkable capacity for regeneration compared 
to that of the central nervous system. This was thoroughly documented in the work 
of Henry Head over 100 years ago, who as well as describing the injuries of his 
patients, injured his own peripheral nerves and documented his recovery (Head & 
Sherren, 1905; Head et al., 1905). Ramón y Cajal observed that the neurons of the 
peripheral and central nervous systems were associated with different glia cells and 
that these glia were likely to be the reason for this contrast. Schwann cells had 
already been observed in the 19th century and are the myelin and non-myelin cells of 
the peripheral nervous system. They originate from the neural crest and go through 
various developmental stages that results in association with large or small calibre 
axons, the myelination of which is determined by size (Jessen & Mirsky, 2005; 
Monk et al., 2015; Feltri et al., 2016). In the adult nerve, Schwann cells maintain the 
myelin sheath and are neuroprotective for small calibre axons. When the nerve is 
injured a repair programme is activated to aid axon regeneration (Arthur-Farraj et al., 
2012). Regeneration deficits are observed in the nerve with increasing injury time 
and age and few clinical advances have been made in the treatment of patients for 
over 50 years.  
 
1.1 Schwann cell and peripheral nerve development  
Schwann cell development is a multistage process that takes place from the initial 
generation of the nervous system and proceeds into early postnatal life. Schwann 
cells originate from neural crest cells which progress into Schwann cell precursors. 
Precursors differentiate into immature Schwann cells which become myelin or 
Remak Schwann cells depending on axon association. Both cell types then adopt a 
repair phenotype upon injury to aid peripheral nerve repair. Each of these stages is 
controlled by a variety of external and internal cues which will be described in the 
pages ahead (Jessen & Mirsky, 2005; Monk et al., 2015; Feltri et al., 2016). A 





Figure 1.1 | A diagram of Schwann cell development  
Neural crest cells initially express Sox 10. This is down-regulated by neuronal cells however remains 
elevated throughout the Schwann cell lineage. Schwann cell precursors differentiate to form immature 
Schwann cells. Immature Schwann cells become myelin or Remak Schwann cells after radial sorting 
pairs them with large or small calibre axons. Following injury, both cell types adopt a repair cell 















1.1.1 The neural crest  
Although Schwann cells are the primary glia of the PNS, other peripheral glia cell 
types include olfactory ensheathing cells - which associate with and protect olfactory 
axons, the terminal glia of neuromuscular junctions, satellite cells that associate with 
the cell body of sensory, sympathetic and parasympathetic ganglia, glia associated 
with sensory nerve endings and the enteric glia of the gut (Jessen & Mirsky, 2005). 
The peripheral nerves and glia originate from the neural crest (Harrison, 1924; 
Douarin, 1982; Le Douarin et al., 1991). Neural crest cells are highly mobile, 
multipotent cells that originate from the neuroepithelium. A single cell can give rise 
to multiple cells types (Bronner-Fraser & Fraser, 1988; Frank & Sanes, 1991; 
Baggiolini et al., 2015). Neural crest cells can migrate initially in a ventral direction 
and later in a dorsolateral direction. Peripheral neurons and glia are derived from the 
first waves of ventrally migrating neural crest cells (Weston, 1963; Le Douarin & 
Teillet, 1974). 
Neural crest cells that express the transcription factor sex determining region Y box 
10 (Sox 10) will generate cells of glia lineage and melanocytes. Mice that do not 
express Sox 10 do not develop peripheral glia despite normal neuron development, a 
feature also conserved in zebrafish (Britsch et al., 2001; Kelsh & Eisen, 2000). 
Neuregulin-1 (NRG1) promotes Schwann cell development and promotes the 
suppression of neurogenesis. In vitro neural crest cells differentiate to form neurons 
and glia, however in the presence in NRG1, only gliogenesis is observed. These 
experiments however examine a culture period of 2 weeks, allowing extensive 
precursor and Schwann cell proliferation, and use a culture medium that contains 
NRG. This finding therefore remains controversial (Shah et al., 1994). NRG1 is not 
required for the generation of all peripheral glia. Schwann cell precursors and 
Schwann cells are largely absent in the peripheral nerves of mice lacking the NRG1 
co-receptor ErbB3, but satellite cells are still generated. Neurogenesis is not affected 
in these mutants, however excessive sensory and motor neuron death occurs during 
subsequent development due to the lack of neuroprotective Schwann cell precursors 
and Schwann cells (Riethmacher et al., 1997). Sox 10 regulates the expression of 
ErbB3 and together Sox 10 and NRG1 promote the survival of neural crest cells 
(Britsch et al., 2001; Paratore et al., 2001).  
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In turn, Sox 10 regulation is controlled by Pax 3. Pax 3 has been implicated in 
Schwann cell differentiation, proliferation and survival throughout the lineage 
(Kioussi et al., 1995; Blanchard et al., 1996; Doddrell et al., 2012). Pax 3 is activated 
by binding and activation of histone deacetylases 1 and 2 (HDAC1/2) to the Pax 3 
promotor. Induction of myelin gene P0 is also controlled by HDAC1/2 binding to the 
P0 promoter. Satellite glia are reduced and no Schwann cell precursors are observed 
when HDAC1/2 is genetically deleted from neural crest cells. Pax 3 and Sox 10 
expression are similarly reduced, demonstrating the importance of these 
transcriptional regulators in the specification of the Schwann cell lineage (Jacob et 
al., 2014).  
With the activation of the appropriate transcription factors, neural crest cells 


















1.1.2 Schwann cell precursors  
Schwann cell precursors are observed in association with bundles of axons in the 
developing rat nerve at embryonic day 14 (E14) (Ziskind-Conhaim, 1988; Jessen et 
al., 1994). Although their appearance is correlated with the extension of nerves 
towards their targets, precursors are not required for initiation of this process but are 
required for the neuron survival and establishing connections with terminal targets 
(Reynolds et al., 1991; Grim et al., 1992; Riethmacher et al., 1997; Morris et al., 
1999; Wolpowitz et al., 2000). Axon contact is similarly required for precursor 
survival, mediated by axonally derived NRG1. When precursors are removed from 
axonal contact in vitro, very few cells survive (Jessen et al., 1994). This effect 
however can be reversed in the presence of NRG1 (Dong et al., 1995). As previously 
described, a failure to respond to NRG1 signalling in vivo corresponds with an 
absence of Schwann cells in peripheral nerves (Riethmacher et al., 1997). This is not 
only due to a lack of precursor survival but an inhibition of their migration. ErbB2 
mutants generate precursors within the DRG which proliferate normally but fail to 
migrate and associate with developing nerves. These however may be cells earlier in 
the lineage as Schwann cell precursors are always associated with axons (Morris et 
al., 1999). Schwann cell migration is similarly affected in zebrafish ErbB2 and 3 
mutants (Lyons et al., 2005). NRG1 signalling is therefore required for Schwann cell 
precursor survival and migration and for the differentiation of precursors into 












1.1.3 Immature Schwann cells  
The generation of immature Schwann cells from Schwann cell precursors is 
controlled by Notch dependent NRG1 signalling. Notch up-regulates ErbB2 
receptors in precursors increasing NRG1 sensitivity. Notch also controls Schwann 
cell proliferation, with an increase observed following activation of the pathway 
(Woodhoo et al., 2009). Immature Schwann cells appear in the nerve at E15-17 in 
rats and E13-15 in mice (Jessen et al., 1994; Dong et al., 1995) where they control 
two important processes in the development of the nerve: (1) arteriogenesis and 
development of nerve structures and (2) the radial sorting of axons.  
Arteries in the limb are aligned with the peripheral nerves. When Schwann cells or 
sensory nerves are absent, branching and arterial markers are disrupted. When nerves 
are present but their growth is disorganised, arterial alignment with misrouted axons 
is maintained (Mukouyama et al., 2002). Arteriogenesis is controlled by vascular 
endothelial growth factor (VEGF) derived from both nerves and Schwann cells 
(Mukouyama et al., 2005).  
Immature Schwann cells also control the formation of normal nerve architecture of 
the epi, peri and endoneurium organisation through desert hedgehog signalling (Dhh) 
(Parmantier et al., 1999). Peripheral nerves are composed of 3 layer of connective 
tissue: an external epineurium, multiple fascicles surrounded by perineurium and 
axons surrounded by endoneurium. The perineurium is the barrier that controls 
cellular and molecular permeation of the nerve (Olsson, 1990) formed of compacted 
layers of epithelial-like cells with a basal lamina linked by gap and tight junctions. 
The epineurium is composed of collagen and fibroblasts (Thomas & Olsson, 1984). 
The epineurium of Dhh null mice however has reduced collagen and is less 
compacted. Lamination of the perineurium was reduced and layers that are present 
are decompressed. The cells of the perineurium have a disrupted basal lamina, 
blurring the boundary distinction between it and the epineurium. The blood nerve 
barrier is also compromised. Minifascicles are observed within the nerve, generated 
by perineural cells dividing groups of nerve fibres. The nerves of humans carrying 
Dhh mutations are also seen to contain these (Parmantier et al., 1999; Umehara et al., 
2002; Sepideh N Bajestan et al., 2006; Sato et al., 2017). The expression of various 
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factors by immature Schwann cells are therefore required for normal peripheral 
nerve development.  
Radial sorting is the process by which large and small calibre axons are sorted for 
myelination, a process which continues to postnatal day 10 in rodents (Figure 1.2). 
Immature Schwann cells mediate radial sorting by organising mixed calibre axons 
into bundles surrounded by basal lamina. This is performed by a unit or “family” of 
3-8 Schwann cells. The larger axons are segregated to the periphery by the Schwann 
cells extension of cytoplasmic lamellipodia. As the Schwann cells proliferate they 
continually segregate single large axons from the bundle and form a 1:1 relationship 
with them. Smaller calibre axons remain unsegregated forming Remak bundles with 
one Remak cell associated with multiple small axons that remain unmyelinated 
(Webster et al., 1973; Jessen & Mirsky, 2005; Feltri et al., 2016) .  
The molecular control of this process is not well characterised although many 
different molecules have been implicated in various stages of the process (Figure 
1.2). Laminin is one of the components of the basal lamina and is required for the 
sorting of axons (Yang et al., 2005) and severe sorting defects have been reported as 
the consequence of  laminin α2 gene mutation (Xu et al., 1994). A disruption in 
laminin receptors with the deletion of β1 integrin also results in disruptive sorting 
with immature Schwann cells failing to maintain and generate axon associated 
processes. This mutation is eventually lethal, emphasising the importance of radial 
sorting in development (Feltri et al., 2002; Pietri et al., 2004). Cdc42 and Rac1 
Schwann cell mutant mice also show severe sorting defects, most likely by acting 
downstream of laminin signalling. Rac1 is required for the correct extension and 
stabilisation of Schwann cell processes whereas Cdc42 is required for Schwann cell 
proliferation (Nodari et al., 2007; Benninger et al., 2007) 
Similar deficits are observed in Jun activation domain–binding protein 1 (Jab1) null 
mice. The nerves of adult mice contain large bundles of unmyelinated axons of 
mixed calibre. Schwann cells surround these bundles and have extended lamellipodia 
but fail to proliferate. Jab1 null Schwann cells presented with abnormal cell cycle 
progression caused by increased levels of p27, a negative regulator of the cell cycle. 
Jab1 null mice also display lower levels of laminin suggesting Jab1 regulates the 
laminin pathway (Porrello et al., 2014).  
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Radial sorting, in line with other stages of the Schwann cell lineage, is also regulated 
by NRG1. When signalling through ErbB is inhibited, Schwann cells are able to 
generate processes but are unable to extend them. Fewer Schwann cells are also 
observed in the nerve, suggesting that NRG signalling is required for Schwann cell 
proliferation and process extension during radial sorting (Raphael et al., 2011). 
Sox 10, which is similarly required throughout the Schwann cell lineage is also 
required for radial sorting and the progression of Schwann cells from the immature 
stage. When Sox 10 is deleted specifically from Schwann cells at the precursor stage, 
the up-regulation of myelin and pro-myelination genes is not observed. Postnatally, 
myelination was absent resulting in alterations in nerve conduction and abnormal 
nerve architecture. The peripheral neuropathy that results from this mutation is lethal 
with poor survival past the seventh post-natal week (Finzsch et al., 2010).  
Together these studies demonstrate the importance of both Schwann cell 
proliferation and process extension during radial sorting. Their work provides an 
insight into the molecular control of this process which is mediated by axons, 




























Figure 1.2 | A diagram of radial sorting 
The diagram depicts the stages of radial sorting. Stage 1: Schwann cell axon units form and basal 
lamina is deposited. Stage 2: Schwann cells extend cytoplasmic lamellipodia. Stage 3 and 4: Larger 
calibre axons are recognised and segregated to the periphery. In the final stage (not shown) Schwann 












1.2 Myelination  
Radial sorting is the determining stage of Schwann cell fate. Schwann cells that 
remain associated with small calibre axons will become Remak (non-myelin) 
Schwann cells and these axons will remain unmyelinated. Schwann cells that have 
associated in a 1:1 relationship with axons greater than 1µm in diameter will become 
myelin Schwann cells and the axons will subsequently be myelinated (Matthews, 
1968; Friede, 1972). During myelination, Schwann cells extend and wrap around 
axons in a spiralling motion. Schwann cells spread over the length of the axon then 
begin to deposit myelin as they rotate around the axon. The rate of movement around 
the axon is greatest during the early stages of myelination (Bunge et al., 1989). 
Myelination of the rat sciatic nerve results in axons with 100 layers of myelin with 
very few axons insulated by fewer than 10 (Friede & Samorajski, 1968). Myelin is 
essential for the rapid saltatory conduction of action potentials and conduction 
velocity increases with myelin thickness (Waxman, 1980). Failure of myelination or 
hypomyelination results in peripheral neuropathy and neuron death (Riethmacher et 
al., 1997; Lewis et al., 2003; Scherer & Wrabetz, 2008).  
Myelination is controlled by the activation and repression of various factors 
including NRG1 (type III), Krox-20, Oct-6, and c-Jun.  
 
1.2.1 Neuregulin  
As previously described, NRG1, particularly type III, is essential for the progression 
of many stages of the Schwann cell lineage (Meyer et al., 1997). It is difficult to 
study the role of NRG1 in myelination as Schwann cell development is inhibited and 
the mutation is lethal. The relationship between NRG1 expression and myelin 
thickness was confirmed in vivo with mouse mutants expressing enhanced or 
reduced levels of neuronal NRG1 and ErbB receptors. Reduced NRG1 expression 
and signalling resulted in hypomyelination with very thin myelin sheaths observed 
on the axons. Enhancing NRG1 resulted in the increased wrapping of the axon with 
abnormally thick myelin sheaths present in adult mice (Michailov et al., 2004). In 
vitro studies have also been used to elucidate this mechanism. When NRG1 is 
removed from neurons, Schwann cells do not associate with or myelinate axons. 
This effect is reversed with the restoration of NRG1 through lentiviral infection. In 
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vitro appropriate NRG1 expression levels are not only required for the initiation of 
myelination but also determine the thickness of the myelin sheath formed. When 
neurons with varying levels of axonal myelination are compared, the axons with the 
thickest sheaths express higher levels of NRG1 (Taveggia et al., 2005).  
 
1.2.2 Krox-20 
The transcription factor Krox-20 is expressed by Schwann cells before the onset of 
myelination and is only observed in pro-myelinating Schwann cells (Murphy et al., 
1996; Parkinson et al., 2004). Schwann cells of Krox-20 null mice, although able to 
radially sort axons, form 1:1 relationships with axons and to perform one and a half 
turns around the axon, fail to form myelin sheaths (Topilko et al., 1994). Krox-20 
controls Schwann cell myelination through the activation of myelin-differentiation 
genes (Parkinson et al., 2003) and inhibits further Schwann cell proliferation 
stimulated by NRG1 (Parkinson et al., 2004). Krox-20-/- Schwann cells do not exit 
the cell cycle and continue to proliferate resulting in increased postnatal apoptosis 
(Zorick et al., 1999).  
 
1.2.3 Oct-6 
Oct-6 is a POU domain transcription factor that is also referred to as SCIP or Tst-1. 
It is expressed in Schwann cells from E16. Expression of Oct-6 gradually decreases 
postnatally. Following nerve injury, it is briefly up-regulated following axotomy but 
is highly expressed in the regenerating nerve following a crush injury where it likely 
to aid remyelination (Scherer et al., 1994). Oct-6 expression is controlled during 
development and regeneration by the Schwann cell specific enhancer (SCE) located 
distally to the transcriptional start site (Mandemakers et al., 2000). Oct-6-/- Schwann 
cells myelinate however the process is delayed. Radial sorting is unaffected, with a 
1:1 relationship observed and normal lamellipodia extension. Oct-6-/- Schwann cells 
are therefore able to initiate myelination but are unable to progress. Myelination is 
normally observed from P4 in mice yet is not observed in mutant mice. Myelin 
sheaths are first observed in mutants at P16 with only the largest calibre axons 
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myelinated. Of those that are myelinated, the majority present with normal nerve 
architecture (Jaegle et al., 2003).   
Although myelination is delayed in Oct-6-/-, it resumes at later stages in 
development. This suggests a compensatory mechanism is in place. Brn-2 is another 
POU transcription factor with almost identical binding to Oct-6, however its 
activation is independent of Oct-6. Over-expression of Brn-2 in Oct-6-/- mice reduces 
the delay in myelination however a double knock out of Brn-2 and Oct-6 further 
delays the myelination of nerves. Nerves are hypomyelinated and are consistent in 
appearance with those of early postal animals (Jaegle et al., 2003). It has been 
demonstrated that Oct-6 and Brn-2 directly bind to Krox-20 activating and 
enhancing myelination in cooperation with Sox 10 (Ghislain et al., 2002; Ghislain & 
Charnay, 2006), the dimeric binding of which with core element 1 to the SCE, 
regulates Oct-6 expression (Jagalur et al., 2011).  
 
1.2.4 The role of c-Jun in myelination  
So far, the activation of various transcription factors have been described to regulate 
myelination. However myelination also requires the down-regulation of many 
factors, such as Sox2 (Le et al., 2005) to commence. c-Jun is expressed in immature 
Schwann cells at E17. Krox-20 however down-regulates c-Jun before initiating 
myelination (Parkinson et al., 2004). If immature Schwann cells were to continue to 
express c-Jun, expression of Krox-20 regulated myelin genes such as P0 and periaxin 
would be inhibited which actively prevents axon myelination. c-Jun is therefore a 
negative regulator of myelination (Parkinson et al., 2008). c-Jun is expressed at low 
levels in adult nerves and is almost undetectable. c-Jun is highly up-regulated again 
following injury (De Felipe & Hunt, 1994; Shy et al., 1996; Arthur-Farraj et al., 







1.2.5 Myelin sheath composition 
The resulting myelin sheath that is generated is composed of protein and lipids. 
Other membranes have a high protein content whereas myelin is approximately 30% 
protein, 70% lipid (Morell & Quarles, 1999). Myelin protein zero (P0) is the main 
component of the myelin sheath (Greenfield et al., 1973). P0 is required for both the 
generation and compaction of the myelin sheath, as demonstrated by knock-out 
studies. Schwann cells in P0
-/- mice show wrapping defects around axons which 
become hypomyelinated. As the mice age, myelin sheaths decrease in thickness and 
onion bulbs form, indicative of active demyelination. Due to the lack of myelin 
sheaths, axon degeneration is later observed (Giese et al., 1992; Martini, Zielasek, et 
al., 1995; Martini, Mohajeri, et al., 1995). This demonstrates the role of P0 not only 
in the generation of myelin and its importance in development but also its role in the 
maintenance of the myelin sheath.  
PMP22 is a glycoprotein that comprises 2-5% of compact myelin (Snipes et al., 
1992; Pareek et al., 1993). PMP22 deficient mice display delayed myelination 
despite normal radial sorting. Some axons are myelinated, with excessive loops of 
myelin leading to hypermyelination. Due to the disorganised structure of the myelin, 
the sheath degrades and axons later degenerate (Adlkofer et al., 1995). PMP22 over-
expression results in hypermyelination of small calibre axons yet hypomyelination of 
large calibre axons (Verhamme et al., 2011; Hantke et al., 2014). Duplications in the 
PMP22 gene are responsible for a majority of human Charcot-Marie-Tooth 
neuropathies (Shy et al., 2008). Appropriate expression of PMP22 is therefore 
required for the correct generation of the myelin sheath and regulates thickness and 
organisation in ways that are not properly understood.  
Myelin basic protein (MBP) composes 15-20% of PNS myelin (Lees and Brostoff, 
1984). It appears to play a greater role in CNS myelin as demonstrated by the 
Shiverer mouse which generates no MBP, fails to compact the myelin sheath and has 
a characteristic shivering gait. Although the CNS is hypomyelinated, peripheral 
nerve myelination is largely normal, suggesting MBP does not play an important role 
in the generation or maintenance of peripheral myelin (Readhead & Hood, 1990).   
Myelin associated glycoprotein (MAG) exists as 2 isoforms, S-MAG and L-MAG 
(Lai et al., 1987). S-MAG is predominately expressed in the PNS throughout 
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development with only low levels of L-MAG observed (Tropak et al., 1988). MAG 
is confined to the periaxonal portion of the myelin sheath. It is also expressed in the 
uncompacted myelin of the Schmidt-Lanterman incisures (Sternberger et al., 1979).  
As previously described, myelin is mainly composed of lipids. Cholesterol 
constitutes 26-28% of myelin lipid content (Norton & Cammer, 1984) and limits the 
rate of myelin production. Conditional knock outs in which cholesterol biosynthesis 
or lipid homeostasis is disrupted in Schwann cells generate hypomyelinated nerve 
fibres and peripheral neuropathy. In vitro, mutants are able to myelinate when in co-
culture with DRGs, however this is largely dependent on the application of 
endogenous lipids (Saher et al., 2009; Verheijen et al., 2009). When tellurium, an 
inhibitor of cholesterol biosynthesis, is orally administered to newly weaned rats, 
progressive demyelination is observed (Lampert et al., 1970; Harry et al., 1989). 
This demonstrates that cholesterol is not only required for myelin synthesis, but also 
for maintenance of the myelin sheath.  
Galactolipids comprised of galactosylceramides and sulfatides constitute 20-30% of 
the other myelin lipids and are the main components of the myelin sheath’s outer 
surface (Eckhardt, 2008). Genetic mutations of sulfatides form regular myelin 
sheaths and display normal nerve conduction. Slight abnormalities are however 
present in myelin compaction and paranodal loop formation (Honke et al., 2002; 
Marcus et al., 2006). However if both galactosylceramides and sulfatides are 
mutated, nerve conduction velocity is impaired. The loss of these components is not 
compensated for by other lipids, therefore mutations result in severe neuropathy and 










1.3 Remak Schwann cells  
Schwann cells that do not form 1:1 relationships with axons and remain with bundles 
of small calibre axons do not generate myelin. These are referred to as Remak cells. 
They outnumber the myelin forming cells and are spaced closer together along axons 
compared to their myelin counterparts (Ochoa & Mair, 1969; Aguayo et al., 1973). 
Although they do not myelinate, NRG1 is still required for maintaining bundle size. 
Specific sensory neuron NRG1 ablation generates larger, closely packed Remak 
bundles, the axons of which are not separated by Schwann cell cytoplasm (Fricker et 
al., 2009). NRG1 signalling through ErbB is also essential for Remak cell survival in 
the adult nerve. When signalling is inhibited, Remak cell apoptosis and sensory 
function is impaired as a result of C-fibre degeneration (Chen et al., 2003).  
Both Remak and myelin Schwann cells activate a repair cell phenotype following 




















1.4 Types of injury  
Peripheral nerve injuries are common, with approximately 100,000 peripheral nerve 
surgeries performed in the USA and Europe every year (Kelsey, 1997). Peripheral 
nerve injuries are common in the military. Combat induced injuries are largely 
localised to the extremities and nerve damage is caused from explosives and shrapnel 
(Korzinek, 1993; Chandler et al., 2017). In civilian life, the most common cause of 
peripheral nerve injury is motor vehicle collision (Noble et al., 1998).  
The success and rate of axon regeneration can depend largely on the type of injury 
sustained by the nerve. Although the varying forms of these injuries have been 
classified (Seddon, 1942; Sunderland, 1951), axonal damage in nerve injury can be 
broadly attributed to a crush or cut injury. A crush injury is more favourable to 
regeneration. The basal lamina of both Schwann cells and axons remain intact 
allowing the axons to easily regenerate. After the nerve is cut however, the basal 
lamina and surrounding connective tissues are disrupted. If the proximal and distal 
nerve stumps are not re-joined, a tissue bridge, composed of matrix and 
inflammatory cells will form in the gap. The axons must overcome this distance to 
reinnervate targets. Schwann cells are sorted by fibroblasts and axons are guided 
through the bridge by Schwann cells, which move along blood vessels towards the 
distal nerve stump. (Morris et al., 1972; Jurecka et al., 1975; Friede & Bischhausen, 












1.5 Wallerian Degeneration  
Following a peripheral nerve cut or crush injury, a cascade of events in the distal 
nerve stump occurs to allow for axon regeneration. This process was first described 
by Augustus Waller in 1850 and is aptly named Wallerian degeneration (Waller, 
1850). Following insult, axons degrade and debris is cleared through macrophage 
infiltration. Schwann cells proliferate and aid axon regeneration through the 
formation of the bands of Büngner and the release of trophic factors. The careful 
orchestration of all these stages is required for successful axon regeneration and 
reinnervation of targets.  
 
1.5.1 Axon survival and degradation  
One of the earliest responses of the nerve to injury is the repair of plasmalemmal 
damage whereby the axons ‘seal’ the ends of the axons. This occurs within minutes 
of axonal damage and is mediated by Ca2+ influx resulting in the accumulation of 
Ca2+ dependent vesicles and other membrane-bound structures such as 
synaptotagmin and syntaxin. When vesicle trafficking and formation is inhibited, 
plasmalemmal sealing is impaired (Spaeth et al., 2010, 2012). Sealing is similarly 
impaired when Ca2+ binding to synaptotagmin or syntaxin is inhibited (Detrait et al., 
2000), overall demonstrating the importance of Ca2+ dependent vesicle formation and 
fusion in plasmalemmal sealing. Plasmalemmal sealing impairment inhibits 
regeneration and compromises neuronal survival (Yoo et al., 2004; Nguyen et al., 
2005).  
Comparatively, axon degeneration is a much slower response. Axons appear normal 
for the first hours post injury with swelling and beading appearing 8 hours after 
injury (Zhai et al., 2003). The nerves are even able to conduct action potentials 
during this time (Moldovan et al., 2009). Degeneration is initiated after several days 
in humans (Chaudhry & Cornblath, 1992). In rodents, degeneration of thin fibres 
begins 22 hours after injury. The timing of fibre degeneration is determined by 
calibre, with the largest axons initiating degeneration last (after 32 hours). 
Fragmentation is initiated at the injury site and spreads distally following cut, but has 
been reported to proceed proximally following crush (Lubińska, 1977; Lunn et al., 
1990; Beirowski et al., 2005).  
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The mechanism by which axon degeneration occurs is currently poorly understood. 
The Wlds mouse undergoes slow axon degeneration following injury (Lunn et al., 
1989). Studies have found that this response is intrinsic to the neuron (Glass et al., 
1993) and is due to the over-expression of Ube4b/Nmnat (Wld) gene (Mack et al., 
2001), implicating the deactivation of this pathway in axon degeneration following 
injury. The Schwann cell response to injury in these mice is also inhibited, 
demonstrated in the delayed activation of c-Jun (Jessen & Mirsky, 2008).  
More recent experiments have shown that the nucleotide precursor of nicotinamide 
adenine dinucleotide (NAD), nicotinamide mononucleotide (NMN), accumulates in 
axons after normal nerve injury promoting axon degeneration (Di Stefano et al., 
2015).  
 
1.5.2 The macrophage response  
In the uninjured nerves there is a small resident population of macrophages present 
that constitute 2-4% of the cell population (Oldfors, 1980; Perry et al., 1987). 
Following injury, macrophages are recruited within 1-3 days and remain present in 
the nerve for up to 3 weeks where they play a key role in the later stages of myelin 
breakdown. Macrophages largely gather around the injury site and diffuse in number 
distally (and proximally after crush) (Perry et al., 1987; Stoll et al., 1989; Raivich et 
al., 1991; Perry et al., 1995; Liu et al., 1995; Hirata et al., 1999; Hirata & 
Kawabuchi, 2002). Macrophage recruitment is also observed at a secondary site 
around the axotomized neuronal cell bodies where their presence is required for 
neurite outgrowth (Lu & Richardson, 1993; Schreiber et al., 1995; Niemi et al., 
2013). Macrophage myelin phagocytosis is regulated through the complement 
receptor-3 and the scavenger receptor AI/II. Inhibition of these receptors results in 
reduced myelin clearance (Brück & Friede, 1991; Makranz et al., 2004). 
Macrophages leave the nerve with the re-emergence of axons through Nogo receptor 
(NgR) upregulation. In crushed nerves were NgR expression is inhibited, the efflux 
of macrophages is impaired (Fry et al., 2007).  
When macrophage infiltration, migration and polarization in the injured nerve is 
altered, the rate of axon regeneration is reduced (Dailey et al., 1998; Barrette et al., 
2008; Vargas et al., 2010; Chen et al., 2015). This is likely not due solely to the 
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presence of inhibitory debris which is normally cleared by macrophages because 
when macrophage infiltration is inhibited, myelin breakdown by Schwann cells is 
still observed particularly in the early days of injury (Perry et al., 1995). 
Macrophages also support axon regeneration through the secretion of trophic factors 
and cytokines (Brown et al., 1991; Reichert et al., 1996; Shamash et al., 2002) and 
promote vascularisation of the nerve bridge between proximal and distal nerve 
stumps through the secretion of vascular endothelial growth factor A (VEGF-A) 
(Cattin et al., 2015).  
 
1.5.3 The Schwann cell response  
Throughout the field, the Schwann cell response to injury has long been described as 
a process of de-differentiation in which the Remak and myelin Schwann cells revert 
to an immature Schwann cell to facilitate axon regeneration although other papers 
describe the response as activation (Chen et al., 2007; Jessen & Mirsky, 2008; 
Webber & Zochodne, 2010). Recent work however is arguing that the response is 
more complicated than this and that the cell is adopting a new phenotype which 
represents a combination of dedifferentiation and activation, a repair cell phenotype 
mediated by c-Jun activation. Although controversial, this is a logical theory. 
Schwann cells in the injured nerve exhibit a different genetic profile compared to 
immature Schwann cells. Olig1, Shh and GDNF are all up-regulated in Schwann 
cells following injury yet they are not expressed by immature Schwann cells (Arthur-
Farraj et al., 2012). Novel behaviours are also exhibited by these cells. They break 
down myelin through the activation of autophagy (Gomez-Sanchez et al., 2015) and 
elongate to form the bands of Büngner, during which they elongate to 7-10x the size 
of immature Schwann cells (J A Gomez-Sanchez et al., 2017).  
In response to injury, Schwann cells must undergo two phases of change. The first is 
the down-regulation of their myelin phenotype. Myelin genes such as MBP and P0 
are down-regulated (Chen et al., 2007; Jessen & Mirsky, 2008; Arthur-Farraj et al., 
2012). As well as down-regulating myelin gene expression, Schwann cells initially 
clear myelin debris from the injured nerve in the days post injury, preceding the 
macrophage response (Perry et al., 1995). Myelin disruption originates at the 
Schmidt-Lanterman incisures 36 hours after injury, resulting in myelin ovoid 
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formation in an actin-dependant process (Ghabriel & Allt, 1979a, 1979b; Jung et al., 
2011). The Schwann cell mediated removal of myelin has long been described as 
phagocytosis. Recent work however has demonstrated that it is however autophagy 
(Gomez-Sanchez et al., 2015), a process by which newly formed membranes 
(phagophores) engulf internal debris and transport it to the lysosome for degradation 
in a double-membraned autophagosome (Davidescu et al., 2012). The importance of 
autophagy in many mechanisms is now heavily emphasised and Yoshinori Ohsumi’s 
work on determining the mechanism of autophagy lead to his award of the Nobel 
prize in 2016.  
The second phase of transition Schwann cells undergo is the activation of the repair 
programme. This results in the up-regulation of trophic factors such as BDNF and 
GDNF (Meyer et al., 1992; Funakoshi et al., 1993; Naveilhan et al., 1997; Höke et 
al., 2000, 2002). Arthur-Farraj et al (2012) characterised the injury response in mice 
with c-Jun specifically knocked out in Schwann cells (c-Jun cKO mice). Although 
these mice develop normally, striking differences were found following nerve injury. 
First, c-Jun cKO Schwann cells did not down-regulate their myelin phenotype. Many 
myelin associated genes such as MBP and P0 were still highly up-regulated 
following injury. Genes associated with axon regeneration such as GDNF, BDNF, 
artemin and GAP-43 where consequently not up-regulated. The formation of the 
bands of Büngner in these mice was distorted and Schwann cell numbers were 
reduced. Together, these factors result in poor axon regeneration and neuronal death, 
demonstrating the importance of Schwann cell c-Jun activation following nerve 
injury (Arthur-Farraj et al., 2012). These findings were further supported by the 
work of Fontana et al (2012). Also using the c-Jun cKO mouse, they observed 
reduced expression in GDNF and artemin following facial nerve injury. This finding 
was also accompanied by poor survival and regeneration of motor neurons (Fontana 
et al., 2012). Despite the importance of the c-Jun pathway, as highlighted by these 
authors, other members of the mitogen-activated protein kinase (MAPK) signalling 
pathway are also activated in Schwann cells following injury.  
p38 MAPK is activated by Schwann cells almost immediately following injury 
(Myers et al., 2003; Zrouri et al., 2004). Activation of this pathway in myelin co-
cultures results in the down-regulation of the myelin Schwann cell phenotype and 
active demyelination. Furthermore, inhibition of this pathway after injury prevents 
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the down-regulation of myelin genes. Activation of p38 is sufficient to induce c-Jun 
expression in Schwann cells, suggesting repair cell activation may be the 
consequence of down-stream p38 signalling (Yang et al., 2012). However recent 
work has demonstrated that axon regeneration is not affected when p38alpha is 
ablated in Schwann cells (Roberts et al., 2017).  
The Ras/Raf/ERK signalling cascade controls the expression of many genes, 
including c-Jun (Minden et al., 1994). Following injury, phosphorylated ERK is up-
regulated in Schwann cells. Activation of ERK signalling in myelin Schwann cells is 
sufficient to induce demyelination through the down-regulation myelin genes 
(Harrisingh et al., 2004). ERK is activated is both proximal and distal nerve stumps 
following injury and remains elevated in the nerve in the weeks that follow (Sheu et 
al., 2000). When ERK signalling is inhibited following nerve injury, expression of 
myelin genes continues, demonstrated that ERK is required for down-regulation of 
the myelin phenotype. Prolonged activation of the ERK pathway however prevents 
functional motor recovery, suggesting ERK signalling must be down-regulated for 
Schwann cells to initiate remyelination (Napoli et al., 2012). As well as down-
regulating the Schwann cell myelin programme, ERK signalling also promotes 
macrophage recruitment. When ERK signalling is activated in uninjured nerves, 
inflammatory cells, such as macrophages, mast cells and neutrophils are recruited, in 
a timescale similar to that observed following injury. This is due to the activation of 
cytokines controlled by ERK signalling such a MCP-1 (Napoli et al., 2012). MCP-1 
is up-regulated by Schwann cells and aides macrophage recruitment to the nerve 
with suppression resulting in decreased macrophage numbers (Fischer, Kleinschnitz, 
et al., 2008). When ERK signalling is inhibited, MCP-1 expression is reduced 
(Fischer, Weishaupt, et al., 2008). Together these studies highlight the importance of 
ERK signalling, not only in the control of the Schwann cell response to injury but in 
the recruitment of inflammatory cells also.  
As highlighted in the c-Jun cKO mice, the bands of Büngner play an important role 
in guiding regenerating axons to their targets. The bands of Büngner are columns 
composed of overlapping Schwann cells inside the basal lamina. Recent work has 
demonstrated the extent of elongation and branching these cells undergo to form the 
bands of Büngner. Remak and myelin Schwann cells increase in length by 2-3 fold, 
adopting a branched, elongated profile (J A Gomez-Sanchez et al., 2017).  
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Following injury Schwann cells also proliferate, increasing in number from 19 hours 
after injury and peaking at 3 days, after which the rate of proliferation remains 
constant (Thomas, 1948; Bradley & Asbury, 1970). It has however been suggested 
that Schwann cell proliferation is not required for axon regeneration, at least initially. 
Schwann cells lacking cyclin D1, a G1 cell cycle protein, do not undergo 
proliferation following injury. Following a crush injury however, axons regenerate 
and remyelinate normally. (Kim et al., 2000; Atanasoski et al., 2001; Yang et al., 
2008) 
Once axons re-enter the nerve, Schwann cells undergo a second phase of 
proliferation and Schwann cell mediated remyelination begins 8 days after injury 
(Pellegrino & Spencer, 1985; Akassoglou et al., 2002). Any excess Schwann cells 
present in the nerve are removed by apoptosis (Yang et al., 2008). Recent work has 
confirmed the long standing assumption in the field that the repair cells become the 
myelin cells in the regenerated nerve. This was demonstrated by grafting a 4 week 
cut nerve segment from a mouse expressing Schwann cell GFP into a WT mouse. 6 
weeks later, GFP positive myelin Schwann cells were observed in the WT nerve (J A 















1.6 The repair cell markers  
The repair cell markers are defined as molecules, trophic factors, transcription 
factors and cell adhesion molecules that are up-regulated in Schwann cells following 
injury. They are either typically associated with aiding axon regeneration or their up-
regulation is restricted to injury and they are not observed at other stages of the 
Schwann cell lineage. Their up-regulation is controlled by c-Jun, demonstrated by 
their dysregulation in the c-Jun cKO nerve. Although 172 genes are dysregulated in 
this mutant following injury, this thesis focuses on c-Jun, trophic factors GDNF, 
BDNF and the receptor p75 NTR, Shh and Olig1 (Arthur-Farraj et al., 2012).  
 
1.6.1 c-Jun 
The transcription factor c-Jun belongs to the JUN gene family, which also consists of 
JUNB and JUND. The activation of c-Jun controls many cellular pathways including 
apoptosis, proliferation and differentiation.  
Phosphorylation of c-Jun by MAPKs, such JNK, in the N-terminal domain at serine 
(Ser) 63 and 73 and threonine (Thr) 91 and 93 is required for transcriptional activity 
(Smeal et al., 1991; Pulverer et al., 1991; Dérijard et al., 1994; Papavassiliou et al., 
1995; Morton et al., 2003), whereas phosphorylation of C-terminal sites Thr 231, Ser 
243 and 249 inhibits c-Jun DNA binding. Ser 243 is phosphorylated by glycogen 
synthase kinase 3 (GSK 3) whereas Thr 231 and Ser 249 are phosphorylated by 
casein kinase II (CKII). Activation of c-Jun can only be achieved through  N-
terminal phosphorylation coupled with C-terminal dephosphorylation (Boyle et al., 
1991; Lin et al., 1992; Chou et al., 1992; Papavassiliou et al., 1995; Morton et al., 
2003). A diagram of c-Jun protein structure, highlighting relivant binding and 
phosphorylation sites is displayed in Figure 1.3.  
c-Jun forms and activates the transcription factors complex activator protein 1 (AP-
1) either through homodimer formation with itself or heterodimer formation with c-
Fos or activating transcription factor (ATF) proteins (Bohmann et al., 1987; Angel et 
al., 1988; Chiu et al., 1988; Rauscher et al., 1988; Franza et al., 1988; Halazonetis et 
al., 1988). The AP-1 complex activates TRE (12-O-Tetradecanoylphorbol-13-acetate 
responsive element) and CRE (cyclic AMP responsive element) through promotor 
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region binding (Lee et al., 1987; Sassone-Corsi et al., 1990). It is unknown what 
conformation of the AP-1 complex is formed in Schwann cells in response to injury, 
however recent work has suggested c-Jun forms heterodimers with Fosl2 and ATF3 
due to their similar up-regulation patterns following peripheral nerve injury (Arthur-
Farraj et al., 2017).  
c-Jun is expressed in Schwann cell precursors and immature Schwann cells. It is 
down-regulated upon myelination with expression in adult nerves mainly observed 
in Remak Schwann cells although it has also been detected at low levels in adult 
myelin cells (Stewart, 1995; Shy et al., 1996; Klein et al., 2014; Hantke et al., 2014) 
c-Jun expression in pre-myelinating Schwann cells is likely to control cell numbers 
as, in vitro it has been shown that c-Jun participates in Schwann cell proliferation 
and apoptosis. Transforming growth factor β (TGFβ) induces apoptosis in high 
density cultured Schwann cells. It has been demonstrated that TGFβ apoptosis is 
mediated by c-Jun transcription. When Schwann cell cultures expressed v-Jun, a 
transcriptional active form of c-Jun (Nishimura & Vogt, 1988; Bohmann & Tjian, 
1989), increased apoptosis was observed in serum free media. Similarly when c-Jun 
transcription was inhibited, cell survival increased (Parkinson et al., 2001). 
Conversely, c-Jun induces Schwann cell proliferation through activation by JNK. 
When JNK activity and thus c-Jun phosphorylation is inhibited, Schwann cell 
proliferation decreases in vitro as indicated by reduced BrdU incorporation. Pro-
myelin gene Krox-20 inhibits c-Jun and Schwann cell proliferation through JNK 
signalling and drives the Schwann cell towards the myelin phenotype (Topilko et al., 
1994; Parkinson et al., 2004). 
Although c-Jun expression is low in adult neurons, it is rapidly up-regulated in both 
neurons and Schwann cells following peripheral nerve injury where it was thought to 
play a role in survival and regeneration (Leah et al., 1991; Jenkins & Hunt, 1991; De 
Felipe & Hunt, 1994; Stewart, 1995; Shy et al., 1996; Herdegen et al., 1997) 
Raivich et al (2004) determined the role of c-Jun up-regulation in neurons of the 
central nervous system by creating a c-Jun neuronal knock out (c-junΔn). Following 
facial nerve injury, c-junΔn neurons were atrophic and regenerated poorly compared 
to WT. It was therefore concluded that neuronal c-Jun up-regulation is required for 
sufficient axon regeneration (Raivich et al., 2004). This is an alternative function 
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compared to development where c-Jun activation has been demonstrated to induce 
apoptosis in sympathetic neurons in vitro in the absence of nerve growth factor. 
Depletion of c-Jun transcription was able to inhibit apoptosis and enhance cell 
survival (Ham et al., 1995).  
Although c-Jun, Jun B and D are all expressed by Schwann cells in vitro, only c-Jun 
protein is up-regulated in vivo following injury (Stewart, 1995). In Schwann cells, c-
Jun is the master regulator of the of the peripheral nerves response to injury, 










Figure 1.3 | A diagram of c-Jun protein structure 
The c-Jun protein structure, highlighting relevant domains and binding sites. The N terminal 
phosphylation sites Ser 63, 73 and Thr 91 and 93 are located next to the delta (𝛿) domain. The delta 
domain regulates the phosphorylation of these N terminal sites (Adler et al., 1992, 1994). The C 
terminal phosphorylation sites Thr 231, Ser 243 and 249 are also annotated. The DNA‐binding 
domain (DBD) and leucine zipper dimerization domain (LZ) are also located in the C terminus. 












































































Oligodendrocyte Transcription Factor 1 (Olig1) expression in Schwann cells is 
unique to the repair cell phenotype. The expression of Olig1 is more commonly 
observed, as its name suggests, in the glia of the CNS - oligodendrocytes. Olig1 is a 
basic helix–loop–helix (bHLH) transcription factor in the Olig gene family which 
also include Olig2 and Olig3. Olig1 expression, which is controlled by Shh, is 
observed in the ventral spinal cord at E9.5 in mice  (Lu et al., 2000; Zhou et al., 
2000; Takebayashi et al., 2000). Olig1-/- is a non-lethal mouse model that has been 
used to study the role of Olig1 in the CNS. Oligodendrocyte progenitor cell number 
is decreased in these mice and their differentiation impaired. The axons of these mice 
are hypomyelinated as a result of this. Although the initiation of myelination is not 
impaired, Olig1 is required for remyelination, through the differentiation of 
oligodendrocyte progenitor cells (Arnett et al., 2004; Dai et al., 2015).  
Although we have previously reported that Olig1 is not observed during other phases 
of the Schwann cell lineage, a recent report suggests otherwise. Schmid et al (2014) 
have reported Olig1 expression in Remak bundles in P7 mouse nerves. qPCRs of 
nerves throughout postnatal development and adulthood, demonstrated increasing 
levels of Olig1 with Schwann cell maturation. Olig1 was expressed in the cytoplasm 
and nucleus of cultured cells but declined in the presence of cAMP, further enforcing 
the link between c-Jun and Olig1 (Schmid et al., 2014). The role of Olig1 in 
peripheral nerve regeneration has been examined. 4 days after crush, Olig1 null mice 
demonstrate impaired regeneration compared to WT littermates. Fewer regenerating 
axons were observed at various distances in longitudinal sections of these nerves. It 
has however been observed that this regeneration deficit was not maintained. Olig1 
null and WT mice demonstrated equal rates of regeneration at later time points (> 1 
week). This suggests that Olig1 activation in Schwann cells plays a role in the initial 
stages of axon regeneration (S.Quintes, personal communication, unpublished data). 
As Shh is also up-regulated in Schwann cells following injury, it may activate Olig1 






1.6.3 Sonic Hedgehog  
Sonic hedgehog (Shh), with Desert and Indian hedgehog, is a component of the 
hedgehog (Hh) signalling pathway. Hh was famously identified as a Drosophila 
larval patterning gene in the Nobel prize winning work of Christiane Nüsslein-
Volhard and Eric F. Wieschaus (Nüsslein-Volhard & Wieschaus, 1980). Shh was 
named by Robert Riddle, a post-doc in the Tabin laboratory at Harvard University 
Massachusetts who first described the role of Shh in limb anteroposterior patterning 
(Riddle et al., 1993). Neural patterning and polarity in the developing CNS is 
controlled by Shh signalling. The differentiation of floor plate cells, motor neurons 
and ventral interneurons is mediated by Shh signalling from the notochord. 
Inhibition of signalling prevents the formation of the spinal column and 
differentiation of motor neurons (Martí et al., 1995; Roelink et al., 1995; Ericson et 
al., 1996; Chiang et al., 1996).  
As previously mentioned, the Hh signalling pathway was initially determined in 
Drosophila. Here, a simplified version of pathway is described: Hh binds to Patched, 
a 12-pass transmembrane protein receptor. (Marigo et al., 1996; Stone et al., 1996). 
The binding of Hh removes Patched inhibition on Smoothened (Smo), a 7-pass 
transmembrane protein and G-protein coupled receptor (Chen & Struhl, 1996; 
Alcedo et al., 1996). Once the repression of Smo is alleviated, it translocates to the 
cell membrane (Zhu et al., 2003) where it activates the GLI transcription factors 
(Gli1, Gli2 and Gli3) (Hynes et al., 1997; Altaba, 1998). It is now known that Smo 
translocates to the cell membrane in the primary cilium. Cyclopamine antagonises 
the Hh pathway by binding directly to Smo and inhibiting Smo activity by 
preventing this translocation (Cooper et al., 1998; Incardona et al., 1998; Chen, 
Taipale, Cooper, et al., 2002; Huangfu et al., 2003; Corbit et al., 2005). Agonists of 
the Hh pathway such as purmorphamine and smoothen agonist (SAG) similarly 
activate signalling through direct binding with Smo (Chen, Taipale, Young, et al., 
2002; Wu et al., 2004; Sinha & Chen, 2006). Figure 1.4 provides a basic summary of 
Hh signalling.  
Shh is not expressed by myelin Schwann cells or during development but is rapidly 
up-regulated upon nerve injury in both neurons and Schwann cells (Arthur-Farraj et 
al., 2012; Lin et al., 2015; Martinez et al., 2015). Shh is neuroprotective and supports 
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axon growth. Martinez et al (2015) demonstrated reduced neurite out growth and 
branching was observed in dissociated DRG cultures that were transfected with Shh 
siRNA (Martinez et al., 2015). In vivo it has been demonstrated that inhibition of Hh 
signalling after injury through cyclopamine application increases motor neuron death 
whereas application of Shh to nerves following injury improves regeneration 
(Pepinsky et al., 2002; Akazawa et al., 2004; Hashimoto et al., 2008; Bond et al., 
2013). The neuroprotective effects of Shh are attributed to the activation of BDNF. 
Hashimoto et al (2008) demonstrated this in vivo by continuously applying 
cyclopamine to the sciatic nerve after injury. This down-regulated Gli1 activity and 
subsequently decreased BDNF RNA and protein expression. Schwann cell cultures 
incubated with Shh significantly up-regulated Gli1 and BDNF expression whereas 












Figure 1.4 | A simplified diagram of Hh signalling  
(A) In the absence of Hh signalling, Patched inhibits smoothened, preventing its translocation to the 
cilium. Gli transcriptional activation is repressed. (B) In the presence of Hh (Shh, Dhh or Ihh), Hh 
binds to Patched, removing the inhibition of smoothened which moves into the cilium. GLI is 















1.6.4 Brain-derived neurotrophic factor  
BDNF, like other members of the neurotrophin family to which it belongs, exists as 
a homodimer in its active form. BDNF was first isolated from the pig brain where its 
contribution towards neurite outgrowth and survival of sensory neurons in vitro was 
noted (Barde et al., 1982). It is expressed prominently in the CNS, however 
expression has been localised in internal organs including the stomach, liver, lungs, 
kidneys and colon (Leibrock et al., 1989; Lommatzsch et al., 1999).  
Activation of the BDNF pathway contributes to a signalling network composed of 
129 molecules (Sandhya et al., 2013). BDNF signals through its receptor trkB which 
is expressed throughout the central and peripheral nervous systems of both rodents 
and humans  (Squinto et al., 1991; Klein et al., 1989; Allen et al., 1994; Klein et al., 
1990). When the active signalling form of trkB is knocked out in mice the mice do 
not survive postnatally, due to their inability to feed due to motor and sensory 
abnormalities. A reduction in neural numbers was observed both centrally, in the 
facial motor nucleus and in the periphery. DRGs were reduced in size and contained 
fewer neurons. This demonstrates the importance of BDNF/trkB signalling in the 
developing nervous system (Klein et al., 1993). BDNF also binds with low affinity 
with the p75 NTR receptor, which will be described later.  
Following peripheral nerve injury, BDNF is gradually up-regulated in the distal 
nerve stump. A significant elevation is only observed 7 days post transection and 
levels continue to increase up to 28 days post injury. This suggests the up-regulation 
observed in these studies is Schwann cell specific (Meyer et al., 1992; Funakoshi et 
al., 1993). BDNF up-regulation in motor neurons is far more rapid and short lived. 
Following axotomy of the facial nerve, BDNF mRNA is detected in motor neurons 
3-8 hours following injury. mRNA levels peak after 1-2 days however protein 
remains elevated for 1 week (Kobayashi et al., 1996).  
BDNF aids axon regeneration in the PNS. When endogenous BDNF signalling is 
inhibited with BDNF antibodies, axon regeneration is reduced by 24%. 
Remyelination is impaired likely due to the observed Schwann cell death and axon 
degeneration (Zhang et al., 2000). Similarly, when a nerve graft genetically lacking 
BDNF is used to repair an injured nerve, axon regeneration into the graft is poor 
(Wilhelm et al., 2012). Although exogenous application has been shown to enhance 
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peripheral nerve growth, the contribution of BDNF to axon regeneration is dose-
dependent. BDNF at low concentrations promotes axon regeneration in the injured 
peripheral nervous system. When a low dose (0.5-2µg) of exogenous BDNF is 
applied to the sciatic nerve every day following chronic denervation, axons 
regenerate well. However higher levels of 12-20 µg inhibit regeneration through p75 
NTR signalling (Boyd & Gordon, 2002a). 
 
1.6.5 p75 neurotrophin receptor 
Despite activation of p75 NTR through neurotrophin signalling, p75 NTR belongs to 
the family of tumour necrosis factor receptors. Signalling through this receptor is 
largely associated with apoptosis. Although p75 NTR binds with all members of the 
neurotrophin family, binding has also been observed with neurotoxic prion protein 
fragment PrP (26−106), a glycoprotein of the rabies virus envelope and the Aβ 
peptide of the amyloid precursor protein, inducing apoptosis (Kuner et al., 1998; 
Tuffereau et al., 1998; Della-Bianca et al., 2001). Apoptotic pathways are thought to 
be activated by the globular six-helix ‘death’ domain located in the juxtamembrane 
and carboxy-terminal domains. Activation of this domain has been demonstrated to 
activate apoptosis through calpain and caspase signalling (Liepinsh et al., 1997; 
Coulson et al., 2000). Activation of p75 NTR in vitro has induced apoptosis in 
embryonic motor and sensory neurons (Sedel et al., 1999; Barrett & Bartlett, 1994), 
neonatal sympathetic neurons (Bamji et al., 1998) and mature oligodendrocytes 
(Casaccia-Bonnefil et al., 1996). 
In Schwann cells, p75 NTR is often used as a cell marker. It is expressed throughout 
Schwann cell development and in Remak cells. Signalling through the receptor has 
been shown to regulate myelination in vitro. Inhibition of the receptor with blocking 
antibodies reduces the expression of myelin proteins MAG and P0 (Cosgaya et al., 
2002) and p75 NTR null mice develop thin myelin sheaths, likely due to the reduced 
expression of these myelin proteins (Gjerstad et al., 2002; Song et al., 2006; Tomita 
et al., 2007). The control of myelination in vivo by p75 NTR is controlled by a series 
of downstream signalling cascades (Tep et al., 2012). Following peripheral nerve 
injury, it is gradually up-regulated in Schwann cells, peaking around 1 week post 
injury. Levels are seen to decline with the re-emergence of axons into the nerve 
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(Heumann et al., 1987; Taniuchi et al., 1988; You et al., 1997). The role of p75 NTR 
signalling in regeneration is complex. Many reports and observations have been 
made suggesting that p75 NTR activation is harmful to Schwann cells and 
regeneration. Inhibition of p75 NTR in neurons and glia reduces Schwann cell 
apoptosis (Firouzi et al., 2011), neurodegeneration induced by oxidative stress 
(Bradley R Kraemer et al., 2014) and enhances axon regeneration (Boyd & Gordon, 
2001). Conversely, reports also demonstrate the importance of p75 NTR in 
regeneration. p75 NTR null mice display poor remyelination following sciatic nerve 
crush (likely due to the role of p75 NTR in the control of myelination) (Song et al., 
2006), reduced apoptosis in P1 nerves following axotomy (Syroid et al., 2000) and 
impaired motor neuron regeneration and functional recovery (Tomita et al., 2007). 
The effect of p75 NTR signalling is dependent on the receptor partner binding 
interactions. Heterodimerisation with trk receptors promotes survival, differentiation 
and growth. Axon regeneration is inhibited through association with Lingo-1 and the 
Nogo receptor whereas apoptosis is induced by Sortilin association (Mi et al., 2004; 
Skeldal et al., 2012; Kraemer et al., 2014; Meabon et al., 2015).   
 
1.6.6 Glial cell-derived neurotrophic factor 
GDNF is a distant member of the transforming growth factor-β family. GDNF was 
originally purified from rat B49 cells, a glial cell line. It was characterisend as a 
glycosylated, disulfide-bonded homodimer that supported survival and 
differentiation of dopaminergic neurons in vitro (Lin et al., 1993). It was later 
demonstrated to be 75x more potent than members of the neurotrophin family in 
promoting motorneuron survival. GDNF however has no effect on embryonic 
sensory neuron survival (Henderson et al., 1994). Outside the nervous system, 
GDNF regulates the development of the kidney (Pichel et al., 1996; Sainio et al., 
1997) enteric neurons (Sánchez et al., 1996) and spermatogonia differentiation 
(Meng et al., 2000). GDNF signalling is mediated by binding GDNF-family 
receptor-α (GFRα) receptors, with GDNF preferentially associating with GFRα1. 
(Jing et al., 1996; Wong & Too, 1998; Treanor et al., 1996). GDNF binding 
stimulates dimerization of GFRα with the RET receptor tyrosine kinase, promoting 
signalling through this pathway. However GDNF does not initiate RET dimerization 
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as when GDNF binding is inhibited, RET signalling is still activated (Eketjäll et al., 
1999). RET activates various pathways, including phosphatidylinositol 3-kinase 
(PI3K)/AKT, JNK and p38 MAPK (Worby et al., 1996; Chiariello et al., 1998; Soler 
et al., 1999).  
GDNF is expressed in Schwann cell precursors and the peripheral nerve at E14.5, 
however it is not observed in immature or mature Schwann cells (Henderson et al., 
1994; Arthur-Farraj et al., 2012). Application of exogenous GDNF to intact adult 
nerves has resulted in myelination of previously unmyelinated small diameter fibres 
and enhanced Schwann cell proliferation (Höke et al., 2003). In Schwann cells, 
GDNF is a direct target of c-Jun activation. In c-Jun cKO nerves, the endogenous 
application of GDNF and artemin alleviates the regeneration defects associated with 
this knock out (Fontana et al., 2012). Following nerve injury, GDNF and GFRα are 
elevated in the distal nerve stump, with expression peaking at 1 week post injury 
(Naveilhan et al., 1997; Höke et al., 2000, 2002). Activation occurs in both myelin 
and Remak cells (Xu et al., 2013). In humans, GDNF is highly up-regulated in the 
peripheral nerve distal to the injury. Expression is observed in both Schwann cell and 
DRG neurons, whereas RET expression is confined exclusively to DRG neurons and 
axons (Bär et al., 1998). When the neuronal response to GDNF is inhibited through 
abolition of RET receptors, axon regeneration is impaired (Fontana et al., 2012). 
Many studies are now utilising GDNF as a method for enhancing nerve repair 












1.7 Factors affecting peripheral nerve regeneration  
Despite the activation of the repair cell phenotype following injury and although the 
PNS does have an intrinsic capacity for regeneration, functional recovery in humans 
is poor. This is due to the fact that axons must travel long distances to reinnervate 
their targets. As axons regenerate at a rate of 1-2mm/day (Buchthal & Kühl, 1979), it 
can take months or even years for them to reach their targets. During this time, the 
initially growth permissive capabilities of both the axons and the Schwann cells 
decline, contributing to the poor regeneration observed. The effects of the declining 
regenerative capacity of the nerve are therefore present proximally and distally to the 
injury in the forms of chronic axotomy and denervation.  
 
1.7.1 Chronic axotomy  
For regeneration to occur, the axon must maintain its capacity to grow. It is 
debatable if chronic axotomy, in which axons proximal to the injury site are 
prevented from regenerating, affects repair. Holmes and Young (1942) transected the 
tibial nerve in rabbits and following 1 year of chronic axotomy, sutured the proximal 
stump to a freshly cut distal nerve stump of the common peroneal. They found no 
effect in the number of axons or the rate at which they regenerated between 
chronically axotomized and immediately repaired nerves (Holmes & Young, 1942). 
Conversely however, the work of Tessa Gordon claims that chronic axotomy does 
affect regeneration. Using the same paradigm as Holmes and Young, it was 
demonstrated that the number of regenerating motor neurons was significantly 
reduced following chronic axotomy. When the nerve was immediately repaired, 137 
regenerating motor neurons made functional connections with the muscle. However, 
following chronic axotomy for any period over 6 months, only 50 motor neurons 
made functional connections. It was however noted that motor neuron branching and 
muscle fibre reinnervation were not affected (Fu & Gordon, 1995). This finding was 
later reinforced by examining motor neuron regeneration with retrograde labelling in 
the same model. The results demonstrated a significant decline in motor neuron 
regeneration following chronic axotomy (Boyd & Gordon, 2002b, 2003). Further 
studies have confirmed that this finding occurs even after only 2 months of axotomy 
(Furey et al., 2007). It could be argued however that these results are due to motor 
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neuron death. After injury, 20-30% of sensory neurons die in the adult DRG (Himes 
& Tessler, 1989). This effect is not observed in motor neurons however, the numbers 
of which are unaltered by axotomy (Carlson et al., 1979). This question was 
definitively answered by Xu et al (2010) who examined motor neuron numbers in 
uninjured, chronically axotomized and repaired chronically axotomized nerves. No 
difference in the number of motor neurons was observed between the first 2 groups, 
however after repair, only 50% of the neurons regenerated (Xu et al., 2010). It may 
be the Holmes and Young’s observation is due to axonal sprouting, which is not 
representative of the number of neurons and could have over-estimated the number 
that are present. These experiments were also performed in rabbits so differences 
may be observed between species.  
 
1.7.2 Chronic denervation  
Following axotomy, the Schwann cells distal to the injury up-regulate the repair cell 
phenotype as previously described. One of the defining features of this is the up-
regulation of trophic factors that support axonal growth. GDNF is rapidly up-
regulated in the days following injury (Naveilhan et al., 1997; Höke et al., 2000, 
2002) whereas BDNF’s increase is gradual  (Meyer et al., 1992; Funakoshi et al., 
1993). This regenerative environment however is not maintained and declines with 
time in a process referred to as the deterioration of the distal nerve stump. This 
process is well defined and characterised by the decrease in trophic support and 
Schwann cell death. p75 NTR expression, although initially highly up-regulated 1 
week after injury, begins to decline thereafter. Expression gradually declines for the 
first 6 months, after which the level is barely detectable. In situ hybridisation and 
dual labelling with S100 antibodies have demonstrated that this decline is Schwann 
cell specific (Heumann et al., 1987; Taniuchi et al., 1988; You et al., 1997).  
The same is true of GDNF expression. GDNF is rapidly up-regulated following 
injury and is detectable within the first 48 hours. Expression peaks 1 week after 
injury, after which levels steadily decline over time. Levels are almost undetectable 
after 6 months of denervation. Interestingly, the expression of GDNF’s receptor 
GFRα1 does not correlate with ligand expression. GFRα1, although up-regulated 
following injury, does not peak in expression until 3 months of denervation have 
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passed. Although reduced, levels of the receptor remain elevated even at 6 months. 
This is likely a compensatory mechanism, induced by autocrine signalling (Höke et 
al., 2000, 2002; Michalski et al., 2008; Eggers et al., 2010).  
As previously mentioned, BDNF’s up-regulation in Schwann cells is gradual with 
levels peaking 1 month following injury. Over the following month BDNF mRNA 
expression then decreases by half. Following 6 months of denervation BDNF mRNA 
levels are similar to those expressed 1 week after injury but protein expression is 
shown to be equal to that expressed in uninjured nerves after 4 months of 
denervation (Michalski et al., 2008; Eggers et al., 2010).  
One of the causes of the decrease in trophic factor expression could be due to the 
reduced number of Schwann cells present in the nerve. Following injury, the number 
of Schwann cells in the distal nerve stump increases to approximately 3x of that 
present in uninjured nerves during the first 20 days. A slow decline in number is then 
observed. This is noted regardless of the length of the study and after 10 week 
denervation, Schwann cell numbers have declined to those observed in uninjured 
nerves (Abercrombie & Johnson, 1946; Weinberg & Spencer, 1978; Siironen et al., 
1994; Benito et al., 2017). The disappearance of Schwann cells in the nerve results in 
the very gradual fading of the bands of Büngner. While it was initially hypothesised 
that the shrinkage and eventual disappearance of the bands could be caused by cell 
migration towards regenerating axons, due to the presence of necrotic cells observed 
in the nerve, apoptosis is likely the cause (Abercrombie & Johnson, 1946; Thomas, 
1966; Weinberg & Spencer, 1978) 
A secondary response to chronic denervation is the ability of the muscle to accept 
reinnervating nerves. Muscle maintenance requires both neurotrophic and electrical 
stimulation, both of which are lost during chronic denervation (Gibson et al., 1988; 
Chevrel et al., 2006). Without input, the muscle becomes atrophic and some studies 
report signs of necrosis. A decline in muscle mass is observed during the first week 
of denervation and mass continues to steadily decline with time. (Fu & Gordon, 
1995; Cockman et al., 2001; Dow et al., 2004; Jonsson et al., 2013). The cross 
sectional area of fibres is reduced and although initially the fast type 2 fibres are 
more susceptible to atrophy, some studies find during chronic denervation all fibres 
are effected equally (Viguie et al., 1997; Bobinac et al., 2000; Ashley et al., 2007). 
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The tetanic tension and force of the muscle declines as a result of this (al-Amood et 
al., 1991; Fu & Gordon, 1995) and fibrous collagen and adipose tissue builds up in 
the muscle (Lu et al., 1997; Ashley et al., 2007).  
Muscle satellite cells which are required to the generation of new tissue in adult 
muscle also decline in number during chronic denervation (Dedkov et al., 2001; 
Viguie et al., 1997). BDNF is required for the differentiation of muscle satellite cells 
(Clow & Jasmin, 2010). Although BDNF is expressed in muscle following nerve 
injury, its expression is largely Schwann cell specific (Griesbeck et al., 1995; Omura 
et al., 2005). The down-regulation of BDNF in chronically denervated Schwann cells 
therefore hinders the regeneration of muscle fibres. Together, these factors result in 
poor functional recovery and a reduced target innervation from the regenerating 
nerves.  
The deterioration of the distal nerve stump implies that the repair cell phenotype is 
not maintained during chronic denervation. Stat3 was recently highlighted as a 
transcriptional regulator of the repair cell phenotype. Stat3 is phosphorylated in 
Schwann cells after injury (Sheu et al., 2000; Lee et al., 2009) and remains 
somewhat elevated during chronic denervation. When Stat3 is knocked out in 
Schwann cells, no difference is observed in the activation of the repair cell 
phenotype. However, during chronic denervation, c-Jun and repair cell markers such 
as GDNF, BDNF, Shh and Olig1 are significantly decreased in mutant nerves. 
Schwann cell survival is affected and fewer Schwann cells are observed in 
chronically denervated stumps. Irregular bands of Büngner form in shapes related to 
those observed 4 weeks after injury in the c-Jun cKO mouse. This demonstrated that 
Stat3, although not required for the activation of the repair cell phenotype, is 
required for maintenance during chronic denervation. The decrease in c-Jun 
expression and the repair cell phenotype suggests that Stat3 signals up-stream from 
c-Jun (Benito et al., 2017).  
This thesis will however focus on the role of c-Jun in maintaining the Schwann cell 





1.8 Aging  
The changes that occur with age are not simply confined to the greying of our hair 
and the wrinkling of our skin. Changes are observed in many systems and at every 
level. The telomeres of our chromosomes shorten, DNA becomes damaged, leading 
to the dysregulation of genes and proteins, cell to cell communication is impaired 
and regenerative systems fail. The nervous system is not exempt from the effects of 
aging and this is often observed in the form of motor and cognitive impairment. With 
advanced aging, the structure, function and regeneration of the PNS all undergo 
change.  
 
1.8.1 Structural and functional changes in the peripheral nerve with age  
The primary function of the PNS is to relay signals to and from the CNS via the 
propagation of action potentials. The ability of the PNS to perform this role is 
measured by the conduction velocity, the speed at which electrical impulses travel 
through nerves. Conduction velocity of peripheral nerves increases during youth and 
early adulthood and is associated with the maturation of the nervous system. This 
observation is conserved between rodents (Birren & Wall, 1956; Sato et al., 1985; 
Verdú et al., 1996) and humans (Rabben, 1995). These observations are refined to 
myelinated fibres, with unmyelinated fibres maintaining a constant conduction 
velocity (Sato et al., 1985).  These observations are therefore likely due to the 
progressive myelination of the nerves, that continues through early adulthood and is 
the likely reason for plateaus observed in the data of young animals. Decreases in 
conduction velocity however are observed with advancing age. This is well 
documented in humans, with impairments observed in both motor and sensory 
nerves (Dorfman & Bosley, 1979; Bouche et al., 1993), a phenomenon also observed 
in rodents (Verdú et al., 1996).  
As well as conveying electrical signals, peripheral axons must also physically relay 
information in the form of axonal transport. Axons in the PNS stretch across long 
distances between neuronal cells bodies and their targets. Information in the form of 
lipids, proteins and organelles is transferred between the axon and cell body by 
antero and retrograde transport. A decline in the rate of axoplasmic transport is 
observed with age. McQuarrie et al (1989) demonstrated a 40% decrease in axonal 
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transport in both the sciatic and optic nerves of 24 month old mice when compared 
to those aged 6 months (McQuarrie et al., 1989). Stromska and Ochs (1982) reported 
a similar, if not as steep a decline in axonal transport between 3 and 37-38 month old 
rats (Stromska & Ochs, 1982). More specifically, it has also been shown that the 
transport of choline acetyltransferase, an enzyme required for acetylcholine 
synthesis, is transported 5x faster in the sciatic nerves of young mice compared to 
old (Jablecki & Brimijoin, 1975) 
The changes observed in nerve function with age are likely due to structural changes 
in nerve architecture. Although nerves maintain a level of relative morphological 
stability during adulthood, age-related changes become apparent with time. Ceballos 
et al (1999) studied these changes at length in the mouse, examining various ages 
and morphological parameters. Although no differences in the number of Schwann 
cells was reported, abnormalities in myelin were observed. Myelin loops formed 
irregular shapes around the axons and the number of myelinated and nonmyelinated 
fibres steadily declined with age, an observation commonly reported in the sciatic 
nerves of humans (Swallow, 1966; O’Sullivan & Swallow, 1968; Jacobs & Love, 
1985; Kanda et al., 1991) and rats (Sharma et al., 1980). The number of resident 
macrophages present in the nerve was also seen to increase (Ceballos et al., 1999). 
The thickness of the myelin that remains decreases with age (Ugrenović et al., 2016) 
and its composition is altered. Decreases in mRNA expression of myelin proteins 
MBP, PMP22 are observed with age. A decline in P0 expression is also observed at 
both the mRNA and protein levels (Melcangi, Magnaghi, Cavarretta, Martini, et al., 










1.8.2 Regeneration in the aging peripheral nervous system  
Impaired healing and regeneration after injury is observed in many systems with 
advancing age. Liver (Bucher et al., 1964; Fry et al., 1984; Biondo-Simões et al., 
2006), lung (Paxson et al., 2011) and skeletal muscle regeneration (McGeachie & 
Grounds, 1995), CNS remyelination (Shields et al., 1999), bone fracture (Meyer et 
al., 2001; Lu et al., 2005) and wound healing (Quirinia & Viidik, 1991; Ashcroft et 
al., 1997; Gosain & DiPietro, 2004) are all impaired with age. Regeneration in the 
peripheral nervous system is similarly affected, with functional impairment observed 
in both neurons and glia.  
 
1.8.2.1 The axonal response  
The age associated decline in peripheral nerve regeneration has been well 
documented. In rabbits, pinch tests (during with the nerve is re-exposed after an 
injury and pinched distally, a response that is equated to the distance regenerated) of 
crushed sciatic nerves demonstrate reduced response with age. This decline is very 
slight, however a greater response is observed in functional recovery. Toe spreading 
in older rabbits was found to be significantly lower after injury. This suggests a 
delay in target reinnervation (Gutmann et al., 1942). Black and Lasek (1979) 
demonstrated that the difference in the initial response to regeneration is not vastly 
impaired in old rats. 4 days after crush, although old rats displayed reduced motor 
neuron regeneration, the difference between young and old mice was not so 
different. However 8 days after crush, the effect of age was evident with an increased 
number of regenerating axons observed in younger rats (Black & Lasek, 1979). This 
response has been confirmed at 9 days after crush. Pestronk et al (1980) documented 
that 9 days after crush, the majority of regenerating axons in 2 month old rats had 
reached 24mm, axons in 10 month old rats had regenerated 12mm whereas axons in 
28 month old rats had only reached 3mm from the crush site. They similarly reported 
no major difference in regeneration between age groups 4 days after crush (Pestronk 
et al., 1980).  
Following injury, axon regeneration is initiated by sprouting whereby fine nerve 
processes extend from the intact axons of the proximal stump. In young mice, after 
crush injury, axon sprouts are observed 4 days after injury and increase in number 
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over a 2 week period. This initial response is similarly observed in older mice but is 
not maintained and a reduction is sprouting is observed (Vaughan, 1992). This 
reduction in axonal sprouting with age has been supported by other work (Pestronk 
et al., 1980). The reduced axonal transport described here previously, as well as the 
axons reduced capacity to respond to neurotrophins is also likely to contribute 
(Parhad et al., 1995). Axons that do regenerate are reported as being smaller in 
diameter with a thinner myelin sheath (Tanaka et al., 1992). However more recent 
work is proposing that the impaired regeneration seen in aged animals is occurring 
independently of the axon. Studies are now demonstrating that the regenerative 
capacity of the axon is maintained throughout life (Kang & Lichtman, 2013; Painter 
et al., 2014). It is instead the environment in which that regeneration is taking place 
that is impaired. This is mainly controlled by the Schwann cell and macrophage 
response to injury.  
 
1.8.2.2 The Schwann cell and macrophage response  
As previously described in this chapter, an essential aspect of regeneration is myelin 
clearance, mediated by both Schwann cells and macrophages. In young animals this 
readily occurs however with age, myelin debris persists (Tanaka & Webster, 1991; 
Vaughan, 1992). Kang and Lichtman (2013) performed a detailed time-lapse 
analysis of axon regeneration in young and aged mice. They demonstrated that axon 
growth in older regenerating nerves is continuously halted by axon and myelin 
debris. Once axons had passed the debris and reached the neuromuscular junction, 
synapse reinnervation readily occurred (Kang & Lichtman, 2013).  
The persistence of myelin debris in the nerve could be due to a variety of factors. As 
mentioned previously, the myelin composition in aged nerves is different to young. 
This could impair the ability of macrophages and Schwann cells to break it down. 
However, parabiosis experiments, in which a young mouse is joined to an older 
mouse, demonstrate the ability of the young macrophages to clear myelin debris in 
the old CNS (Ruckh et al., 2012). Painter et al (2014) demonstrated that macrophage 
recruitment is impaired in old nerves. It has previously been demonstrated that 
macrophage suppression can diminish the regenerative response in young mice 
(Tanaka et al., 1992). However parabiosis studies performed by Painter et al (2014), 
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where young mice were joined to old, were unable to rescue the regenerative 
capacity of aged nerves. It is more likely that the impairment in myelin clearance lies 
in the intrinsic capacity of Schwann cells. Schwann cells from young and old nerves 
cultured in the presence of myelin display different rates of myelin clearance. A 
similar observation is conserved in vivo where Schwann cell internalization of 
myelin is delayed in aged nerves following injury. Due to nerve grafts from young 
mice enhancing axon regeneration in old nerves, it is therefore likely that the age 
associated decline in regeneration is Schwann cell specific (Painter et al., 2014) .  
Painter et al (2014) go on to investigate the activation of the repair cell phenotype, 
the importance and induction of which was discussed previously in this chapter. 
Genetic screens of young and old nerve following injury revealed an impairment in 
the activation of several repair cell marker genes as well as an inhibition of myelin 
gene down regulation. c-Jun is highly up-regulated in young nerves 1 day after 
injury. This elevation is not observed in old mice, however levels of c-Jun gradually 
increase with time post injury at both ages. It is therefore suggested that the 
diminished regenerative capacity of peripheral nerves observed with advancing age 
is due to a delay in the activation of the repair cell phenotype (Painter et al., 2014). 
The field must now adjust its views on aging to accept that the deficits in 













1.9 Current treatments in peripheral nerve repair  
The greatest advances in peripheral nerve repair were made over half a century ago 
following World War II. During this time clinicians were exposed to large numbers 
of patients presenting with peripheral nerve injuries and were able to develop our 
understanding on how best to treat them. The majority of early treatments involved 
simply suturing the transected nerve back together (often described as end to end 
suture) (Platt & Bristow, 1924) (Seddon, 1947). It was believed that the stretching of 
the nerve aided its repair. However, it was later presented, as we now know, that this 
is not the case. Stretching the nerve over large gaps leads to extensive damage that 
prevents functional recovery (Highet & Sanders, 1943); Highet and Holmes, 1943). 
End to end suture is still a valuable technique for smaller nerves gaps. It has been 
developed further to enhance repair whereby fascicles are separated in both nerve 
stumps, matched and sutured together. This technique is however very delicate and 
increases risks of microbleeds and scarring (Lundborg, 1987).  
A solution therefore had to be found to repair transected nerves where large gaps 
were present. Thus began the process of nerve grafting, using donor nerves to fill the 
gaps. Little success was initially observed with hetero and homogenous grafts. 
Heterogenous grafts were discredited as an idea very early. Homogenous grafts, in 
the form of nerves taken from other members of the same species, were found to 
become necrotic and become replaced by connective tissue (Seddon et al., 1942). 
Little regeneration is observed into these grafts even during long-term studies 
(Spurling et al., 1945). Autogenous grafts however proved highly successful. 
Autographs survived and featured Schwann cell proliferation and formation of the 
bands of Büngner. Myelin clearance and remyelination are also observed (Seddon et 
al., 1942; Titrud, 1947; Seddon, 1947; Aguayo et al., 1976). Grafts initially survive 
from the diffusion of molecules from the surrounding tissues before revascularisation 
begins a few days later (Almgren, 1975).  
Autografts however give rise to various issues. Grafts are mainly obtained from the 
sural nerve due to its accessibility and thickness (Lundborg, 1987). The sural nerve 
is a sensory nerve and removing part of it reduces somatosensory function in 
patients. Furthermore, motor neurons preferentially reinnervate motor pathways and 
shown reduced regeneration into sensory branches (Brushart, 1988). Repair with a 
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sensory autograft has been shown to result in less successful regeneration with 
improved regeneration seen in the use of motor or mixed nerve grafts (Nichols et al., 
2004). Patients with larger nerve gaps may also not be able to provide enough graft 
material. Many studies are now aiming to create artificial nerves in vitro for grafting.  
There are many studies aiming to determine the best material and properties of tubes 
to emulate nerves and to enhance regeneration. The most common composition is 
collagen type 1 with aligned Schwann cells. Tubes with cells are shown to improve 
nerve regeneration compared to empty tubes (Phillips et al., 2005; Georgiou et al., 
2013). However this procedure if yet again limited by the amount of neural tissue the 
patient can provide as Schwann cell cultures must be generated. Many studies are 
now generating Schwann-like cells from sources such as adipose-derived stem cells 
(Jiang et al., 2008), human dental pulp (Martens et al., 2014) and hair follicle stem 
cells (Amoh et al., 2005) which have been shown to improve nerve regeneration 
across gaps. However when much larger gaps are present (15mm in rat, 6mm in 
mice) regeneration is poor or not observed (Lundborg et al., 1982; Gómez et al., 
1996). Indeed longer grafts have been associated with an increased rate of Schwann 
cell senescence (Saheb-Al-Zamani et al., 2013). In animal models, these grafts never 
achieve the rate of regeneration seen with autografts of peripheral nerves. 
Electrical simulation has been shown to enhance nerve regeneration in models of 
both chronic axotomy and denervation (Al-Majed, Neumann, et al., 2000; Elzinga et 
al., 2015). Electrical stimulation increases the up-regulation of regeneration 
associated genes (Geremia et al., 2007) and activates trophic factors GDNF and 
BDNF (Al-Majed, Brushart, et al., 2000; Willand et al., 2016). New studies are 
aiming to pharmaceutically enhance the regenerative capacity of the axons and 
Schwann cells that are currently in the nerve. Many studies demonstrate enhanced 
regeneration following the application of trophic factors (Boyd & Gordon, 2002b, 
2003; Lang et al., 2008; Wood et al., 2012, 2013). Studies investigating regeneration 
in crushed nerves have found Shh to enhance regeneration in both the sciatic 
(Pepinsky et al., 2002) and cavernous nerve (Bond et al., 2013; Angeloni et al., 
2013).  
Other work focuses on the effects of nerve regeneration from drugs that are already 
approved in humans by the US Food and Drug Administration. FK506 is an 
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immunosuppressant commonly administered to prevent organ rejection following 
transplant (Starzl et al., 1989). FK506 has been demonstrated in vitro to enhance 
neurite growth (Lyons et al., 1994) and in vivo enhances regeneration following 
nerve grafting or sciatic nerve crush (Gold et al., 1994, 1995; Doolabh & 
Mackinnon, 1999; Lee et al., 2000). During chronic injury however, FK506 is only 
able to improve motor neuron regeneration in models of chronic axotomy, not 
chronic denervation (Sulaiman et al., 2002) suggesting FK506 cannot restore the 
regenerative capacity of Schwann cells.  
Ibuprofen is non-steroidal anti-inflammatory painkiller that has been suggested to 
improve nerve regeneration when administered directly to the injury site (Raisi & 
Mohammadi, 2015). Evidence for this however is poor. Although functional 
recovery is improved in rats receiving the drug, control littermates show no signs of 
recovery, an unusual finding for a rodent regeneration study. Furthermore, although 
functional improvements are present, no difference in the number of regenerating 
neurons is observed and only a slight improvement in remyelination is documented 
(Madura et al., 2011).  
Although many scientific studies have aimed to enhance nerve regeneration, very 
few clinical advances have been made in this field. The gold standard for nerve 
repair remains the use of autografts. This thesis aims to aid our understanding of the 
effects of chronic denervation and advancing age and apply these findings to restore 











1.10 Aims  
The work in this thesis aims to contribute to our understanding to peripheral nerve 
regeneration deficits. Transgenic mouse lines will be generated and utilised to restore 
the regenerative capacity of peripheral nerves. Although each chapter will set out to 
achieve smaller, individual aims, the overall aims of this work are to: 
1. Determine if c-Jun and thus the repair cell phenotype are maintained 
following chronic denervation (Chapter 3). 
2.  Determine if c-Jun and the repair cell phenotype can be maintained during 
chronic denervation (Chapter 4). 
3. Determine if maintaining c-Jun restores the regenerative capacity of the nerve 
following chronic denervation (Chapter 5). 
4. Confirm if c-Jun activation is impaired in aged nerves following injury 
(Chapter 6). 
5. Determine if restoring c-Jun activation restores the regenerative capacity of 
aged nerves (Chapter 6). 
6. Determine if c-Jun can be pharmacologically activated by Hh signalling 














2. Materials and methods  
 















10ml 2.50% Agar Scientific 
0.2 M 
cacodylate 
buffer (pH 7.3) 
50ml 0.1M N/A 




Component Amount Company 
Agar 12g Agar Scientific 
DDSA 8g Agar Scientific 














10x PBS, use at 1x diluted in ddH20: 
 
Component Amount Company 
NaCl 80g Fisher Scientific 
Na2HPO4 11.5g Sigma 
KCl 2g Sigma 
KH2PO4 2g Sigma 




Component Amount Company 
FBS 20ml Perbio 


















Tissue Culture  
 
100ml defined medium: 
 
Component Amount Final Concentration Company  
DMEM/F12 
(1:1) 
100ml 100% Invitrogen 
Glutamine 2ml 2mM Sigma 
BSA 1ml 0.04% Sigma 
Putrescine 1ml 16μg/ml Sigma 
Transferrin 1ml 100 mg/ml Sigma 
T4 (L-
Thyroxine) 
100μl 400 ng/ml Sigma 
Progesterone 100μl 60 ng/ml Sigma 
Insulin 100μl 10-6M Sigma 
Dexamethasone 77μl 38 ng/ml Sigma 
T3 (L-
Thyronine) 
10μl 10.1 ng/ml Sigma 
Selenium 10μl 160 ng/ml Sigma 
 






FBS 3% Perbio 
NRG-1 10ng/ml in PBS R+D Systems 
















NRG-1 10ng/ml R+D Systems 
Forskolin 2μM Calbiochem 
 
Cell lysis buffer: 
 














Western Blotting  
 
RIPA buffer, for 20.2ml, use 75µl per sample: 
 
Component Amount Company 

















5x Laemmli buffer, use at 1x: 
 
Component Amount Company 
1M Tris pH 6.8 1.25ml Sigma 
20% SDS 5ml BDH 










8% resolving gel, 1 gel:  
 
Component Amount Company 
ddH2O 6.8ml N/A 








10% SDS 125μl BDH 
10% APS 100μl Sigma 











5% stacking gel, 1 gel:  
 
Component Amount Company 
H2O 3.1ml N/A 










10% SDS 50μl BDH 
10% APS 37.5μl Sigma 
TEMED 7.5μl Sigma 
 
10x running buffer, pH to 8.3, use at 1x diluted in ddH20: 
 
Component Amount Company 
Tris Base 30g Sigma 
Glycine 144G Sigma 
SDS 10g BDH 




Component Amount Company 
48mM Tris 5.82g Sigma 
39mM Glycine 2.93g Sigma 
10% SDS 3.75ml BDH 
100% Methanol 200ml BDH 






10x TBS, use at 1x diluted in ddH20: 
 
Component Amount Company  







Alkaline lysis reagent pH 12 (Hotshot), use 75µl per sample:  
 
Component Amount Company 






ddH20 50ml N/A 
 
Neutralising reagent pH 5, use 75µl per sample: 
 
Component Amount Company 
40mM Tris-HCl 315.2mg Sigma 












2.2 List of antibodies  
 
Primary antibodies – Immunofluorescence  
 
Antibody Host Dilution Diluent Company 
Arginase Goat 1:100 
ADS 0.2% Triton X-
100 
Santa Cruz 






1x PBS 5% DS, 1% 




DAPI N/A Various 1x PBS 
Thermo 
Scientific 
F4/80 Rat 1:200 
ADS 0.2% Triton X-
100 
R + D Systems 
Sox 10 Goat 1:100 
1x PBS 5% DS, 1% 
BSA, 0.1% Triton 
X-100 
R + D Systems 
 
 
Secondary/biotinylated antibodies – Immunofluorescence  
 
Antibody Host Dilution Diluent Company 
Anti-goat (IgG) 
Alexafluor 488 
Donkey 1:1000 1x PBS 
Molecular 
Probes 























Primary antibodies – Western Blotting  
 
Antibody Host Dilution Dilutant Company 


























Secondary antibodies – Western Blotting  
 


























House Keeping Sequence 
Primer conc 
(FWD/REV) 
Calnexin Fwd CAACAGGGGAGGTTTATTTTGCT 
200/300 
Calnexin Rev TCCCACTTTCCATCATATTTGGC 
GAPDH Fwd AGGTCGGTGTGAACGGATTTG 
200/200 
GAPDH Rev TGTAGACCATGTAGTTGAGGTCA 
Yhaz Fwd TAAATGGTCTGTCACCGTCT 
200/300 







BDNF Fwd TCATACTTCGGTTGCATGAAGG 
200/200 
BDNF Rev AGACCTCTCGAACCTGCCC 
c-Jun Fwd (Cells) AATGGGCACATCACCACTACAC 
200/300 
c-Jun Rev (Cells) TGCTCGTCGGTCACGTTCT 
c-Jun Fwd (Tissue) CCTTCTACGACGATGCCCTC 
200/300 
c-Jun Rev (Tissue) GGTTCAAGGTCATGCTCTGTTT 
GDNF Fwd GATTCGGGCCACTTGGAGTT 
200/300 
GDNF Rev GACAGCCACGACATCCCATA 
Olig1 Fwd CCGCCCCAGATGTACTATGC 
200/300 
Olig1 Rev AACCCACCAGCTCATACAGC 
Shh Fwd AAAGCTGACCCCTTTAGCCTA 
200/300 









Primer Sequence (5’- 3’) 
c-JunOE Fwd TGGCACAGCTTAAAGCAGAAA 
c-JunOE Rev GCAATATGGTGGAAAATAAC 
P0 cre Fwd GCTGGCCCAAATGTTGCTGG 
P0 cre Rev CCACCACCTCTCCATTGCAC 
Rosa26 Fwd GGAGTGTTGCAATACCTTTCTGGGAGTTC 
Rosa26 Rev TGTCCCTCCAATTTTACACCTGTTCAATTC 
PLP Fwd CACTCTGTGCTTGGTAACATGG 























2.4 Genotyping: mastermix and PCR conditions  
 






Buffer 5x 5 Invitrogen 







dNTPs (10µM) 0.5 Invitrogen 
Taq 0.2 Invitrogen 
H2O 13.05 - 
DMSO 1.25 Sigma 
DNA 1 - 
 






4 minutes 94  
30 seconds 94 
x30 
cycles 
1 minute 50 
1 minute 72 













4 minutes 94  
15 seconds 94 
x36 
cycles 
40 seconds 60 
40 seconds 72 
2 minutes 72  
 






5 minutes 94  
30 seconds 94 
x34 
cycles 
45 seconds 55 
1 minute 72 
7 minutes 72  
 






2 minutes 94  
30 seconds 94 
x35 
cycles 
45 seconds 54 
45 seconds 72 




2.5 qPCR conditions  
 






2 minutes 95 
 
15 seconds 95 
x49 cycles 
1 minute 55 
5 seconds 

























2.6 Animals  
Animals were housed in the BSU at UCL in individually ventilated cages. All 
procedures were carried out in accordance with Home Office guidelines. All animals 
over P10 were culled via Schedule 1. Animals under P10 were culled by 
decapitation, a procedure for which we are licensed. All work was carried out with 
the 3Rs mind (reduce, replace, refine). The mice used in Chapters 3-5 are 6-10 
weeks old. The young mice in Chapter 6 are also 6-10 weeks old and the old mice 
are 1 year old. All mouse lines are on a C57BL/6 background. 
All rat pups were acquired from the UCL BSU where they are maintained and bred.  
 
P0 cre mice 
P0 cre mice were a gift from Dr L. Feltri, Buffalo, USA. A mP0TOT(Cre) transgene 
is driven by the P0 promoter (Feltri, D’Antonio, Previtali, et al., 1999). 
 
c-Jun cKO mice 
c-Jun cKO mice have c-Jun specifically knocked out in their Schwann cells under 
the control of the P0 cre promoter. Mice were gifted from the Dr A. Behrens, 
London. Mice were generated by crossing c-Junfl/fl mice (Behrens et al., 2002) with 
P0 cre mice. Mice from this crossing were then crossed back with c-Jun
fl/fl mice. c-
Jun cKO mice are described at length by (Parkinson et al., 2008; Arthur-Farraj et al., 
2012).  
Homozygous mice were used for all experiments and were genotyped using P0 cre 
primers (see 2.4). P0 cre
- littermates were used as experimental controls and are 







c-Jun OEfl/fl mice 
Mice were gifted from the lab of Dr K. Rajewsky. These mice have the potential to 
over-express c-Jun in any cell in their body due to a c-Jun cDNA insert on the 
Rosa26 locus. The transgene expression is controlled by a lox-p flanked STOP 
cassette in front of a CMV early enhancer/chicken β actin (CAG) promotor (Figure 
2.1). Homozygote mice were used in this thesis and homozygosity was confirmed by 
genotyping with both c-JunOE and Rosa26 primers.  
 
OE/+ and OE/OE mice 
OE/+ and OE/OE mice over-express c-Jun specifically in Schwann cells. c-Jun 
OEfl/fl mice were crossed with P0 cre mice generating P0 cre
+/c-JunOE/+ mice, referred 
to hereafter as OE/+ mice. Homozygotes were generated by crossing OE/+ mice 
back with c-Jun OEfl/fl mice, hereafter referred to as OE/OE mice. P0 cre
- littermates 
were used as experimental controls and are hereafter referred to as WT mice. Hetero 





Figure 2.1 | Diagram of the c-Jun OE construct  
A lox-P flanked STOP cassette is located in front of a CAG promoter. In the presence of cre, the lox-





Rosa26 locus  




To generate an inducible mouse line, PLP creERT2+/- mice (Leone et al., 2003), were 
crossed with c-Jun OEfl/fl mice. The resulting mice were then back crossed with c-Jun 
OEfl/fl mice generating a tamoxifen inducible c-Jun over-expressing mouse line. 
170mg/kg tamoxifen dissolved in sunflower oil (Sigma) and 100% ethanol (10:1) 
was administered daily for 5 days. Mice were genotyped with PLP primers. 
Tamoxifen activates the ERT2 receptor which in turn excises the lox-P sites through 

















Figure 2.2 | A diagram of the tamoxifen inducible over-expression of c-Jun  
Mice express a cre-recombinase linked estrogen receptor (ER) under the PLP promoter. The 
expression of this receptor is therefore Schwann cell specific. 1. In the absence of tamoxifen, the 
receptor remains in the cytoplasm. In the nucleus, the loxP sites flank the stop codon preventing 
expression of the transgene. 2. Injected tamoxifen crosses the cell membrane and binds to the ER 
receptor. 3. The CreER receptor complex translocates to the nucleus where the cre excises the loxp 
sites releasing the stop codon. 4. The cre-recombinase mediated removal of the stop codon induces 
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2.7 Materials  
 
General  
15ml and 50ml Falcon tubes were bought from BD Biosciences. Stripettes (5ml, 
10ml, 25ml) were bought from Costar. Tips were from Clear Line. Gloves were from 
Shield Scientific. Eppendorf tubes (0.5ml, 1.5ml and 2ml) were from Sarstedt. 
Pasteur pipettes (1.5ml and 3ml) were bought from Scientific Instruments Services. 
100% ethanol and isopropanol were from BDH.  
 
EM 




Agarose was from Invitrogen. TAE 50x buffer was from VWR. 100bp ladder was 
from Fisher Scientific. Ethidium bromide was from Sigma. Agarose gels were 
viewed and imaged using a dual-intensity transilluminator from UVP.  
 
Immunofluorescence 
Tisse Tek OCT and moulds were from Agar Scientific. Super frost slides were 
purchased from Fisher Scientific. Southern Biotech provided Fluromount-G. 22 x 50 
mm coverslips were from VWR.  
 
qPCR  
Primers from Invitrogen. PrecisionPLUS qPCR Mastermix with SYBR Green was 
from Primerdesign. White hard shell 96 well plates, microseal seals and the CFX96 




All surgical and dissection tools were provided by Fine Scientific Tools. Scalpel 
blades were purchased from Swann-Morton. Hydrex pink was from Ecolab. Sterile 
drapes, gowns, swabs, isoflurane, surgical gloves, 0.9% NaCl saline, bupivacaine, 
carprofen and vetergesic were provided by the UCL BSU. Silicon tubing was from 
Freudenberg Medical. Lacri-Lube was bought from Allergan. Flurogold was from 
Flurochrome. Clips were purchased from VET-TECH. Suture information is 





Material Absorbant Company 






7 Prolene No Ethicon 
Repairing 
nerves 
8 Nylon No S&T 
 
Tissue culture  
All dishes, flasks and plates were bought from VWR. 13mm round cover slips were 
bought from BDH. Collagenase was purchased from Worthington. L15, DMEM 
media and 0.25% trypsin-EDTA were from Invitrogen. Penicillin streptomycin and 
trypsin were brought from PAA. Tips were from Star Labs. Purmorphamine was 
from Sigma. SAG was from Merk. Cyclopamine was from Insight Biotechnology.  
 
Western blotting  
Mini protean tank, semi-dry transfer system, extra thick blot paper and chemidoc 
were from Bio-rad. BCA protein assay kit and PageRuler prestained protein ladder 
were distributed by Thermo Fisher Scientific. Amersham provided nitrocellulose 
hybond membrane, ECL and ECL prime kits. Skirted 2ml tubes and easy grip screw 
caps were from Star Labs. Semi-skimmed milk powder was from Sigma. 
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2.8 Methods  
 
2.8.1 Tissue culture 
 
Rat Schwann cell cultures  
P3/4 Sprague Dawley rats of either sex were obtained from the UCL BSU. 1 rat was 
needed per plate. Pups were culled by decapitation. Bodies were sprayed with 70% 
ethanol and the sciatic nerves and brachial plexuses were removed into L15 medium 
on ice. Nerves were cleaned and de-sheathed. In a hood, the L15 was removed and 
300l trypsin and 300l collagenase was added. The nerves were incubated with the 
enzymes for 1 hour in the incubator (37C, 5% CO2). Nerves were triturated 10x 
with a 1ml tip then incubated for a further 10 minutes. Nerves were further triturated 
10x will a 1ml tip and 10x with a 200l tip. The digestion was halted with 1ml 
DMEM 10% FBS and the cell suspension was transferred to a 15ml Falcon tube. The 
35mm dish was washed with a further 1ml to remove any remaining cells and the 
wash transferred to the Falcon tube. The cells were spun at 1000rpm for 10 minutes. 
The pellet was resuspended in 2ml DMEM 5% FBS + P/S and cells were plated on 
laminin and PLL coated dishes. 20l of Ara C (1:100, final conc. 10-5M) was added 
to eliminate fibroblasts (Brockes et al., 1979; Stevens et al., 1998). The cells were 
incubated at 37C, 5% CO2 for 3 days. The cells were then changed into rat 
expansion medium.  
 
Mouse Schwann cell cultures  
P8-10 mouse pups of either sex were culled by decapitation. 4 mice were needed per 
plate. Bodies were sprayed with 70% ethanol and the sciatic nerves were removed 
into L15 medium on ice. Nerves were cleaned and de-sheathed. In a hood, the L15 
was removed and 300l trypsin and 300l collagenase was added. The nerves were 
incubated with the enzymes for 1 hour in the incubator (37C, 5% CO2). Nerves 
were triturated 10x with a 1ml tip then incubated for a further 10 minutes. Nerves 
were further triturated 10x with a 1ml tip and 10x with a 200l tip. The digestion 
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was halted with 1ml DMEM 10% HS and the cell suspension was transferred to a 
15ml falcon tube. The 35mm dish was washed with a further 1ml to remove any 
remaining cells and the wash transferred to the falcon tube. The cells were spun at 
1000rpm for 10 minutes. The pellet was resuspended in 2ml DMEM 5% HS + P/S 
and cells were plated on laminin and PLL coated dishes. 20l of Ara C (1:100, final 
conc. 10-5M) was added to eliminate fibroblasts. The cells were incubated at 37C, 
5% CO2 for 3 days. The cells were then changed into mouse expansion medium. 
 
Schwann cell passaging  
When cultures were 70-80% confluent, medium was removed and the cells were 
washed 2x in 1x PBS. 0.25% trypsin-EDTA (1x) was added to remove the cells from 
the dish. Cells were incubated in the enzyme for 5 minutes at 37C, 5% CO2. A half 
volume of 10% FBS DMEM was added to halt the reaction and the cell suspension 
was transferred to a 15ml falcon tube. The dish was washed with the remaining 10% 
FBS DMEM. The wash was added to the 15ml falcon tube. Cells were spun at 
1000rpm for 10 minutes. The pellet was resuspended and the cells were plated in 
expansion medium.  
 
Mouse Schwann cell virus infection  
All virus infections were carried out in a dedicated containment level 2 virus lab in 
the UCL MRC laboratory for molecular cell biology (LMCB). Once cells were 70-
80% confluent, cells were infected with 1:500 adenovirus in DM 0.5% HS and 2µM 
forskolin. The viruses had previously been titrated to determine the correct dilution 
for ~100% infection and only cultures with >95% Schwann cell purity were infected. 
The medium was changed after 24 hours to DM 0.5% HS. After 48 hours, cells 
underwent protein, RNA extraction or fixation.  
 
Schwann cell culture experiments  
During all experimental conditions, Schwann cells were incubated in DM and 0.5% 




Purmorphamine, Smoothened agonist (SAG) and cyclopamine  
Purmorphamine, SAG, and cyclopamine were dissolved in DMSO to generate a 
stock concentration of 10mM. Stock solutions were aliquoted and stored at -20C 
until use. One aliquot was used per experiment to prevent multiple freeze thaw 
cycles.  
 
Schwann cell immunofluorescence  
For immunofluorescence experiments, 5000 Schwann cells were plated in a 35l 
drop on a PLL laminin coated coverslip. Cells were given 24 hours to sit down, then 
were topped up with DM. At the experimental end point, cells were washed 2x with 
1x PBS. Cells were fixed with 4% PFA for 10 minutes. Cells were then washed for 5 
minutes in 1x PBS. Fresh PBS was added to the wells and the lid was parafilm 
sealed. Dishes were stored at 4C until use.  
 
Schwann cell ELISA 
Cells were washed 2x with 1x PBS then incubated with 0.1M HCl for 10 minutes. A 
cell scraper was used to detach the cells from the plate and the suspension was kept 
on ice. Samples were spun at 1000rpm for 10 minutes at 4C. The supernatant was 
stored at -80C for no more than 1 week. A cAMP ELISA kit (Enzo) was used as per 
the manufacturer’s instructions to determine the levels of cAMP present in the 
sample. This was then divided by the total protein of the sample which was 
calculated by BCA (described later in this chapter).  
 
Schwann cell protein extraction  
Cells were washed 2x with 1x PBS and incubated with 100l cell lysis buffer. Cells 
were physically detached from dishes using a cell scraper and the cell lysate was 
kept on ice in a 1.5ml eppendorf tube. Lysate was spun for 2 minutes at 1000rpm to 
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pellet the debris. The supernatant was transferred to a fresh eppendorf tube and spun 
for a further 2 minutes at 1000rpm. The protein was stored at -80C until use.  
 
Schwann cell RNA extraction  
RNA from cells was extracted using an RNeasy Micro Extraction Kit (Qiagen). 
1,000,000 cells were used per sample. Extractions were carried out in a laminar flow 
hood. All surfaces and pipettes were sprayed with RNase ZapTM and gloves were 
changed regularly to prevent RNA degradation. Media were removed and cells were 
washed 2x with 1x PBS before the extraction. Extractions were carried out as per the 
manufacturer’s instructions. An in-column DNase digest was included as part of the 
extraction protocol. RNA quality and concentration was determined after the 
extraction using a nanodrop 2000 machine (Thermo). RNA was stored at -80C until 
use. 
 
Schwann cell cDNA synthesis 
1µg of RNA was converted to cDNA using SuperScriptTM II Reverse Transcriptase 













2.8.2 Nerve processing for EM  
Mice were culled by Schedule 1 and the sciatic nerve was exposed. A few drops of 
EM fix was added to the nerve and left for 15 minutes. This was to ensure the nerve 
was fixed straight. The nerve was removed and left in EM fix overnight at 4C. The 
nerve was washed in 0.1M cacodylate buffer 3x for 15 minutes. To osmicate the 
nerve, equal parts 2% osmium tetroxide in ddH2O and 0.2M cacodylate buffer were 
mixed. The 1% osmium tetroxide solution generated was then added to the nerves 
for 2 hours at 4C. The nerve was washed for 2x 15 minutes in ddH2O. The samples 
were dehydrated by washing in progressively higher percentage ethanol solutions: 
25% ethanol / 5 minutes, 50% ethanol / 5 minutes, 70% ethanol / 5 minutes, 90% 
ethanol / 10 minutes, 100% ethanol / 10 minutes (x4), propylene oxide / 10 minutes 
(x3).  
The dehydrated nerve was incubated in a 25:75 resin:propylene oxide mixture for 45 
minutes. The nerve was then incubated for 1 hour in a 75:25 resin:propylene oxide 
mixture. The nerve was then blocked in resin, shaking overnight. The nerve was re-
blocked for 2 hours the next day in fresh resin. The nerve was then embedded in 
fresh resin in EM molds and baked for 24 hours at 60C. Once ready, transverse 
ultrathin sections were cut 5mm from the injury site by Mark Turmaine (Electron 
Microscopy Unit). All the cells with a visible nucleus were counted in a whole tibial 
nerve profile at x8000 magnification on a Jeol 10p0 electron microscope equipped 
with a digital camera. Schwann cells were identified by the presence of a basal 
lamina and morphology, whereas fibroblasts, macrophages, mast and other cell types 
were confirmed by morphology. Counts were performed with the help of R. Mirsky 









2.8.3 Surgical procedures  
All surgical procedures were performed under aseptic conditions in the surgical 
theatres of the BSU. All surgical procedures were carried out on the right sciatic 
nerve only. Mice were anesthetized with isoflurane. The surgical site was shaved and 
skin was sterilized with hydrex pink. Lacri-Lube was applied to the eyes to keep 
them hydrated during procedures. Mice were placed on a heat mat to maintain their 
body temperature. During every procedure, mice were given the minimum analgesia 
of 2 drops of bupivacaine diluted 1:10 in 0.9% saline administered at the incision site 
at the time of closure with number 5 forceps. After all surgical procedures, mice 
were placed in a recovery chamber at 27C and returned to clean cages once fully 
ambulatory. Surgical clips were removed after 10 days and any sutures used to close 
were dissolvable. 
 
Sciatic nerve crush  
To ensure consistency, all sciatic nerve crushes were performed by Shaline Fazal.  A 
vertical incision was made on the right hip using dissection spring scissors. If a 
second surgery was to be performed, a horizontal incision was made, this established 
an easier second incision and closure. The muscle was separated and the sciatic 
nerve exposed. The whole sciatic nerve was crushed at the sciatic notch with fine 
forceps for 3x 15 seconds at 3 rotation angles. The muscle was moved back into 
place and 2 drops of bupivacaine were administered to the site using number 5 
forceps. The incision was closed using 2 autoclips.  
 
Whole sciatic nerve cut (acute denervation < 1 week) 
A vertical incision was made on the right hip using dissection spring scissors. The 
sciatic nerve was exposed and cut at the sciatic notch with fine scissors. The muscle 
was replaced and 2 drops of bupivacaine were administered to the site using number 





Whole sciatic nerve cut (chronic denervation > 1 week) 
If a cut nerve was to be examined at a time point of greater than 1 week, the 
proximal nerve stump had to be tied back into the muscle to prevent axon 
regeneration into the distal nerve stump. To perform this, a vertical incision was 
made on the right hip using dissection spring scissors and the sciatic nerve was 
exposed. A double knot was tied around the nerve at the sciatic notch using a prolene 
suture and the nerve was cut distal to this. The proximal stump was cleaned, 
allowing it be moved freely. A ‘channel’ was made from the nerve to the anterior of 
the biceps femoris by pushing number 5 forceps through the muscle. The suture was 
then passed through this channel and the proximal stump was pulled through to rest 
on the anterior of the biceps femoris. The proximal stump was anchored with a 
double knot. The distal nerve stump was left in place. 2 drops of bupivacaine were 
administered to the site using number 5 forceps and the incision was closed using 2 
autoclips.  
 
Tibial nerve cut and repair (immediate repair) 
A 1.5cm horizontal incision was made using number 10 surgical blade from the hip 
towards the knee. The muscle was separated to expose the sciatic nerve from below 
the sciatic notch to the knee. The individual branches of the sciatic nerve were 
separated by inserting a pair of nerve 5 forceps between the visible branching at the 
knee. The forceps were gently opened and moved towards the notch, carefully 
separating the nerve branches. A knot was tied using a prolene suture where the sural 
nerve branched from the tibial nerve. The tibial nerve was cut distal to the suture 
leaving the other branches intact. The proximal stump of the tibial nerve was tied 
into the adjacent muscle to prevent axon regeneration. The common peroneal nerve 
was then cut and any visible distal stump was removed. This prevented the common 
peroneal nerve regenerating into its own distal stump as opposed to the tibial nerve 
distal stump. In order to repair the nerves and hold them together, a nylon suture and 
a silicon tube was used (Figure 2.3). The suture was inserted through the side of the 
tube and out of an opening. The common peroneal proximal stump was secured to 
the suture by the epineurium. The suture was then moved inside and through the 
tube. The tibial nerve distal stump was also secured to the suture by the epineurium. 
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Special care was taken not to push the suture through the whole nerve as this could 
impair axon regeneration. The suture was then passed back into the tube and pushed 
through the side of the tube where it had originally entered (Figure 2.3 A). Both ends 
of the suture were gently pulled bringing both nerves into the tube and connecting 
the stumps (Figure 2.3 B). A knot was then tied to hold the stumps in place (Figure 
2.3 C). The muscle was closed with a horizontal mattress stich using a vicryl suture. 
2 drops of bupivacaine were administered to the site using number 5 forceps and the 
incision was closed with a continuous subcuticular suture with a vicryl suture. Mice 
were given a subcutaneous injection of 0.1mg/kg vetergesic and carprofen was 
administered in their water for 5 days post-surgery (1 ml of 50mg/ml stock in 200ml 






































Figure 2.3 Diagram of surgical nerve repair  
(A) The nylon suture is passed through the side of the silicon tube and out through the end opening. 
The suture secures the epineurium of the nerve and is passed through the tube. The suture goes 
through the epineurium of the adjoining nerve and is passed back inside the tube and out through the 
side it originally entered through. (B) Both ends of the suture are gently pulled to bring the nerves 







Tibial nerve cut and repair (chronic denervation: 10 weeks) 
Mice underwent the same early stages of the procedure described above for tibial 
nerve cut followed by immediate repair. However, once the tibial nerve was cut and 
the proximal stump was sutured into the muscle, the distal nerve stump was also tied 
back. A loop was made in a prolene suture and saline was added to the site. This 
allowed the distal nerve stump to be ‘floated’ through the loop, preventing damage, 
and a knot was tied to it. The distal nerve stump was then sutured into the adjacent 
muscle. This ensured the nerve could be easily located following chronic 
denervation, during which the nerve shrinks and due to myelin break down, becomes 
transparent. The site is then closed as described previously. 10 weeks later the site 
was re-opened and the nerve exposed (Figure 2.4 A). The tibial nerve distal stump 
was cut free from the muscle. The common peroneal nerve was cut and sutured to 
the tibial nerve distal stump as previously described in Figure 2.3 (Figure 2.4 B). The 
site was then closed and post-operative care was administered as previously 































Figure 2.4 | Nerve cross suturing following chronic denervation   
Representative images taken by the author. Here, a rat is used to demonstrate the procedure. The 
larger nerves provide more detailed images. The nerves in these images have not been chronically 
denervated to further improve clarity of the procedure. (A) Following 10 weeks of chronic 
denervation the injury site is reopened. The proximal and distal stumps of the tibial nerve were 
previously tied back into the muscle and are easy to locate due to the blue suture. The sural nerve 
remains intact. The common peroneal nerve is now cut with a long proximal stump allowing plenty of 
nerve to work with. (B) The distal stump of the tibial nerve is cut free from the muscle. This is 
sutured to the proximal stump of the common peroneal nerve (as previously decribed in Figure 2.3) 
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Retrograde labelling with Fluorogold  
This technique was adapted from Catapano et al., 2016. Training in this technique 
was received directly from the authors of this work.  
After sciatic nerve crush or tibial nerve repair, sufficient time was given to allow for 
axon regeneration. Retrograde labelling was then used to assess regeneration of 
motor and sensory neurons. In short-term crush injuries, the previous incision site 
was reopened. In nerve repair surgeries, a new incision was made parallel to the 
previous one using a number 10 blade. The muscle was opened and the sciatic nerve 
was exposed. In crush injuries, the desired distance was measured from the crush site 
at the sciatic notch. The nerve was then cut. With tibial nerve repairs, the tube used 
to hold the repair site together was carefully removed. 4mm was then measured from 
the site of repair down the tibial nerve and cut. The procedure uses a well technique 
to administer Fluorogold to the nerve (Figure 2.5). This method has been found to 
more accurate than the injection of tracers and is easier than the silicon cap 
technique, which yields similar results (Catapano et al., 2016). A 1cm x 0.5 cm 
rectangle of parafilm was cut. A hydrophobic barrier of petroleum jelly (Vaseline) 
was used to create a 0.5cm x 0.5cm well (Figure 2.5 A). The cut nerve was then 
placed into this well and the hydrophobic barrier reinforced (Figure 2.5 B). 4% 
Fluorogold in saline, which had been previously prepared and stored at -20C, was 
thawed and added to the well (Figure 2.5 C). The nerve was left in the well for 1 
hour. During this time, the open surgical site was covered with sterile gauze swabs 
soaked in sterile 0.9% saline to prevent infection and to keep the area hydrated. Mice 
were also injected with 0.9% saline (0.06ml/10g bodyweight) to remain hydrated. 
The isoflurane was reduced and breathing and heat mat temperature were closely 
monitored. After an hour, the nerve was removed from the well which was disposed 
of. If the incubation had been successful, the nerve tip that was exposed to the 
Fluorogold would be stained yellow (Figure 2.5 D). The site was washed 3x with 
0.9% saline. The site was closed and post-operative care was administered as 


















Figure 2.5 | Retrograde labelling with Fluorogold  
For ease, a rat nerve is shown, which is larger in size than that of the mouse. (A) A hydrophobic 
barrier of petroleum jelly created a 0.5cm x 0.5cm well. (B) The cut nerve was placed into this well 
and the hydrophobic barrier reinforced. (C) 4% Fluorogold in saline is added to the well and the nerve 
was left for 1 hour. (D) The nerve is removed from the well and is stained yellow to indicate 













1 week after retrograde labelling, mice were perfused. This allowed sufficient time 
for optimum labelling (Novikova et al., 1997). The spinal cord and L4 DRG were 
removed and fixed in 4% PFA/PBS for 24 hours at 4C. Tissue was then transferred 
to 30% sucrose in 4% PFA for 72 hours at 4C. Spinal cords were embedded in OCT 
in 24 x 24 x 5 mm moulds. DRGs were embedded in OCT in 15 x 15 x 5 moulds. 
Spinal cords were cut longitudinally at 50m, DRGs were cut at 20m. Sections 
were collected on super frost slides. All sections of the spinal cord were counted and 
the Abercrombie correction was applied to compensate for double counting 
(Abercrombie, 1946). This was calculated to be 0.625. To avoid double counting in 
the DRGs, every fifth section was counted. Neuronal cell bodies in the DRG have 
been observed to be 70-100m in size in the mouse (Lawson, 1979)S. Fazal, 
unpublished observations). Each section was therefore counted 100m apart. All 





                            
             
   
Figure 2.6 | The Abercrombie correction  
Correction was applied to all counts from the spinal cord to prevent the double counting of cells. P is 
the average number of cells. A is the number of cells counted. Section thickness in µm is M. L is the 
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Nerve RNA extraction 
When experimental time points were reached, mice were culled by Schedule 1 
procedure. The dissection area, cork board and tools were sprayed with RNase 
ZAPTM and tools were kept on an RNase free sheet of aluminium. Tools were re-
sprayed between animals. Injured sciatic nerves were removed and snap frozen in 
liquid nitrogen in RNase free eppendorf tubes. The uninjured contralateral nerve was 
taken as a control. Extractions were performed under the conditions previously 
described. RNA was extracted using a RNeasy lipid tissue kit (Qiagen). Chronically 
denervated and uninjured nerves had to be pooled, 2 per n to generate a usable 
concentration of RNA. Acutely denervated nerves were not pooled using 1 nerve per 
n. An in column DNase step was performed and the RNA was suspended in 30l 
RNase free water. RNA quality and concentration was determined after the 
extraction using a nanodrop 2000 machine (Thermo). RNA quality was further tested 
using an ExperionTM RNA HighSens CHIP kit. Samples given a RNA quality 
indicator value of greater than 6.5 were converted to cDNA. RNA was stored at -
80C until amplification.  
 
Tissue cDNA amplification 
Due to low RNA concentration yields from nerves, it has previously been found that 
up to 8 nerves need to be pooled to generate quality cDNA to run an efficient qPCR 
reaction (Benito et al 2017). To reduce the number of animals needed for these 
experiments, RNA was amplified during the cDNA conversion using a QuantiTect 
whole transcriptome kit. 10ng of RNA was amplified as per the manufacturer’s 
instructions using the standard amplification protocol (2 hour amplification) 







cDNA was diluted (Mouse Schwann cells 1:16, rat Schwann cells 1:32 and nerve 
1:1024) in RNase free water and prepared with primers and PrecisionPLUS 
mastermix with SYBRgreen. GAPDH and calnexin were used as house keeping 
genes in cell experiments, GAPDH, calnexin and Yhaz were used for uninjured 






















2.8.5 Western Blotting 
 
Tissue protein extraction  
Nerves were dissected, placed in 1.5ml eppendorf tubes and snap frozen in liquid 
nitrogen. Samples were stored at -80C until use. For protein extraction, nerves were 
placed in 2ml graduated skirted tubes with 9 10B lysing beads with 75ml RIPA 
buffer and homogenized using a Fastprep fp120 homogeniser. Samples were run 
twice at speed 6 for 45 seconds. Lysates were then centrifuged at 13000rmp for 2 
minutes at 4C to pellet the debris. The supernatant was transferred to a new 1.5ml 
eppendorf tube and centrifuged at 13000rmp for 2 minutes at 4C. The supernatant 
was transferred to a new 1.5ml eppendorf tube and the protein extract was stored at -
80C until a BCA protein assay could be performed. 
 
BCA protein assay  
Protein concentrations from extracts were determined using a Pierce™ BCA protein 
assay kit as per the manufacturer’s instructions. To ensure equal concentrations were 
added to Western blots, a standard test was used (range: 2000-25g/ml). To 
determine the protein concentrations of samples extracted in 0.1M HCL for ELISA 
assays, an enhanced test was used (range 5-250g/ml). The assay was performed on 
a 96 well plate with samples and standards run in duplicate. The plate was read at 
510nm and sample protein concentrations were determined by creating a standard 
curve.   
 
Western blots  
Antibodies and dilutions can be found in 2.2. 
Protein was diluted in the appropriate lysis buffer to ensure 10g was loaded to each 
gel. 5x Laemmli buffer was added to samples at a working concentration of 1x. 
Samples were heated to 95C for 5 minutes to denature the protein. 20l of sample 
was loaded per well and run on an 8% gel at 60mV for 3 hours. Protein from the gel 
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was transferred to a nitrocellulose membrane. Extra thick blot paper, the 
nitrocellulose membrane and the 8% gel were soaked in transfer buffer for 5 
minutes. A sandwich of paper, membrane, gel, paper was prepared. Between the 
addition of each layer, bubbles were rolled out using a glass Pasteur pipette. The 
transfer was performed on a semi-dry transfer system at 25mV for 45 minutes. Once 
the transfer was complete, membranes were briefly soaked in Ponceau S to 
determine that the transfer has been successful and that equal levels of protein had 
been loaded in the gel. Membranes were briefly washed in ddH20 to remove excess 
Ponceau and blocked in 5% milk TBS-T for 1 hour shaking at room temperature. 
Membranes were then incubated with appropriate antibodies in heat sealable 
polyethylene bags to reduce the volume of antibody required. Membranes were 
attached to a rotatory wheel to ensure even antibody coverage and incubated 
overnight at 4C. Membranes were washed 3x 10 minutes in 1x TBS-T then 
incubated with the appropriate secondary antibody in heat sealable polyethylene 
bags, rotating for 1 hour at room temperature. Membranes were washed 3x 10 
minutes in 1x TBS-T before developing. For development of GAPDH, membranes 
were incubated with ECL for 1 minute and developed on a Bio-Rad Chemidoc 
machine. For the development of all other antibodies, membranes were incubated 
with ECL prime for 5 minutes then developed. Membranes were automatically 
exposed to prevent saturation. Blots were analyzed using Bio-Rad Imagelab. Protein 
levels were determined by dividing the protein of interest against the house keeping 
protein (GAPDH or calnexin). All blots were then normalized to one sample (e.g 1 










2.8.6 Immunofluorescence  
 
Antibody dilutions and diluents can be found in 2.2. 
 
Sox10 c-Jun dual immunolabelling  
Distal nerve stumps were dissected and cut into 2mm segments. Segments were fresh 
frozen in OCT. Blocks were sectioned in transverse at 10m on a cryostat. Sections 
were collected on super frost slides. Sections were stored at -80C until use. Before 
use, sections were dried at room temperature for 10 minutes. Sections were fixed in 
100% acetone for 10 minutes at -20C. Sections were washed 6 x 5 minutes in 1x 
PBS and blocked for 1 hour with 5% DS, 1% BSA, 0.3% Triton X-100. Sections 
were washed 6 x 5 minutes in 1x PBS then incubated with Sox 10 antibody 
overnight at room temperature. Sections were washed 6 x 5 minutes in 1x PBS, 0.1% 
Tween-20 and incubated with Alexa 488 donkey anti-goat IgG for 1 hour at room 
temperature. Sections were washed 6 x 5 minutes in 1x PBS, 0.1% Tween-20, then 
incubated with c-Jun antibody over night at room temperature. Sections were washed 
6x 5 minutes in 1x PBS then incubated with cy3 anti-rabbit IgG and DAPI 1:40000 
for 1 hour at room temperature. Sections were finally washed 6x 5 minutes in 1x 
PBS, 0.1% Tween-20 and mounted in Citifluor mounting medium. When 
immunolabelling is performed on cell cultures, cells are fixed in 4% PFA and the 
acetone fixation is omitted. DAPI is incubated 1:1000.  
 
Arginase/F4/80 dual labelling  
Nerves were dissected and fixed in Bouin's solution for 4 hours. Nerves were washed 
in 1x PBS until it ran clear and incubated in 30% sucrose overnight at 4C. Nerves 
were embedded in OCT and 10m longitudinal sections were cut on a cryostat and 
collected on super frost slides. A hydrophobic barrier was drawn with a DAKO pen 
and sections were washed 6x 2 minutes in 1x PBS. Sections were blocked in 1% 
milk in 1x PBS for 1 hour at room temperature then incubated with arginase primary 
antibody overnight at 4C. Sections were washed 6x 2 minutes in 1x PBS and 
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incubated with Alexa 488 donkey anti-goat IgG for 1 hour at room temperature. 
Sections were washed 6x 2 minutes in 1x PBS then incubated with F4/80 primary 
antibody overnight at 4C. Sections were washed 6x 2 minutes in 1x PBS then 
incubated with anti-rat IgG biotin for 2 hours at room temperature. Sections were 
washed 6x 2 minutes in 1x PBS then incubated with streptavidin cy3 and DAPI 
1:1000 for 15 minutes at room temperature. Sections were washed 6x 2 minutes in 
1x PBS then mounted in Citifluor. 
 
CD16/32 immunolabelling 
Nerves were dissected and fixed in 4% PFA for 4 hours. Nerves were washed 3x 5 
minutes in 1x PBS and transferred to 30% sucrose overnight at 4C. Nerves were 
embedded in OCT and 10m longitudinal sections were cut and collected on super 
frost slides. A hydrophobic barrier was drawn with a DAKO pen and sections were 
washed 6x 2 minutes in 1x PBS. Sections were blocked in 1% milk in 1x PBS for 30 
minutes at room temperature then incubated with CD16/32 primary antibody 
overnight at 4C. Sections were washed 6x 2 minutes in 1x PBS then incubated with 
anti-rat IgG biotin for 2 hours at room temperature. Sections were washed 6x 2 
minutes in 1x PBS then incubated with streptavidin cy3 and DAPI 1:1000 for 15 
minutes at room temperature. Sections were washed 6x 2 minutes in 1x PBS then 












2.8.7 Genotyping  
For initial genotyping, ear notches were performed at P15 and the tissue disks 
collected. For re-genotyping, tail tips were taken following Schedule 1 procedures. 
Tissue was incubated with 75µl hotshot buffer at 95C for 1 hour. 75µl neutralizing 
reagent was then added to each sample (Truett et al., 2000). DNA was then added to 
the PCR mastermix and run under the appropriate conditions.  
 
2.9 Statistical analysis  
All surgeries and cell counts were performed blind. Cell counts of 
immunofluorescence were performed on ImageJ from images taken on a Nikon 
Labophot 2 fluorescence microscope. Data was analysed and graphs were prepared 

















3.Repair cell maintenance during chronic denervation of peripheral nerves  
Unlike the CNS, the PNS has a remarkable capacity for regeneration. Following 
peripheral nerve injury, the AP-1 transcription factor c-Jun is rapidly up-regulated in 
Schwann cells (De Felipe & Hunt, 1994; Shy et al., 1996). c-Jun is the master 
regulator of the repair cell phenotype. When c-Jun is specifically knocked out in 
Schwann cells and its activation is prevented after nerve injury, axon regeneration is 
compromised. This is contributed to by deficient up-regulation of trophic factors 
such as GDNF, BDNF and artemin. The regeneration tracks of the bands of Büngner 
do not form, inhibitory myelin debris is not cleared and Schwann cell survival is 
poor (Fontana et al., 2012; Arthur-Farraj et al., 2012). Despite the initial activation of 
the repair cell phenotype, peripheral nerve regeneration in humans is poor. Axons 
regenerate at a rate of 1-2mm per day (Buchthal & Kühl, 1979). In human injuries, 
axons travel vast distances to reinnervate their targets, which, due to their slow rate 
of regeneration can take months to years. It is known that the supportive, 
regenerative environment initially activated following injury, is not maintained. 
Growth supportive trophic factors activated upon injury gradually decline in the 
Schwann cells of the distal nerve stump (You et al., 1997; Höke et al., 2002; 
Michalski et al., 2008; Eggers et al., 2010). It has previously been shown, GDNF, 
BDNF and p75 NTR expression in Schwann cells is controlled by c-Jun (Arthur-
Farraj et al., 2012). As these factors are decreasing the distal nerve stump Schwann 
cells, it is likely that c-Jun is also decreasing and thus the repair cell phenotype is not 
maintained during chronic denervation.   
The aims of this chapter are therefore: 
-To examine c-Jun expression in distal nerve stumps during periods of acute and 
chronic denervation  
- To determine if any changes in c-Jun expression observed are Schwann cell 
specific  
- To examine expression of other markers of the repair cell phenotype during acute 





3.1 c-Jun decreases in the distal nerve stump following chronic denervation  
To examine c-Jun expression during acute and chronic denervation, WT mice 
underwent a sciatic nerve cut for periods ranging from 3 days to 10 weeks (Figure 
3.1). Western blots of the distal nerve stumps demonstrated that c-Jun levels 
increased with injury and remained elevated during acute denervation (1-3 weeks) 
(Figure 3.1 A). However, from 6 weeks, c-Jun levels began to decrease. c-Jun levels 
then continued to decline consistently over time with levels even at lower at 8 and 10 
weeks, the earliest time points classified as chronic denervation in rodent models 
(Sulaiman & Gordon, 2000; Boyd & Gordon, 2002a, 2003).   
Western blots were quantified by dividing the c-Jun protein levels by those of the 
house keeping protein calnexin. c-Jun levels in blots were then normalised to 1 week 
post injury (Figure 3.1 B).  Analysis of the data revealed that the increases in c-Jun 
levels after injury were significant, with highest expression observed 1 week after 
injury. It further demonstrated the gradual decline in c-Jun protein levels with time, 
with levels significantly lower (55.25%) 10 weeks after injury.  
These results demonstrate that although c-Jun is activated after injury, levels 
decrease in the distal nerve stump during chronic denervation. It was thus decided in 
further experiments to compare c-Jun levels and repair cell markers after acute 
denervation 1 week post injury with levels after chronic denervation, classified as 



























Figure 3.1 | c-Jun protein expression decreases in the distal nerve stump following injury 
(A) Representative Western blot of c-Jun expression in distal nerve stumps following injury. Extracts 
from uninjured nerves (UI) and from distal nerve stumps taken 3 days (D) to 10 weeks (W) following 
injury were compared. c-Jun expression increased following injury then gradually declined over time. 
(B) Quantification of Western blots. c-Jun expression was normalised relative to calnexin and all time 
points were compared to 1 week after injury to determine the fold change in expression. c-Jun 
significantly increased following injury, with levels peaking 1 week after injury. Expression gradually 
declined with time and was significantly decreased by 10 weeks post injury. Graph of means ± SEM, 
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3.2 Changes in c-Jun expression are not observed in other cells during acute or 
chronic denervation    
Although Schwann cells make up the majority of the cell population of peripheral 
nerves, many other cell types are present, particularly after injury. Macrophages 
invade the injured nerve and remain present for up to 3 weeks, although a small 
population of resident macrophages is present in uninjured adult nerves (Perry et al., 
1987; Stoll et al., 1989; Hirata et al., 1999). Macrophages have been observed to 
express c-Jun in injured nerves (S.Fazal, C. Benito, R. Mirsky, K.R Jessen, 
unpublished observations) and during macrophage differentiation in other systems 
(Gaynor et al., 1991; Hannemann et al., 2017). c-Jun is also expressed in fibroblasts, 
controlling proliferation and survival in vitro (Johnson et al., 1993; Behrens et al., 
1999; Arthur-Farraj et al., 2012). The changes in c-Jun levels may therefore be due 
to the influx and gradual exodus or presence of other cell types into the nerve. To 
test this hypothesis, the c-Jun cKO mouse can be used. These mice, as previously 
described, have c-Jun conditionally knocked-out in Schwann cells. These mice 
develop normally, however, following peripheral nerve injury, do not up-regulate 
Schwann cell c-Jun, leading to disruptions in the activation of the repair Schwann 
cell phenotype, axon regeneration and Schwann cell survival (Parkinson et al., 2008; 
Arthur-Farraj et al., 2012; Fontana et al., 2012). As these mice do not up-regulate 
Schwann cell c-Jun, any c-Jun detected in the injured nerves of these mice is 
therefore expressed by other cell types.  
To examine the c-Jun levels in these mice after injury, c-Jun cKO mice and WT 
littermates underwent a sciatic nerve cut for 1 or 10 weeks (Figure 3.2). Western 
blots of these nerve demonstrated that WT littermates up-regulate c-Jun after injury 
and, as previously observed, c-Jun protein levels decreased with time. The c-Jun 
cKO mice however did not up-regulate c-Jun following injury. c-Jun levels in these 
mice remained constant between uninjured and injured nerves with only a slight 
decrease observed after 10 weeks (Figure 3.2 A). Analysis of these blots revealed the 
WT mice significantly up-regulated c-Jun 1 week after injury and that these levels 
were significantly reduced by 30.1% at 10 weeks (Figure 3.2 B). No significant 
difference was observed in c-Jun up-regulation following injury in c-Jun cKO mice. 
Furthermore, although a slight decrease in c-Jun levels were observed between 1 
week and 10 weeks this was not found to be significant. This suggests a baseline 
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expression of c-Jun is present in other cells in the nerve, however it is very low and 
is not affected by injury. Together, this data demonstrates that the changing levels of 



































Figure 3.2 | c-Jun protein expression is consistant in the c-Jun cKO distal nerve stump following 
acute and chronic injury 
(A) Representative Western blot of c-Jun expression in the distal nerve stumps of WT and c-Jun cKO 
mice following injury. Distal nerve stumps were examined 1 and 10 weeks post injury. c-Jun levels 
increased post injury in WT mice but had decreased by 10 weeks. In the c-Jun cKO mice, no 
difference in c-Jun levels were observed. (B) Quantification of Western blots. c-Jun expression was 
normalised relative to calnexin and all time points were compared to WT 1 week after injury to 
determine the fold change in expression. In WT mice, c-Jun levels significantly increased following 
injury but were significantly lower 10 weeks post injury. No significant difference in c-Jun levels 
were observed between any of the time points examined in the c-Jun cKO nerves. Graph of means ± 
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3.3 c-Jun decreases in the Schwann cells of the distal nerve stump following 
chronic denervation  
The results so far have established that the decrease in c-Jun observed during chronic 
denervation is Schwann cell specific. However, Schwann cell numbers change 
during acute and chronic denervation. Schwann cells proliferate following injury, 
however numbers decline with time post injury (Abercrombie & Johnson, 1946; 
Weinberg & Spencer, 1978; Siironen et al., 1994; Hall, 1999; Benito et al., 2017). 
Therefore, to further confirm that the decrease in c-Jun observed is the result of 
Schwann cell down-regulation as opposed to a decline in cell numbers, 
immunofluorescent dual staining of c-Jun with Schwann cell marker Sox10 can be 
performed. Sox10 is a marker of Schwann cells. Unlike other cell markers, it is the 
only marker that is present through all stages of development as well as being 
present in the adult cells (Kuhlbrodt et al., 1998). It is essential for Schwann cell 
development, with Sox10 knock out mice failing to develop myelin or Remak 
Schwann cells, leading to nerve abnormalities and axon death. Knock out mice do 
not survive past postnatal week seven (Britsch et al., 2001; Finzsch et al., 2010)  
As with the previous experiments, mice underwent a sciatic nerve cut, and were 
examined after 1 or 10 weeks. Nerves were removed, cut into 2mm segments and 
fresh frozen in OCT. Transverse 10m frozen sections were cut and immunolabelled 
with antibodies for Sox10 and c-Jun (Figure 3.3). From the images, it can be seen 
that 1 week after injury, almost all the Sox10 positive cells are also c-Jun positive 
(Figure 3.3 a and b). Some cells however were c-Jun positive, Sox10 negative 
(Figure a’ and b’, arrows). This demonstrates the importance of determining the 
specific cells in which the c-Jun decrease is occurring. Figure 3.3 a and b does 
however demonstrate that c-Jun is largely expressed in Schwann cells. The images 
also demonstrate that after 10 weeks of chronic denervation, large populations of 
Schwann cells have down-regulated c-Jun (Figure 3.3 c and d), with many Sox10 
positive, c-Jun negative cells being observed (Figure c’ and d’, arrows). The number 
of Sox10 c-Jun positive cells in WT mice is quantified in comparable experiments 
described in a later chapter (Chapter 4, Figure 4.5). 
Overall, this experiment demonstrates that following injury and during acute 
denervation, c-Jun is up-regulated predominately in Schwann cells. It subsequently 
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shows that during chronic denervation, Schwann cells down-regulate c-Jun. 
Together, this demonstrates that the changes in c-Jun expression observed are 
occurring in Schwann cells, concluding that during chronic denervation, Schwann 
























Figure 3.3 | c-Jun expression decreases in the Schwann cells of the distal nerve stump during 
chronic denervation  
c-Jun was elevated in almost every Schwann cell 1 week after injury (a and b). However, cells that 
were not Schwann cells, characterised as Sox 10 negative cells, were also seen to express c-Jun (a’ 
and b’, arrows). 10 weeks after injury, many Schwann cells, although still expressing Sox 10, were no 






















3.4 Repair cell marker p75 NTR declines in the distal nerve stump during 
chronic denervation 
 
Now that I have shown that c-Jun decreases in Schwann cells during chronic injury 
(Figures 3.1-3.3), it was hypothesized that other markers of the repair cell phenotype 
might also not be maintained. Markers of the repair cell phenotype are defined as 
cell surface proteins, trophic factors and transcription factors controlled by c-Jun that 
contribute to peripheral nerve regeneration (Arthur-Farraj et al., 2012). p75 NTR is a 
low affinity nerve growth factor receptor. It is up-regulated in the distal nerve stump 
during the first days post injury, peaks 1 week after sciatic nerve cut and levels 
remain elevated during the first month after injury (Taniuchi et al., 1986, 1988; 
Heumann et al., 1987; Roberson et al., 1995; You et al., 1997).  
 
c-Jun regulates p75 NTR protein expression but does not up-regulate mRNA levels - 
c-Jun cKO mice have significantly lower levels of p75 protein yet normal mRNA 
levels (Arthur-Farraj et al., 2012). p75 NTR expression has been previously found to 
decrease in Schwann cells following chronic denervation (You et al., 1997). It was 
therefore hypothesised that p75 NTR protein expression might decline in the distal 
nerve stump following injury in line with c-Jun levels. To examine this, WT mice 
underwent a sciatic nerve cut as described previously. Following acute (3 days - 3 
weeks) or chronic denervation (6-10 weeks), Western blots of nerves were run 
(Figure 3.4 A). It was found that p75 NTR was highly up-regulated 1 week post 
injury. Protein levels were then found to gradually decrease with time in a similar 
trend to that of c-Jun levels previously observed (Figure 3.1). Quantification of blots 
showed that the increase in p75 NTR after injury is significant (Figure 3.4 B). 
Interestingly, no significant difference was observed between levels in UI nerves and 
at 3 days post injury, demonstrating that p75 NTR is not immediately activated 
following injury but that it gradually increases. After peaking at 1 week, p75 NTR 
levels were found to decrease over time with a significant decrease in levels (58%) 
observed 10 weeks after injury. The p75 NTR levels were almost equal to those 
present in the early stages of injury (3 days) and in UI  
nerves. These results confirm that a down-stream target of c-Jun that contributes to 

















Figure 3.4 | p75 NTR protein expression decreases in the distal nerve stump following injury 
(A) Representative Western blot of p75 NTR expression in distal nerve stumps following injury. 
Distal nerve stumps were examined 3 days to 10 weeks following injury. p75 NTR levels increased 
post injury and levels then declined over the 10 week period. (B) Quantification of Western blots. p75 
NTR expression was normalised relative to calnexin and all time points were compared to 1 week 
after injury to determine the fold change in expression. p75 NTR significantly increased after injury 
with levels peaking after 1 week. Expression declined with time and levels were significantly lower 
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3.5 Discussion  
c-Jun is a master regulator of the Schwann cell repair cell phenotype that facilitates 
axon regeneration in the peripheral nervous system (Arthur-Farraj et al., 2012). 
Despite the activation of this repair phenotype, peripheral nerve regeneration in 
humans is poor. This is in part due to the deterioration of the distal nerve stump 
which is characterised by the decline in trophic support for the axons and Schwann 
cell death (Abercrombie & Johnson, 1946; Weinberg & Spencer, 1978; Siironen et 
al., 1994; You et al., 1997; Hall, 1999; Höke et al., 2002; Michalski et al., 2008; 
Eggers et al., 2010; Benito et al., 2017) 
As the expression of many of these factors (GDNF, BDNF and p75 NTR) have been 
shown to be controlled by c-Jun, this chapter aimed to examine if the deterioration of 
the distal nerve stump during chronic denervation was caused by the Schwann cells 
inability to maintain the expression of c-Jun and therefore aspects of the repair cell 
phenotype. This chapter therefore examined the expression of c-Jun and began to 
assess markers of the repair cell phenotype during acute and chronic denervation. 
Western blots of distal nerve stumps of the sciatic nerve following transection 
demonstrated that c-Jun is significantly elevated following injury. These levels are 
not maintained however, with c-Jun gradually decreasing with prolonged 
denervation (Figure 3.1). As these are transected nerves in which the proximal stump 
has been tied back to prevent regeneration, it can be concluded that this down-
regulation is not occurring due to axonal contact (Stewart, 1995).  
However, changes in c-Jun expression could still be due to a number of factors. The 
rate of Schwann cell proliferation increases during the first week post injury while 
during chronic denervation, Schwann cells numbers decline (Abercrombie & 
Johnson, 1946; Weinberg & Spencer, 1978; Siironen et al., 1994; Hall, 1999; Benito 
et al., 2017). Changes in c-Jun levels observed here could be due simply to changes 
in Schwann cell numbers. Other cells are also present in the nerve following injury. 
Although there is a small resident population of macrophages present in the nerve 
(Oldfors, 1980; Perry et al., 1987), numbers increase very significantly after injury. 
Macrophages invade  the nerve as early as 2 days after injury. Their numbers 
increase in the first 2 weeks and they remain in the nerve up to 21 days after cut and 
crush injuries (Perry et al., 1987; Stoll et al., 1989; Hirata et al., 1999). Macrophages 
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are even observed in the distal nerve stumps of chronically denervated tibial nerves, 
however in reduced numbers compared to those observed following acute injury 
(Benito et al., 2017). The changes in c-Jun expression could therefore have been due 
to the influx and exodus of macrophages in the injured nerve.  
It was therefore important to determine that the changes in c-Jun expression were not 
due to changes in macrophage or Schwann cell numbers.  
To determine that the changes in c-Jun expression were not due to macrophage or 
fibroblast population shifts, Western blots of acute and chronically denervated sciatic 
nerves from the c-Jun cKO mouse were examined. No significant difference in c-Jun 
expression was observed in cKO mice at any time point examined (Figure 3.2). As c-
Jun expression in fibroblasts and macrophages in these nerves is normal (Arthur-
Farraj et al., 2012) and no difference in c-Jun was seen during denervation, it can be 
concluded that the changes in c-Jun expression observed in WT nerves is due to 
Schwann cell expression.  
Surprisingly, the decrease in c-Jun expression in WT mice in Figure 3.2 was 
different to that of WT mice in Figure 3.1. Figure 3.1 found WT nerves express 
55.25% less c-Jun at 10 weeks compared to 1 week nerves. Figure 3.2 found only a 
30.1% decrease at 10 weeks. Both results however were significant.  It is likely that 
the difference observed in the percentage decrease between WT mice in Figure 3.2 
and the WTs previously examined is due to the samples in Figure 3.2 being 
compared with samples with very low levels of c-Jun during the development of the 
blots. However this difference is more likely to be observed due to strain differences. 
The WT mice in Figure 3.1 are pure C57/Bl6 mice, however the WT control 
compared in Figure 3.2 is a WT littermate - a transgenic mouse that expresses the c-
Junfl/fl gene however does not express P0 cre. The differences observed in c-Jun 
expression are therefore likely to be due to the different genetic backgrounds of these 
animals.  
Although quantifying c-Jun expression in c-Jun cKO nerves demonstrates that the 
decline in c-Jun is Schwann cell specific, it does not account for the number of 
Schwann cells present in the nerve. Changes in c-Jun expression could still be due to 
Schwann proliferation and death in the nerve. To ultimately determine that changes 
are c-Jun expression are Schwann cell specific, c-Jun was dual immunolabelled with 
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antibodies for Schwann cell marker Sox 10. Sox 10 is one of the most reliable 
markers of Schwann cells as it is expressed throughout the Schwann cell lineage 
(Kuhlbrodt et al., 1998). Other markers of Schwann cells such as glial fibrillary 
acidic protein (GFAP) and S100 are less reliable. GFAP is only expressed from E18 
in immature Schwann cells and is supressed by myelin Schwan cells. It is however 
activated in the absence of axons by Schwann cells in vitro (Jessen et al., 1990). 
S100 is expressed by Schwann cells (Stefansson et al., 1982) however expression 
declines during chronic denervation (Cicero et al., 1970; Stefansson et al., 1982; You 
et al., 1997). Protein and RNA screens of cultured Schwann cells have found delays 
in S100 activation in culture compared to Sox 10 (Liu et al., 2015). p75 NTR is 
another marker of Schwann cells, however its expression is regulated by injury and 
is variable in chronic denervation (Heumann et al., 1987; You et al., 1997). Sox 10 
expression however, when studied by microarray, has found to be unchanged 
following nerve injury and in the weeks that follow (Nagarajan et al., 2002; Arthur-
Farraj et al., 2012). It was therefore concluded that Sox 10 was the most reliable 
marker for examining Schwann cells in acute and chronically denervated nerves. 
1 week after cut, almost all cells that were Sox 10 positive were c-Jun positive, 
however not all c-Jun positive cells were Schwann cells, although the majority were. 
It was observed that 10 weeks after injury, many cells in the nerves were Sox 10 
positive however they were also c-Jun negative.  
The final experiment of this chapter aimed to examine if the down-regulation of c-
Jun resulted in the fading of the repair cell phenotype. To examine this, p75 NTR, a 
marker of the repair cell phenotype was examined during acute and chronic injury. 
Activation of p75 NTR was gradual, with no difference observed between injured 
and 3 day cut nerves. Previous work however has found only a small increase in p75 
NTR mRNA at 3 days relative to 1 week where levels are highest (Taniuchi et al., 
1986; Heumann et al., 1987). However, after 1 week, p75 NTR expression gradually 
decreased with time. This is consistent with previous findings that p75 NTR protein 
and mRNA levels decrease specifically in Schwann cells during chronic denervation. 
mRNA levels have been shown to decline between 7 and 20 days, a similar trend 
observed with these protein levels. (Heumann et al., 1987; You et al., 1997). 
119 
 
To further examine repair cell marker expression during chronic denervation, qPCR 
experiments are required. These will be performed in the next chapter where the 























4. Maintaining the repair cell phenotype during chronic denervation of 
peripheral nerves 
The results described in Chapter 3 of this thesis demonstrated that c-Jun and some 
markers of the repair phenotype are not maintained during chronic denervation of 
peripheral nerves. If the repair cell phenotype were maintained during chronic 
denervation, the deterioration of the distal nerve stump might be prevented. The 
characteristic features of the distal nerve stump deterioration, such as the previously 
described down-regulation of trophic support and cell adhesion molecules, and 
Schwann cell death. Many of the trophic factors and cell adhesion molecules down-
regulated have been previously found to be controlled by c-Jun and are disrupted in 
the c-Jun cKO mouse (Arthur-Farraj et al., 2012; Fontana et al., 2012).  
Previous work has demonstrated that over expression of c-Jun in cultured Schwann 
cells leads to increased expression and secretion of GDNF and BDNF and increased 
proliferation (Huang et al., 2015). Furthermore, exposure of chronically denervated 
Schwann cells to trophic factors has previously been shown to enhance their ability 
to aid axon regeneration (Boyd & Gordon, 2003; Wood et al., 2013) It was therefore 
hypothesized that maintenance of c-Jun during chronic denervation might maintain 
the repair cell phenotype and prevent the deterioration of the distal nerve stump.  
To examine this, we were gifted the OEfl/fl mouse. This mouse has the ability to over-
express c-Jun in every cell as the transgene is expressed under the control of the 
Rosa26 promoter. In the presence of cre, the loxp sites flanking the transgene will be 
excised, activating the transgene and leading to the over-expression of c-Jun. 
Schwann cell cultures from these nerves can initially be used to examine the effect of 
c-Jun over-expression in Schwann cells in vitro. This mouse can then be crossed 
with a mouse expressing cre under the control of the P0 promoter to generate a 
mouse that over-expresses c-Jun specifically in Schwann cells (Jose A Gomez-
Sanchez et al., 2017; Fazal et al., 2017). This mouse can then be used to examine the 






The aims of this chapter are therefore: 
- To determine if c-Jun and markers of the repair cell phenotype are elevated in 
OEfl/fl Schwann cell cultures following cre recombinant adenovirus infection 
- To determine if c-Jun and markers of the repair cell phenotype are maintained in 
OE/+ Schwann cells following chronic denervation  






















4.1 Infection with cre recombinant adenovirus elevates c-Jun in OEfl/fl Schwann 
cell cultures  
To initially examine the effect of over-expressing c-Jun in Schwann cells, cultures 
from OEfl/fl mice can be generated and infected with a cre recombinant adenovirus. 
To first confirm that the transgene system is working in this mouse, Schwann cells 
were cultured from P8-10 OEfl/fl mice. Schwann cell cultures were infected with a 
cre recombinant adenovirus or a GFP adenovirus as a control. Naïve cells which 
underwent no viral infection were also examined as a further control (referred to as 
control cells). c-Jun protein levels in these cultures were then examined by Western 
blot (Figure 4.1).  
The results showed no difference in c-Jun levels between the control cells and the 
GFP virus infected cultures, demonstrating that viral infection of Schwann cells has 
no effect on c-Jun expression. Infection with the cre virus however led to a big 
increase in c-Jun expression (Figure 4.1 A). Quantification of this increase revealed 
it to be a significant 3-fold increase relative to both control cells and GFP virus 
infected cells. No significant difference was observed between control and GFP virus 
infected cells (Figure 4.1 B). To visualise the increase in c-Jun in OEfl/fl cre infected 
cultures, GFP and cre infected cultures were fixed and immunolabelling of c-Jun 
performed (Figure 4.1 C). Greater c-Jun fluorescence was observed in the cre virus 
infected cultures compared to GFP virus infected ones.  
Together, Figure 4.1 confirms that the transgene insert in OEfl/fl mice can be 
activated by cre. c-Jun was successfully over expressed in Schwann cells cultured 
from this mouse infected with an cre adenovirus. The double control used in this 
study of naïve cells and an infection control in the form of GFP virus, which showed 
























Figure 4.1 | c-Jun protein expression increases in Cre infected OE/OEfl/fl mouse Schwann cell 
cultures 
(A) Representative Western blot of c-Jun expression in OE/OEfl/fl mouse Schwann cell cultures. 
Schwann cell cultures were infected with GFP virus, cre virus or no virus (con) for 48 hours. 
Infection with GFP virus had no effect on c-Jun levels however cre viral infection resulted in an 
increase in c-Jun levels. (B) Quantification of Western blots. c-Jun expression was normalised relative 
to GAPDH and samples were compared to the non-viral infection (control) to determine the fold 
change in expression. Infection with cre virus significantly increased c-Jun levels almost 4 fold 
compared to GFP virus and control infections. No significant differences in c-Jun levels were 
observed between control and GFP infected Schwann cells. (C) OE/OEfl/fl mouse Schwann cell 
cultures were immunolabelled for c-Jun and DAPI following viral infection. Cultures infected with 
cre virus expressed higher levels of c-Jun compared to those infected with GFP virus, confirming 
Western blot results. Graph of means ± SEM, n=4, one-way ANOVA and Tukey’s test, **=p<0.005. 
Scale bar: 100μm. 
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4.2 c-Jun and Shh mRNA is elevated in cre recombinant adenovirus infected 
OEfl/fl Schwann cell cultures  
The previous section has confirmed that c-Jun can be successfully over-expressed in 
the Schwann cells of the OEfl/fl  mouse. This model can be used to examine the effect 
of c-Jun over-expression in Schwann cells in vitro. Huang et al (2015) over 
expressed c-Jun in Schwann cell cultures using a lentivirus with a c-Jun vector. This 
study found that over expression of c-Jun in Schwann cells by this method led to 
increased levels of trophic factor expression and secretion by the cells. GDNF, 
BDNF and artemin were all examined. This increase in trophic factor production was 
credited for the increased neurite outgrowth observed when DRG explants were co-
cultured with the over-expressing cells (Huang et al., 2015). Based on these findings, 
it was hypothesized that over-expression of c-Jun in OEfl/fl cre infected cultures 
could lead to increased trophic factor expression. GDNF and BDNF are both 
contributors to the repair cell phenotype (Arthur-Farraj et al., 2012). If over-
expression c-Jun leads to increased trophic factors expression, other markers of the 
repair cell phenotype might also be affected. 
To examine effect of c-Jun over-expression on levels of repair cell markers in vitro, 
qPCRs for GDNF, BDNF, Olig1, c-Jun and Shh were performed on GFP virus and 
cre virus infected OEfl/fl   Schwann cell cultures (Figure 4.2). Results from this 
experiment further confirmed the activation of the c-Jun transgene in these mice with 
c-Jun expression increasing 3-fold in cre virus infected cells relative to those 
infected with GFP virus (p=0.0017) (Figure 4.2 A). Controversially, no significant 
increase in GDNF or BDNF expression was observed following cre infection (Figure 
4.2 B and C). Although a slight increase in BDNF was observed, this result was 
found not to be significant (p=0.413). GDNF expression was observed to be 
decreased in the cre infected cells although this was not a significant trend 
(p=0.0857). Olig1 expression was similarly lower in the cre infected cells but this 
data also proved to not be significant (p=0.2405) (Figure 4.2 D). Shh expression 
however was found to increase in the cre infected cells (p=0.0496) (Figure 4.2 E). 























Figure 4.2 | c-Jun and Shh mRNA expression increases in Cre infected OE/OEfl/fl mouse 
Schwann cell cultures 
(A) Viral infection of OE/OEfl/fl mouse Schwann cell cultures with cre virus for 48 hours significantly 
increased c-Jun RNA expression (p= 0.0017). No significant difference in RNA expression was 
observed in (B) GDNF, (C) BDNF or (D) Olig1. (E) Shh RNA expression also significantly increased 
following cre virus infection relative to the GFP virus control (p=0.0496). Graph of means ± SEM, 







4.3 p75 NTR protein expression is not affected by over-expression of Schwann 
cell c-Jun in vitro 
As previously described, p75 NTR is regulated by c-Jun at the protein level and is a 
marker of the repair cell phenotype (Arthur-Farraj et al 2012). Although over 
expression of c-Jun in vitro only led to a significant increase in Shh, it may lead to 
alterations in p75 NTR expression. To examine this, Western blots were performed 
on OEfl/fl mouse Schwann cell cultures infected with cre or GFP adenovirus. Naïve 
cells with no viral infection were also examined (referred to as control). The results 
showed that the infection did not lead to an increase in p75 NTR with control and 
GFP cultures expressing similar levels (Figure 4.3 A). The same effect was observed 
in c-Jun Western blots previously (Figure 4.1). No increase in p75 NTR was 
observed once the cells were infected with cre virus either however. Overall it was 
found that there was no significant difference in p75 NTR levels between any of the 



























Figure 4.3 | p75 NTR protein expression is not altered in Cre infected OE/OEfl/fl mouse Schwann 
cell cultures 
(A) Representative Western blot of p75 NTR expression in OE/OEfl/fl mouse Schwann cell cultures 
following viral infection. p75 NTR expression was similar under all conditions. (B) Quantification of 
Western blots found no significant difference between con, GFP virus or cre virus infected cultures. 
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Overal the results from these experiments to examine the effect of c-Jun over-
expression in vitro on the expression of repair cell markers only produced one 
significant finding. The expression of trophic factors GDNF and BDNF were not 
seen to increase, as they were expected to, based on the previous literature (Huang et 
al., 2015). It was further surprising that no increase in p75 NTR was observed 
despite the significant increase in c-Jun up-regulation, considering the relationship 
previously described between them (Arthur-Farraj et al., 2012). These results could 
be the consequence of various factors that will be discussed at the end of this 
chapter. However, most importantly, this work does demonstrate that the transgenic 




















4.4 Uninjured OE/+ Schwann cells do not express repair cell characteristics 
The work in the previous section of this chapter described examining the ability to 
increase c-Jun levels in Schwann cells in vitro by infecting cells from the OEfl/fl 
mouse with a cre adenovirus. By crossing the OEfl/fl mouse with a P0 cre mouse, a 
mouse mutant that specifically over-expresses c-Jun in Schwann cells can be 
generated.  
The cre-mediated recombination in Schwann cells occurs between embryonic day 
(E) 13.5 and 14.5 and the transgene remains active throughout life (Feltri, 
D’Antonio, Previtali, et al., 1999; Feltri, D’Antonio, Quattrini, et al., 1999) 
OE/+ and OE/OE mouse development has been extensively characterized (Fazal et 
al., 2017). c-Jun is a negative regulator of myelination (Parkinson et al., 2008) so it 
is important to determine not only the level of c-Jun activation in these mice but also 
the normality of their Schwann cells and nerve architecture. Uninjured OE/+ nerves 
express 6 times more c-Jun protein compared to WT nerves at postnatal day 7 
whereas OE/OE nerves express a 19-times more. Despite the elevation of c-Jun, the 
OE/+ mouse development is relatively normal with only a slightly thinner myelin 
sheath forming compared to WT littermates with a slightly delayed onset of 
myelination. The OE/OE nerves however have no myelin sheaths around larger 
axons or alternatively thin myelin sheaths, a larger nerve area and characteristics of 
peripheral neuropathies (Fazal et al., 2017).  
As Fazal et al (2017) have demonstrated, c-Jun is over-expressed in the uninjured 
nerves of OE/+ and OE/OE mice. As we know that c-Jun is the global regulator of 
the Schwann cell repair phenotype, it is important to determine if repair cell 
characteristics can be seen in the uninjured nerves of these mice. To examine this, 
qPCRs of repair cell markers in uninjured nerves from OE/+, OE/OE and WT 
littermates were compared (Figure 4.4). Trophic factors GDNF and BDNF were 
examined. Shh was also examined as work earlier in this chapter found that over-
expression of Schwann cell c-Jun led to a significant up-regulation of Shh (Figure 
4.2). c-Jun was also examined to determine the level of mRNA in the uninjured 
nerves. The results also demonstrate the increase of c-Jun required to elevate repair 
cell markers. As uninjured WT nerves were found to have very low expression of 
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repair cell markers, qPCR data was analysed as fold increase relative to the uninjured 
OE/+ mouse. 
 Interestingly, the data from these qPCRs found no significant difference in c-Jun 
levels expressed between WTs and OE/+ mice, despite the differences in c-Jun 
protein levels previously reported (Figure 4.4 A). OE/OE mice however had a 
significant 3-fold increase in c-Jun mRNA compared to both the WT and OE/+ 
nerves. In line with in vitro work described earlier in this chapter, Shh increased 
when c-Jun was also elevated (Figure 4.4 B). A significant 6-fold increase in Shh 
occurred in OE/OE nerves relative to OE/+ and WT, in which Shh levels were found 
to be equal.   
No significant difference in trophic factor expression was found either between WT 
and OE/+ nerves (Figure 4.4 C and D). GDNF and BDNF levels were consistent 
between these samples. A large increase in GDNF levels was however observed in 
OE/OE nerves (Figure 4.4 C). These uninjured nerves showed an almost 90-fold 
increase in expression. This up-regulation was found to be significant compared to 
low levels observed in WT and OE/+ nerves. Despite the over-expression of c-Jun in 
OE/OE nerves, no change was observed in BDNF expression (Figure 4.4 D). Levels 
were even observed to be lower in this mutant compared to the OE/+ nerves.  
Together, these experiments provide further evidence that the nerves of OE/OE mice 
are abnormal. Schwann cells in these nerves have several markers of the repair cell 
phenotype activated. This suggests that a 3-fold increase in c-Jun mRNA levels in 
vivo is sufficient to activate markers of the repair cell phenotype. It is however 
surprising that no change is observed in c-Jun expression between WT and OE/+ 
nerves, despite the increase in protein. However, no increase in repair cell markers 
were observed in these nerves either. This finding is positive as it demonstrates that 
the uninjured nerves of these mice are relatively normal. The insertion of the 
transgene is not sufficient to elevate c-Jun RNA levels even if increased protein 
levels are seen. The lack of repair cell markers expressed in these nerves 
demonstrates the Schwann cells present in the nerve are currently adult myelin and 



















Figure 4.4 | Uninjured OE/OE nerves express increased levels of c-Jun, Shh and GDNF mRNA 
(A) qPCR of uninjured nerves showed that no significant difference was observed in c-Jun expression 
between WT and OE/+ nerves. OE/OE nerves however expressed significantly higher levels of c-Jun 
relative to WT (p=<0.005) and OE/+ nerves (p=<0.05). (B) Shh was highly expressed in OE/OE 
nerves (p=<0.05) whereas no change was observed between WT and OE/+. (C) GDNF was 
significantly up-regulated in OE/OE nerves (p=<0.05) compared to WT and OE/+ nerves. (D) BDNF 
up-regulation however was not observed across any of the genotypes. Graph of means ± SEM, n= 4, 










4.5 OE/+ nerves maintain c-Jun during chronic denervation  
Now it has been confirmed that uninjured OE/+ nerves are largely normal, the c-Jun 
expression in these mice can be examined after injury. OE/+ mice and WT 
littermates underwent sciatic nerve cut followed by 1, 3 or 10 weeks denervation 
(Figure 4.5). Subsequent Western blots found that there was no difference in the 
levels of c-Jun 1 week after injury (Figure 4.5 A). WT samples were found to down-
regulate c-Jun following the period of chronic denervation, as was previously 
observed in Chapter 3. Samples from the OE/+ mice however showed consistent 
levels of c-Jun expression throughout the period examined. OE/+ uninjured nerves 
were found to have increased levels of c-Jun protein relative to WT, although this 
was not found to be significant (Figure 4.5 B). No significant difference was 
observed between the WT and OE/+ c-Jun levels during acute denervation (1-3 
weeks). However, after chronic denervation, the difference in c-Jun observed 
























Figure 4.5 | OE/+ distal nerve stumps maintain c-Jun protein expression following chronic 
denervation  
(A) Western blots showed that WT nerves followed previously observed patterns of c-Jun up-
regulation and decline during injury. In contrast, OE/+ nerves maintained consistent levels of c-Jun 
throughout chronic denervation. (B) Analysis of the blots showed that WT nerves down-regulated c-
Jun following chronic denervation. OE/+ nerves however maintained c-Jun expression from acute 
injury through chronic denervation. OE/+ nerves expressed significantly higher levels of c-Jun 
following chronic denervation compared to WT littermates (p=<0.05). Graph of means ± SEM, n= 5, 
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4.6 c-Jun maintenance in OE/+ nerves in chronic denervation is Schwann cell 
specific 
OE/+ mice maintain c-Jun in the distal nerve stump during chronic denervation, 
however, as previously discussed, the peripheral nerve is composed of several cell 
types after injury. As was shown in Chapter 3, cells other than Schwann cells 
express c-Jun (Figure 3.3 a’ and b’). It is therefore necessary to confirm that the 
maintenance of c-Jun observed in these mice is Schwann cell specific. Sox 10 c-Jun 
dual immunolabelling described previously can be utilized to examine this. OE/+ 
mice and WT littermates underwent a sciatic nerve cut for 1 or 10 weeks. Transverse 
sections of nerves were sectioned and immunolabelled with antibodies for c-Jun and 
Sox10 (Figure 4.6). Very few c-Jun positive cells were observed in the uninjured 
nerves of WT mice. Almost all cells however were c-Jun positive and Sox 10 
positive 1 week after injury. After 10 weeks however, many cells were Sox10 
positive c-Jun negative, while OE/+ uninjured nerves had many c-Jun positive Sox 
10 positive cells. Similarly to the WT nerves, at 1 week, almost all cells were c-Jun 
positive Sox 10 positive, however unlike in WT nerves, 10 weeks after injury many 
cells were still c-Jun positive, Sox 10 positive. The number of Sox10 positive cells 
were counted as was the number of these cells that also expressed c-Jun. The 
percentage of c-Jun Sox 10 positive cells after injury was then calculated (Figure 4.6 
B). 1 week after sciatic nerve cut, 94% of WT Schwann cells had up-regulated c-Jun. 
Similarly, 98% of OE/+ Schwann cells expressed c-Jun. However, following chronic 
denervation, 30% of Schwann cells present in WT nerves had down-regulated c-Jun 
while in OE/+ nerves, 94% of Schwann cells still express c-Jun.   
Together, these data demonstrate that during chronic denervation, OE/+ Schwann 
cells maintain c-Jun levels. If the repair cell phenotype is therefore similarly 
maintained, the deterioration of the distal nerve stump might be prevented and thus 
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Figure 4.6 | OE/+ Schwann cells in the distal nerve stump maintain c-Jun expression during 
chronic denervation  
(A) Sox 10 c-Jun dual immunolabelling of transverse sections from WT and OE/+ nerves (B) The 
percentage of c-Jun positive Sox 10 positive cells. WT Schwann cells had significantly down-
regulated c-Jun following chronic denervation (p=<0.001) OE/+ Schwann cells did not down-regulate 
c-Jun and after 10 weeks denervation expressed significantly higher levels compared to WT 
littermates at 10 weeks after denervation (p=<0.001). Graph of means ± SEM, n= 3, two-way 





















4.7 p75 NTR is not maintained in WT or OE/+ nerves during chronic 
denervation  
Having demonstrated that OE/+ Schwann cells maintain c-Jun levels during chronic 
denervation, it is now possible to assess whether the repair cell phenotype is also 
maintained. To start examining this, p75NTR expression following acute and 
chronic denervation can be measured in OE/+ nerves compared to WT. As 
previously shown, p75 NTR is down-regulated in WT nerves during chronic 
denervation (Chapter 3, You et al; 1997). OE/+ Schwann cell may maintain p75 
NTR during chronic denervation in response to the maintenance of c-Jun. As c-Jun 
only regulates p75 NTR protein and not mRNA expression, Western blots of WT 
and OE/+ nerves were performed following acute or chronic denervation (Figure 4.7 
A). As in Figure 3.4, p75 NTR expression was highly up-regulated following injury 
in WT nerves and steadily declined with time. Surprisingly however, p75 NTR was 
not initially as highly up-regulated in OE/+ nerves and these lower levels were 
maintained with time. Quantification of this data demonstrated that there were no 
significant differences in p75 NTR expression between WT and OE/+ nerves during 
acute or chronic denervation (Figure 4.7 B). Uninjured nerves had equal levels of 
expression which is consistent with the findings in this chapter that OE/+ uninjured 
nerves c-Jun elevation is not elevated enough to activate the repair cell phenotype. 
During acute denervation of 1-3 weeks injury, no difference is observed in c-Jun 
levels and no significant difference in p75 NTR expression is observed between the 
two genotypes, although the OE/+ expression is slightly but not significantly higher 
at 3weeks. However, as shown earlier following chronic denervation, c-Jun OE/+ 
mice maintain c-Jun in the distal nerve stump at 10 weeks after denervation (Figure 
4.5-6), yet despite the previous links between c-Jun and p75 NTR protein levels, 
OE/+ mice only show slightly higher levels of  p75 NTR expression from WT nerves 



















Figure 4.7 | p75 NTR protein expression is not maintained in WT or OE/+ nerves during 
chronic denervation 
(A) WT nerve expression of p75 NTR was similar to that observed previously. Protein was highly 
elevated at 1-3 weeks after injury with levels declining by 10 weeks after injury. OE/+ nerves 
however initially expressed slightly lower levels of p75 NTR following injury compared with WT 
nerves,  although the difference was not significant (B) Quantification of blots showed that WT and 
OE/+ nerves displayed similar expression patterns of p75 NTR following injury with no significant 
differences in expression observed at any time point. Graph of means ± SEM, n=5, two-way ANOVA 
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4.8 Trophic factors are not maintained during chronic denervation by WT or 
OE/+ nerves  
As it was found that p75 NTR expression was not maintained in the distal nerve 
stump during chronic denervation, other markers of the repair cell phenotype were 
examined. Nerves from WT mice 1 and 10 weeks following injury and nerves from 
OE/+ mice 10 weeks after injury were examined for c-Jun, Shh, GDNF and BDNF 
mRNA expression by qPCR (Figure 4.8). It was found that c-Jun was significantly 
down-regulated in WT nerves following chronic denervation with c-Jun mRNA 
expression decreasing 70% (Figure 4.8 A). OE/+ nerves did down-regulate c-Jun 
with time after denervation, but this finding was not significant and levels were 
higher compared to those in chronically denervated WT nerves. Shh was similarly 
found to significantly decrease during chronic denervation in both genotypes (Figure 
4.8 B). Shh expression decreased by 89% in WT nerves and 59% in OE/+ nerves. 
Nevertheless, OE/+ nerves retained significantly higher Shh expression compared to 
WT nerves at 10 weeks. Trophic factors GDNF and BDNF decrease in the distal 
nerve stump following chronic denervation (Höke et al., 2002; Michalski et al., 
2008). This finding was confirmed here. GDNF was significantly down-regulated in 
WT nerves following chronic denervation. Interestingly, GDNF expression was not 
elevated in OE/+ nerves and levels were even lower than those observed in WT 
nerves (Figure 4.8 C). BDNF expression was decreased in WT nerves following 
chronic denervation however this was not a significant finding (Figure 4.8 D). BDNF 
expression is gradually up-regulated following injury, therefore WT nerves express 
similar levels during acute and chronic denervation (Michalski et al., 2008). OE/+ 
nerves however did significantly down-regulate BDNF by 86%. These results 
demonstrate that some elements of the repair cell phenotype, such as expression of c-
Jun and Shh, are higher in OE/+ nerves compared to WT following chronic 
denervation. However trophic factors GDNF and BDNF are not elevated in these 
nerves and are observed to be even lower. Possible reasons for these findings will be 



















Figure 4.8 | Repair cell marker mRNA is not maintained in WT or OE/+ distal nerve stumps 
following chronic denervation  
qPCR of  nerve stumps of WT and OE/+ nerves following chronic denervation compared with acutely 
denervated WT nerves. (A) c-Jun significantly decreased in WT nerves following chronic 
denervation. Levels were elevated in OE/+ nerves and were not significantly lower than levels 
expressed during acute injury. (B) Shh was significantly decreased in both genotypes however OE/+ 
expressed significantly more than chronically denervated WT nerves. (C) GDNF was also 
significantly decreased in both genotypes with OE/+ expressing even lower levels than WT nerves. 
(D) BDNF expression was decreased in both genotypes, however this was only significant in OE/+ 
nerves. Graphs are means ± SEM, n=3, two-way ANOVA with Tukey’s test. *=p=<0.05, 









4.9 OE/+ nerves have significantly more Schwann cells and macrophages than 
WTs following chronic denervation   
The deterioration of the distal nerve stump, as well as being defined by the nerve 
down-regulating trophic factors that promote axon regeneration, is further defined by 
the death of Schwann cells (Abercrombie & Johnson, 1946; Weinberg & Spencer, 
1978; Siironen et al., 1994; Hall, 1999; Benito et al., 2017). c-Jun has previously 
been shown to control Schwann cell proliferation through activation via JNK 
signalling although c-Jun cKO nerves only have reduced proliferation under certain 
conditions (Parkinson et al., 2004; Arthur-Farraj et al., 2012). Uninjured adult OE/+ 
Schwann cells also demonstrate an increased rate of proliferation compared to WT 
(Fazal et al., 2017).  
It was therefore hypothesized that maintaining c-Jun expression in the distal nerve 
stump, might prevent Schwann cell death. To investigate Schwann cell numbers in 
acute chronically denervated nerves, nerves were processed and counted by EM 
(Figure 4.9 D). In contrast to some previous findings, no significant Schwann cell 
death was observed in chronically denervated WT nerves at the time period 
examined (Figure 4.9 A). Although no significant difference in Schwann cell number 
was observed between genotypes in acute denervation, 1 week injured OE/+ mice 
had significantly more Schwann cells than WT 10 weeks after injury. OE/+ Schwann 
cell numbers were maintained during chronic denervation, with numbers slightly 
increasing. These numbers were significantly higher compared to WT nerves at any 
stage examined.  
Other cell populations can be examined by EM such as macrophages and fibroblasts. 
Macrophages were counted in acute and chronically denervated nerves. Cells with 
typical macrophage morphology and a visible nucleus were counted (Figure 4.9 D). 
Counts showed that WT and OE/+ nerves had equal numbers of macrophages 
present in the nerve following injury (Figure 4.9 B). Macrophage numbers then 
significantly decreased in WT nerves during chronic denervation. Macrophage 
numbers in OE/+ nerves however did not decline. OE/+ nerves had significantly 
more macrophages remaining in the nerve compared to WT nerves. Fibroblasts were 
also counted. Cells that displayed typical fibroblast morphology with a visible 
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nucleus were counted (Figure 4.9 C and D). No difference in fibroblast numbers 




















































Figure 4.9 | OE/+ nerves have more Schwann cells and macrophages than WT following chronic 
denervation 
(A) Schwann cells were counted by EM in WT and OE/+ nerves following acute and chronic 
denervation. Equal numbers of cells were observed during acute injury, with OE/+ nerves containing 
an increased number of Schwann cells following chronic denervation relative to WT. (B) Macrophage 
numbers following acute and chronic denervation in both genotypes. Numbers significantly decreased 
in WT nerves following chronic denervation. Macrophages however remained present following 
chronic denervation of OE/+ nerves. (C) Fibroblast numbers remained consistent in both genotypes 
following both injury paradigms. (D) Representative images of each cell type counted. EM images 
taken 10 weeks after injury. Four Schwann cells (Sc) are depicted in the left panel. A fibroblast (Fb) 
and macrophage (Mc) are shown in the right. The fibroblast is characterised by its bipolar 
morphology whereas the macrophage extends multiple processes. Graphs of means ± SEM, 1W WT 
n= 4, 1W OE/+ n=5, 10W WT and OE/+ n=3, two-way ANOVA with Tukey’s test, *=p=<0.05, 




















4.10 OE/+ nerves recruit a greater number of macrophages to the injury site 
OE/+ nerves have a greater number of macrophages present following chronic 
denervation. Although OE/+ nerves did not have higher macrophage numbers 
following acute injury than WT nerves when examined by EM, there may still be 
higher numbers present at earlier time points. c-Jun cKO mice have a reduced 
number of macrophages 1mm from the cut site in the nerve 3 days after cut. This 
difference is only observed close to the injury site and was attributed to the c-Jun 
cKO Schwann cells reduced capacity to recruit macrophages to this site (Arthur-
Farraj et al., 2012). It could therefore be argued that OE/+ Schwann cells may recruit 
more macrophages to the injury site compared to WT in the early days of injury. The 
EM data discussed previously (Figure 4.9) is taken 5mm from the injury site. The 
injury site and the distal nerve stump should therefore both be examined. To examine 
macrophage numbers in OE/+ and WT mice, nerves were crushed for 3 days and 
transverse sections of the whole nerve taken. Sections were labelled for the universal 
macrophage marker F4/80 (Austyn & Gordon, 1981; Hirsch et al., 1981) (Figure 
4.10 A). F4/80 positive cells with a visible nucleus were counted within the field of 
view grid at various distances distal to the crush site (Figure 4.10 B). No overall 
differences were observed throughout the nerve in macrophage numbers, however a 
trend towards higher numbers at the crush site was observed in OE/+ nerves. When 
the data from the crush site was individually examined (Figure 4.10 C), it was found 
that OE/+ nerves had greater numbers of macrophages present at the injury site 
(p=0.0054). Individual examination of other distances found no significant 
differences. This increase in macrophage numbers to the injury site may help 











































Figure 4.10 | OE/+ nerves attract more macrophages to the crush site  
(A) F4/80 immunolabelling in transverse nerve sections. (B) Counts of macrophage numbers 
throughout the nerve. OE/+ nerves were observed to attract more macrophages to the injury site. No 
difference was found in the number of macrophages present in the nerve overall, two-way ANOVA 
with Sidak’s test. (C) The number of macrophages at the crush site. OE/+ nerves attracted 
significantly more macrophages to the injury site compared to WT (p=<0.005), unpaired Student’s T-























4.11 OE/+ nerves recruit higher numbers of M2 macrophages to the injury site 
Current work in immunology is emphasizing the importance not only the presence of 
macrophages but the polarization of subpopulations. Macrophages can be classified 
broadly as M1 or M2. M2 subtypes M2a, M2b and M2c are present and are normally 
grouped as M2 (Mills et al., 2000; Stein et al., 1992) (for review - (Mosser, 2003; 
Mantovani et al., 2004). Generally, M1 macrophages are classified as inhibitory and 
pro-inflammatory whereas M2 are involved with regeneration and tissue remodelling 
(Kigerl et al., 2009; Ruffell et al., 2009; Zhang et al., 2010; Sindrilaru et al., 2011; 
Mokarram et al., 2012) 
To examine the different subpopulations of macrophages after injury, transverse 
sections of 3 day crushed nerves were stained with arginase, a marker of M2 
macrophages (Hesse et al., 2001; Edwards et al., 2006; Kigerl et al., 2009) and F4/80 
to confirm macrophage specification (Figure 4.11 A). Counts of these sections found 
a very significant increase in M2 macrophages present at the injury site in OE/+ 
nerves, with almost double the number of M2 macrophages present (Figure 4.11 B). 
No difference in M2 numbers was observed at any other distance distal to the injury 
site, with cell numbers steeply declining from 2mm onwards. As M2 macrophages 
have been shown to improve regeneration in peripheral nerves (Mokarram et al., 
2012), OE/+ nerves may have improved axon regeneration initially during short term 














Figure 4.11 | OE/+ nerves attract more M2 macrophages to the crush site 
 (A) Transverse sections of 3 days crushed nerves were immunolabelled with the M2 macrophage 
marker arginase. (B) Counts of M2 macrophages as various distances distal to the crush site found the 
OE/+ nerves had significantly more cells present at the crush site compared to WT (p=<0.0001). No 
difference was observed at other distances distal to the crush. Graph of means ± SEM, WT n=4, OE/+ 


















4.12 M1 macrophages are present in the peripheral nervous system 
Ydens et al (2012) have suggested that the regenerative capacity of the PNS is due to 
the presence of M2 macrophages. They suggested that inhibitory, inflammation 
inducing M1 macrophages are not present in the PNS and that only M2 macrophages 
are activated following nerve injury (Ydens et al., 2012). It was hypothesized that 
this may be incorrect and that due to the significantly higher numbers of M2 
macrophages present at OE/+ injury sites, OE/+ may have a reduced number of M1 
macrophages. Nerves were initially labelled with antibodies for the M1 macrophage 
marker iNOS but no positive labelling was observed (data not shown) (Kigerl et al., 
2009; Ydens et al., 2012) . It was therefore concluded that M1 macrophages in the 
PNS may not express iNOS and that other markers should be examined. Pilot studies 
of labelling with CD16/32 antibodies demonstrated labelled cells in the peripheral 
nerve 3 days after crush (Figure 4.12 A). A trend towards OE/+ nerves potentially 
recruiting more M1 macrophages was observed (Figure 4.12 B). As with previous 
work, the greatest difference between the two genotypes was observed at the injury 
site (4.12 C). However, due to the low sample size examined, a large spread is 
observed in the data. Further experiments are required to determine if a true 
difference is present. This work however suggests that M1 macrophages are present 


























Figure 4.12 M1 macrophages are present in the sciatic nerve post injury  
(A) Respresentative CD16/32 immunolabelling in the sciatic nerve 3 days after crush (B) Counts of 
CD16/32 positive macrophages in the nerves of WT and OE/+ 3 days after crush. OE/+ nerves were 
observed to have slightly more M1 macrophages present in the nerve closer to the injury site. (C) 
Counts of CD16/32 positive macrophages at the crush site. OE/+ nerves attracted slightly more M1 
macrophages to the injury site compared to WT nerves, however the small sample size prevents 









4.13 Discussion  
This chapter aimed to examine if c-Jun maintenance during chronic denervation can 
be achieved through the use of the OE/+ mouse. The OE/+ mouse was generated by 
breeding the OEfl/fl mouse with a P0-cre line. To initially examine the effect of c-Jun 
over-expression on Schwann cells, cultures from the OEfl/fl mouse were generated. 
Infection of OEfl/fl Schwann cell cultures significantly increased levels of both c-Jun 
protein and mRNA (Figures 4.1 and 4.2). Work by Huang et al (2015) has previously 
shown that over-expression of c-Jun in cultured Schwann cells increases secretion 
and expression of trophic factors GDNF and BDNF. Here however no such increases 
were seen in vitro despite a 3- fold increase in c-Jun protein and RNA expression 
(Figure 4.1 and 4.2). However, this increase may not be enough to elevate trophic 
factors. Cultured Schwann cells already express high levels of GDNF and BDNF 
(Acheson et al., 1991; Meyer et al., 1992; Springer et al., 1995). It may not be 
possible to elevate levels further. The previous study also fails to report the 
quantitative increase in c-Jun that is generated through their viral infection, only that 
it is successful. As the level of c-Jun increase required to elevate trophic factors is 
not reported, the data presented here cannot be compared to this study as the 
elevation of c-Jun required may be significantly higher than that reported here 
(Huang et al., 2015). Although the results from these experiments (Figure 4.2) were 
contradictory to the literature and the desired increases in repair cell markers were 
not observed, these experiments did demonstrate that the transgene in the OEfl/fl 
mouse is functional. Experiments were therefore carried out to examine the effect of 
c-Jun over-expression and maintenance in vivo by crossing the OEfl/fl mouse with a 
P0-cre line to generate a mouse that over expressed c-Jun specifically in Schwann 
cells.  
Although expression of c-Jun in uninjured nerves of mouse model of CMT1A 
neuropathy has previously been found to be neuroprotective (Hantke et al., 2014), 
OE/OE mice exhibit disrupted myelination and Schwann cell proliferation (Fazal et 
al., 2017). The uninjured nerves of these mice at postnatal day 7 express 19 times 
more c-Jun protein than WT nerves. Here, it was found that Schwann cells in 
uninjured nerves from these mice express high levels of repair cell markers, such as 
Shh and GDNF. This data further contributes to the abnormal characterisation of this 
mouse. The results here however indicated that OE/+ nerves do not express higher 
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levels of c-Jun mRNA despite a significant elevation in c-Jun protein. c-Jun RNA 
expression may be different between the two genotypes, but the method might not be 
sensitive enough to detect it as c-Jun protein expression is low in WT nerves (Hantke 
et al., 2014). The most important finding from these experiments was that uninjured 
OE/+ nerves do not have markers of the repair cell phenotype elevated, further 
enforcing the previous findings that the nerves of these mice are largely normal. 
These mice can therefore be used to examine the effect of c-Jun over-expression on 
acute and chronic injury.  
It was found that following short term injury (1-3 weeks), WT and OE/+ Schwann 
cells express equal levels of c-Jun. However, 10 weeks after injury, whilst WT 
Schwann cells down-regulated c-Jun, OE/+ Schwann cell levels were maintained. 
These mice can thus be used to examine if c-Jun maintenance during chronic 
denervation maintains the repair cell phenotype.  
p75 NTR was described previously as a maker of the repair cell phenotype and it 
was shown that it is not maintained during chronic denervation (Figure 3.4) (You et 
al., 1997). Surprisingly, p75 NTR decreased in the distal nerve stumps of OE/+ mice 
during chronic denervation despite the maintenance of c-Jun. c-Jun has previously 
been shown to control p75 NTR protein expression, with c-Jun cKO nerves showing 
suppressed elevation of p75 NTR after injury (Arthur-Farraj et al., 2012). It was 
therefore expected that p75 NTR would be maintained in the distal nerve stump of 
OE/+ nerves. However other studies into peripheral nerve injury have found no 
correlation between c-Jun and p75 NTR protein levels. Stat3 cKO mice have a 
Schwann cell specific deletion of Stat3. Following chronic denervation, Stat3 cKO 
mice have significantly lower levels of c-Jun protein and RNA expression compared 
to WT mice. p75 NTR protein levels however remain consistent between the two 
genotypes. This suggests there is not always a direct correlation between c-Jun and 
p75 NTR protein levels (Benito et al., 2017).  
Suppression of p75 NTR may be beneficial to regeneration. Studies on p75 NTR-/- 
mice demonstrate that although p75 NTR is important for the development of the 
PNS, its activation during injury may be detrimental (Lee et al., 1992; Barrett & 
Bartlett, 1994; Ferri et al., 1998; Boyd & Gordon, 2001). The role of p75 NTR 
signalling has been suggested to involve apoptosis of neurons and oligodendrocytes 
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(Rabizadeh et al., 1993; Barrett & Bartlett, 1994; Casaccia-Bonnefil et al., 1996; 
Frade et al., 1996). Blockade of p75 NTR signalling after axonal injury in p75 NTR-/- 
mice found a decrease in Schwann cell apoptosis, demonstrating that the p75 NTR 
also mediates apoptosis in Schwann cells (Ferri et al., 1998; Syroid et al., 2000). 
Axon regeneration after injury has also been examined in p75 NTR -/- mice. 
Following peripheral nerve crush motor neuron regeneration and survival is 
enhanced in p75 NTR -/- mice (Ferri et al., 1998). Further studies examining motor 
neuron regeneration into repaired chronically denervated common peroneal nerves, 
found that motor neuron regeneration was greatly increased in p75 NTR -/- mice 
compared to WTs (Boyd & Gordon, 2001). The benefits of low p75 NTR expression 
in glia cells have further been demonstrated in olfactory ensheathing cells (OECs). In 
the olfactory bulb, there are two population of OECs, those expressing high p75 
NTR levels and those expressing low levels. Low p75 NTR expression in OECs 
results in activation of  genes that control cell adhesion and axon guidance (Honoré 
et al., 2012). Repression of p75 NTR maintenance may therefore improve nerve 
regeneration and Schwann cell survival.  
Other markers of the repair cell phenotype can be examined by qPCR. Experiments 
demonstrated that c-Jun and Shh are elevated in OE/+ nerves following chronic 
denervation however trophic factors GDNF and BDNF are not. GDNF and BDNF 
both enhance axon regeneration following chronic denervation (Boyd & Gordon, 
2003). GDNF is directly controlled by c-Jun (Fontana et al., 2012), it is therefore 
conflicting that c-Jun is elevated in OE/+ nerves while GDNF is even lower in these 
nerves compared to WT nerves. However c-Jun RNA expression in OE/+ nerves 
following chronic denervation is decreased by 44%, yet the protein levels are 
maintained. It is therefore important to also examine the protein levels of GDNF and 
BDNF. It may also be that the technique used here is not sensitive enough to detect 
small changes in expression. These samples should therefore be subjected to RNA 
sequencing to determine changes in these genes and genes other than the ones 
examined here to provide a more comprehensive method for deciphering significant 
changes in both WT and OE/+ acute and chronically denervated nerves.  
Despite c-Jun maintenance not maintaining some markers of the repair cell 
phenotype, it may affect other aspects of the deterioration of the distal nerve stump 
such as Schwann cell death (Abercrombie & Johnson, 1946; Weinberg & Spencer, 
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1978; Siironen et al., 1994; Hall, 1999; Benito et al., 2017). Schwann cell numbers 
were counted in the distal nerve stump by EM following acute and chronic 
denervation. Counts revealed that OE/+ nerves had significantly more Schwann cells 
present following chronic denervation compared to WT distal nerve stumps. 
However, Schwann cell numbers counted by electron microscopy did not change 
between 1 week and 10 weeks in WT nerves. Previous work that has used this 
method has found that 1 week after injury, almost 100 more cells are present in the 
WT nerve compared to the numbers reported here (Arthur-Farraj et al., 2012). It is 
impotant to remember however that although these mice are considered to be WT 
controls, they are still transgenic mice carrying an inactive form of the transgene. 
This could account for the discrepancies in Schwann cell numbers seen between 
Figure 4.9 and those reported by Arthur-Farraj et al (2012), as two transgenic lines 
are being compared as opposed to pure WT animals. To investigate this issue further, 
experiments will be repeated on acutely denervated WT nerves from the appropriate 
strains at 1 week and 2 weeks after injury to confirm these findings. Previous 
investigations into Schwann cell numbers by this method in 10 week denervated 
stumps however confirmed numbers similar to those observed here so these data will 
not be repeated (Benito et al., 2017).  
Macrophage numbers were also counted by EM. Macrophages play a key role in 
regeneration in the peripheral nervous system. Macrophages are recruited to the 
injured nerves 1-2 days post injury and remain present in the nerve for up to 3 weeks 
where they play a key role in the later stages of myelin breakdown (Perry et al., 
1987; Stoll et al., 1989; Raivich et al., 1991; Perry et al., 1995; Liu et al., 1995; 
Hirata et al., 1999; Hirata & Kawabuchi, 2002). When macrophage infiltration, 
migration and polarization in the injured nerve is altered, the rate of axon 
regeneration is reduced (Dailey et al., 1998; Barrette et al., 2008; Vargas et al., 2010; 
Chen et al., 2015).  
Counts of macrophages in chronically denervated distal nerve stumps of WT and 
OE/+ mice indicated that OE/+ nerves retained macrophages. It was also found that 
3 days after crush, OE/+ nerves recruited more macrophages to the injury site 
compared to WT nerves. A link between c-Jun and macrophage recruitment has 
previously been established (Arthur-Farraj et al., 2012), it was therefore expected 
that OE/+ nerves would attract a greater number to the injury site.  
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The increased number of M2 macrophages in OE/+ nerves could aid peripheral 
nerve regeneration. Mokarram et al (2012) polarised macrophages to M1 or M2 
populations in the peripheral nerve using a scaffold containing IFN-γ (M1) or IL-4 
(M2) to bridge a transected sciatic nerve. M2 macrophage polarisation was found to 
improve Schwann cell migration into the graft and improve axon regeneration 
(Mokarram et al., 2012). Similarly, exposure to M2 macrophages increases growth 
of adults DRGs through inhibitory chondroitin sulfate proteoglycans and promotes 
cortical neuron growth and survival (Kigerl et al., 2009). Increased number of M2 
macrophages observed in OE/+ nerves may therefore enhance axon regeneration.  
In contrast to M2 macrophages, M1 macrophages are generally classed as inhibitory. 
It has been previously suggested that there are no M1 macrophages in the PNS 
(Ydens et al., 2012). To test this, transverse sections from 3 day crushed nerves were 
immunolabelled with CD16/32 antibodies. The results showed that there were many 
CD16/32 positive cells present in the nerve. Other studies have found M1 
macrophages present in the PNS after injury. However, representative images of 
iNOS labelling from this work is weak (CLR De La Hoz et al., 2003). Work for this 
thesis was unable to detect positive iNOS staining in injured nerves, hence CD16/32 
was examined. Although it was hypothesized that OE/+ nerves might attract fewer 
M1 macrophages to the injury site due to their increased M2 population, more were 
observed compared to WT. However, this work only had a sample size of 2 so 
further experimental repeats are required before any conclusion can be drawn. In 
order to truly confirm macrophage subpopulations in the nerve, multiple markers for 
each classification should also be tested especially as macrophages can express 
markers from other subtypes. Arginase for example is induced in M1 macrophages 
under certain conditions (El Kasmi et al., 2008). Guidelines are now proposed on 
how to correctly report macrophage activation and polarization, (Murray et al., 2014; 
Martinez & Gordon, 2014). However, this work so far does dispute the fact that M1 
macrophages are not present in the PNS.  
Overall, the work in this chapter has found that Schwann cell c-Jun can be 
maintained during chronic denervation. However, maintenance of c-Jun does not 
equate to maintenance of all the markers of the repair cell phenotype. Trophic factor 
expression significantly decreased during chronic denervation in both WT and OE/+ 
nerves, while Shh and c-Jun expression was higher in OE/+ nerves. c-Jun 
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maintenance however resulted in an increase in the number of Schwann cells and 
macrophages present in the distal nerve stump following chronic denervation. This 
alone may enhance axon regeneration into chronically denervated distal nerve 






















5. The regenerative capacity of WT and OE/+ nerves following acute and 
chronic denervation  
The reduced capacity for chronically denervated distal nerve stumps to promote axon 
regeneration in the PNS has been a topic of study for many decades (Cajal, 1959); 
(Holmes & Young, 1942; Sunderland, n.d.). 
One of the factors that contributes to this phenomenon is the deterioration of the 
nerve stump distal to the injury. This is defined as the decline in the ability of the 
distal nerve stump to support axonal growth due to down-regulation of trophic 
support for axon regeneration and a gradual decline in cell numbers (Abercrombie & 
Johnson, 1946; Weinberg & Spencer, 1978; Siironen et al., 1994; You et al., 1997; 
Hall, 1999; Höke et al., 2002; Michalski et al., 2008; Eggers et al., 2010; Benito et 
al., 2017). As axons regenerate at a rate of 1-2mm per day (Buchthal & Kühl, 1979), 
the distal nerve stump they are regenerating into has often already lost its ability to 
support them when they arrive.  
The work presented in this thesis has revealed that c-Jun, and the repair cell 
phenotype, are not maintained during chronic denervation and this is suggested to be 
the cause of many aspects of distal nerve stump deterioration. I have shown that 
OE/+ Schwann cells maintain c-Jun expression from acute to chronic injury (Figure 
4.5-6). Although trophic factors are not maintained in OE/+ nerves during chronic 
denervation, Shh and c-Jun expression is elevated (Figure 4.8). OE/+ nerves also 
have an increased number of Schwann cells and macrophages present in the nerves 
following chronic denervation (Figure 4.9). It is therefore hypothesized that c-Jun 
maintenance may prevent the regeneration deficit observed with chronic denervation.  
To examine regeneration into denervated distal nerve stumps, a nerve cross suture 
model can be used (sometimes referred to as cross-anastomosis). This model has 
been used extensively to examine regeneration into denervated stumps. Commonly, a 
branch of the sciatic nerve, the tibial or common peroneal, is transected then later 
repaired by suturing the denervated distal nerve stump to a freshly cut promixal 
stump of a neighbouring nerve. This overcomes the issues that would arise if the 
repair was performed with the nerve’s own proximal stump.These include nerve 
shrinkage and the inhibitory effects of chronic axotomy on nerve regeneration. 
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(Abercrombie & Johnson, 1946; Holmes & Young, 1942; Fu & Gordon, 1995; Boyd 
& Gordon, 2002a, 2003) 
The regeneration into denervated stumps then must be quantified. One of the most 
accurate methods for analysis is counting cell bodies of neurons that have been 
labelled by retrograde labelling. A labelling dye is applied to the distal nerve stump 
either through injection into the stump or muscle or cutting the nerve. Regenerating 
axons exposed to the dye will transport the dye retrogradely, resulting in labelling of 
their somas. Motor neurons can be counted in the spinal cord and sensory neurons in 
the DRGs. Flurogold is a widely used in retrograde labelling due to its low diffusion 
and lack of fading. It is also not taken up by undamaged fibres (Schmued & Fallon, 
1986; Brushart, 1993; Sagot et al., 1998; Puigdellívol-Sánchez et al., 1998; Sulaiman 
& Gordon, 2000; Haenggeli & Kato, 2002; Boyd & Gordon, 2002b, 2003; Catapano 
et al., 2016). 
The aims of this chapter are therefore to use nerve-cross suture and retrograde 
labelling with flurogold to: 
-  determine that WT and OE/+ nerves have equal numbers of motor and 
sensory neurons  
- establish the regenerative capacity of WT and OE/+ nerves during acute and 
chronic denervation  
- investigate if the regenerative capacity of the distal nerve stump can be 










5.1 WT and OE/+ common peroneal nerves have equal numbers of motor and 
sensory neurons  
Before the regenerative capacity of OE/+ nerves following denervation can be 
examined, it is first important to confirm that WT and OE/+ mice have equal 
numbers of motor and sensory neurons. No difference has previously been observed 
in the number of axons present in the tibial nerves of these mice (Fazal et al., 2017). 
However it is also important to determine that backfilling with flurogold is equally 
efficient in both genotypes. To confirm these points, both genotypes underwent 
backfilling of the uninjured common peroneal nerve, as the common peroneal nerve 
proximal stump will be used to repair the tibial nerve. The branches of the sciatic 
nerve were separated and the common peroneal was cut and immediately exposed to 
fluorogold (Catapano et al., 2016). Mice were sacrificed 1 week post-surgery and the 
number of motor neurons in the spine and sensory neurons in the L4 DRG were 
counted (Figure 5.1). Brightly labelled cell bodies were found in the spinal cord and 
DRG (Figure 5.1 A and B). Counts of labelled motor neurons showed no significant 
difference in cell numbers between WT and OE/+ mice (Figure 5.1 C) (p=0.7153). 
Comparably, counts of cell bodies in the L4 DRG of each genotype showed no 
significant difference in cell numbers between the two genotypes (Figure 5.1 D) 
(p=0.1872). OE/+ mice did however demonstrate a trend towards lower sensory 
neuron numbers.  
Overall, the results from this experiment demonstrate that there is no difference in 
the number of motor or sensory neurons present in the common peroneal nerve 
between WT and OE/+ mice. This result also suggests that backfilling with 
fluorogold is an effective way to examine cell numbers with bright staining observed 
in both samples and equal numbers of cell labelled. It can now be confirmed that any 





















Figure 5.1 | WT and OE/+ uninjured common peroneal nerves have equal numbers of motor 
and sensory neurons 
(A) All labelled cell bodies in 50µm sections of the spinal cord were counted (arrows). (B) Sensory 
neuron cell bodies were labelled in the L4 DRG. (C) The Abercrombie correction was applied to the 
counts from the spinal cord to prevent double counting. There was no significant difference in the 
number of labelled motor neurons between genotypes (p=0.7153).  (D) Every 5th section collected 
from the L4 DRG was counted to prevent double counting. Although OE/+ DRGs had a lower 
number of sensory neurons labelled, no significant difference was found between the two genotypes 









5.2 Selecting a model of acute denervation  
Before the effect of chronic denervation on regenerative capacity in WT and OE/+ 
mice can be examined, it is first important to establish a time point during acute 
injury where regeneration readily occurs. Previous studies have examined various 
timepoints. Many use immediate repair as a model, whereby a branch of the sciatic 
nerve is cut and immediately repaired by attaching the distal nerve stump to the 
proximal stump of a neighbouring nerve (Bain et al., 2001; Boyd & Gordon, 2002a, 
2003; Willand et al., 2016). Other models allow a short period of denervation to 
occur (1-4 weeks) before repairing the nerve (Sulaiman & Gordon, 2000). 
As it has been shown that c-Jun is highly up-regulated in Schwann cells 1 week after 
injury (Chapter 3, Figure 3.1 and 3.3), it was decided to examine 2 acute injury 
paradigms: Immediately repairing the nerve following injury or cutting the nerve and 
repairing it after 1 week of denervation. As the paradigm selected is to be directly 
comparable to chronically denervated nerve repair, it was decided that the tibial 
nerve distal stump would be sutured to the common peroneal proximal stump. As the 
nerve shrinks during chronic denervation, the tibial nerve distal stump is likely to be 
better size-matched with the common peroneal nerve than if the reverse was 
performed (Abercrombie & Johnson, 1946; Fu & Gordon, 1995; Vuorinen et al., 
1995; Bain et al., 2001; Willand et al., 2016). 6-10 week old WT mice underwent 
surgeries in which their tibial nerves were cut. Either the distal nerve stump was 
immediately sutured to the proximal stump of the common peroneal nerve (Figure 
5.2 A), or the distal nerve stump was denervated for 1 week before suturing to the 
freshly cut proximal stump of the common peroneal nerve (Figure 5.2 B). 
Backfilling with fluorogold was then performed 2 weeks after repair to examine 
regeneration. 
Counts of motor neurons showed that no significant difference was observed 
between these two paradigms (Figure 5.2 C). The regenerative capacity of the nerve 
at both acute injury time points was equal. It was therefore decided to adopt 
immediate repair as the method for quantifying regenerative capacity during acute 
denervation. Not only did this method demonstrate the strong regenerative capacity 
of the nerve during acute denervation, but using this method also allows the mice to 
















Figure 5.2 | No difference in motor neuron regeneration is observed in immediate and 1 week 
repair models of acute denervation  
(A) Summary diagram of the immediate repair model timeline. 6-10 week old mice underwent a tibial 
and common peroneal nerve cut. The distal stump of the tibial nerve was then immediately repaired to 
the proximal stump of the common peroneal nerve. After 2 weeks, the distal nerve stump of the 
repaired nerve was cut 4mm from the repair site and exposed to fluorogold. Mice were perfused 1 
week later. (B) Summary diagram of the 1 week repair model. Mice underwent a tibial nerve cut. The 
nerve was denervated for 1 week then sutured to the proximal stump of the freshly cut common 
peroneal nerve. After 2 weeks, the distal nerve stump of the repaired nerve as cut 4mm from the repair 
site and exposed to fluorogold. Mice were perfused 1 week later. (C) Counts of motor neurons in the 
spinal cords showed no significant difference in regeneration between the 2 paradigms (p=0.9). Graph 
of means ± SEM, n = 3, unpaired Student’s T-test.   
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5.3 WT and OE/+ display similar rates of regeneration during acute 
denervation  
Now the paradigm for examining regeneration in acute denervation had been 
established, regeneration could be compared between WT and OE/+ nerves (Figure 
5.3). WT and OE/+ mice underwent tibial nerve transection followed by immediate 
repair to the common peroneal. Backfilling with fluorogold was then performed 2 
weeks later to examine regeneration of axons from the common peroneal into the 
tibial nerve distal stump.  
Counts of labelled motor neurons in the spinal cord showed no difference in cell 
numbers between WT and OE/+ mice (Figure 5.3 C) (p=0.1698). In parallel, no 
significant difference in sensory cell numbers was observed in the L4 DRG between 
the genotypes (Figure 5.3 D) (p=0.9195). These results show that during acute 
denervation, the regenerative capacity of WT and OE/+ nerves is equal.  
This result correlates with the c-Jun expression in the Schwann cells of these nerves. 
In Chapter 4 it was shown that 1 week after injury, WT and OE/+ distal nerve 
stumps express equal levels of c-Jun. It should be noted, however, that after chronic 
denervation c-Jun levels differ in the distal nerve stumps of these mice since they are 




























Figure 5.3 | WT and OE/+ nerves have similar rates of regeneration during acute denervation  
(A) Cell bodies of motor neurons in the spinal cord of WT and OE/+ mice. (B) Sensory cell bodies 
were labelled in the L4 DRG of WT and OE/+ mice. (C) All labelled cell bodies in the spinal cord 
were counted. The Abercrombie correction was applied to account for double counting. Although 
OE/+ had fewer regenerating motor neurons compared to WT, this was not found to be significant 
(p=0.1698). (D) Every 5th section from the L4 DRG was counted. No difference in the number of 
regenerating sensory neurons was observed between WT and OE/+ nerves (p=0.9195). Graphs of 









5.4 The regenerative capacity of OE/+ nerves is maintained during chronic 
denervation  
It has previously been widely reported that the regenerative capacity of the nerve 
decreases with time post injury.  
In order to examine if Schwann cell c-Jun maintenance during chronic denervation 
maintains the regenerative capacity of the nerve, WT and OE/+ mice underwent a 
tibal nerve cut followed by 10 weeks chronic denervation. The deteriorated distal 
nerve stump was then sutured to the freshly cut common peroneal proximal stump. 2 
weeks later, backfilling with fluorogold was used to measure axon regeneration into 
the tibial nerve distal stump (Figure 5.4 A).  
To determine if any decrease in regenerative capacity in the nerves had occurred, the 
chronically denervated repaired nerves were compared to the immediately repaired 
WT nerves. Counts of motor neurons in the spinal cord revealed that the regenerative 
capacity of WT nerves significantly decreases following chronic denervation (Figure 
5.4 D). Following chronic denervation there was a 48% decrease in the number of 
motor neurons regenerating into the tibial nerve. However, when c-Jun was 
maintained in the Schwann cells of the distal nerve stump during chronic 
denervation, as in the nerves of the OE/+ mice, no significant difference in motor 
neuron cell numbers was observed between acute or chronically denervated nerves. 
OE/+ nerves had significantly more motor neurons regenerating into their 
chronically denervated distal nerve stumps compared to WT nerves.  
To further examine the restorative capabilities of c-Jun maintenance in the distal 
nerve stump during chronic denervation, labelled sensory cell bodies in the L4 DRG 
were counted (Figure 5.5). Similarly to the counts of motor neurons, a 47.3% 
decrease in the number of sensory neurons regenerating into the tibial nerve from the 
common peroneal nerve was observed between immediately repaired and chronically 
denervated WT nerves (Figure 5.5 E). No significant difference however was 
observed between WT acute denervation and chronic denervation in OE/+ nerves. 
Following chronic denervation, OE/+ nerves had significantly more sensory neurons 
from the common peroneal nerve regenerating into the chronically denervated tibial 
nerve compared to WT.  
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Overall, these experiments confirm that the regenerative capacity of the nerve is 
reduced following chronic denervation. However, if c-Jun is maintained during 
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Figure 5.4 | OE/+ nerves maintain regenerative capacity during chronic denervation  
(A) A summary diagram of chronic denervation followed by repair experimental timeline. Mice 
underwent a 10 week tibial nerve cut. The tibial nerve distal stump was then repaired by suturing to 
the freshly cut common peroneal nerve. After 2 weeks, the repaired nerve was then cut 4mm from the 
repair site and exposed to fluorogold. 1 week later the mice were perfused. (B) Many bright motor 
neuron cell bodies were observed in the spinal cords of immediately repaired nerves. However, 
following chronic denervation and repair the number of visible cells was reduced. In OE/+ spinal 
cords however many brightly labelled cells were seen. (C) Sensory neuron cell bodies were brightly 
labelled in the DRGs of immediately repaired nerves. Fewer labelled cells were however seen in WT 
nerves following chronic denervation. This difference was not observed in the L4s of OE/+ mice, with 
many labelled cells observed throughout the DRG.  (D) All labelled cells in the spinal cords were 
counted and the Abercrombie correction was applied to prevent double counting. WT nerves had 
significantly fewer regenerating motor neurons as demonstrated by the lower cell body counts 
(p=<0.005). OE/+ nerves however maintained their regenerative capacity with no difference observed 
between the number of regenerating motor neurons compared to immediately repaired nerves. OE/+ 
nerves had significantly more regenerating motor neurons compared to chronically denervated WT 
littermates (p=<0.005). WT immediate repair n=5, WT and OE/+ chronic denervation n=8. (E) Every 
5th section from the L4 DRG was counted. Counts showed that significantly fewer sensory neurons 
regenerated into the repaired tibial nerve following chronic denervation (p=<0.05). The number of 
sensory neurons regenerating into OE/+ following chronic denervation was significantly higher 
(p=<0.05). Although the number of sensory neurons was not as many as those observed regenerating 
into immediately repaired nerves, no difference was found between immediately repaired and 
chronically denervated nerves (p=>0.05). WT immediate repair and chronic denervation n= 6, OE/+ 













5.5 OE/+ nerve area does not significantly decrease following chronic 
denervation  
It is well established that during chronic denervation, nerve size is reduced 
(Abercrombie & Johnson, 1946). As mentioned above, it was decided that the tibial 
nerve would be chronically denervated and the common peroneal nerve would be 
used as the repair nerve, as their sizes would be more compatible. Nerves of similar 
size will fit together better when sutured. As previously observed however, OE/+ 
nerves have a greater number of Schwann cells present during chronic denervation 
(Chapter 4, Figure 4.8). An increased number of cells could result in a greater nerve 
size. If OE/+ nerves maintain cell numbers during chronic denervation, they may 
also maintain nerve area. To examine this, transverse sections of nerves 1 and 10 
weeks after cut were stained with DAPI (Figure 5.5 A). The tibial nerve was 
identified and the area measured. The results indicated that 1 week after injury there 
was no difference in nerve area between genotypes (Figure 5.5 B). Following 
chronic denervation, the area of WT nerves was significantly reduced compared to 
WT (p=<0.005) and OE/+ (p=<0.05) acutely injured nerves. Although a decrease in 
area was observed in OE/+ nerves, this result was not significant. OE/+ nerve area 
was twice as large as WT following chronic denervation. These findings further 
reinforce that over-expression of c-Jun prevents the deterioration of the distal nerve 




























Figure 5.5 | The area of OE/+ tibial nerves does not significantly decrease following chronic 
denervation 
(A) DAPI staining of transverse sections of WT and OE/+ nerves following acute and chronic 
denervation. The area of the tibial nerve (highlighted, white dotted line) was measured. (B) Following 
chronic denervation, WT tibial nerves were 3 times smaller than acutely denervated nerves 
(p=<0.005). OE/+ nerves however were only 1.5 times smaller and the difference between the acute 
and chronically denervated nerves was not significant. Graph of means ± SEMs, n=3, two-way 
















5.6 Chronic denervation of the distal nerve stump cannot be reversed  
Results earlier in this chapter demonstrated that maintenance of Schwann cell c-Jun 
expression maintains the regenerative capacity of the distal nerve stump during 
chronic denervation. It was thus hypothesized that restoration of Schwann cell c-Jun 
levels following chronic denervation might restore the regenerative capacity of the 
nerve. This can be examined using an inducible transgenic mouse model. A 
PLPCreERT2 OE/+ mouse was generated which, once injected with tamoxifen, was 
able to over-express c-Jun specifically in Schwann cells (Figure 2.2). During chronic 
denervation, the distal nerves of these mice down-regulate c-Jun as previously 
observed in WT nerves. However, if tamoxifen is administered after 8 weeks of 
chronic denervation, by 10 weeks c-Jun levels are significantly elevated (J.A 
Gomez-Sanchez, Appendix 1).  
These mice can therefore be used to examine the effect of restoring c-Jun levels in 
chronically denervated Schwann cells. Mice underwent chronic denervation of the 
tibial nerve for 8 weeks. Mice were then injected with 170mg/kg tamoxifen or 
vehicle for 5 days. 10 weeks after tibial nerve transection, the nerve was repaired by 
suturing to the freshly cut common peroneal nerve. 2 weeks post repair, tibial nerve 
stumps were exposed to fluorogold and mice were sacrificed 1 week later (Figure 5.6 
A).  
Counts of labelled motor neurons in the spinal cord showed no significant difference 
in motor neuron regeneration between vehicle (Veh) and tamoxifen (TMX) injected 
mice (Figure 5.6 B) (p=0.9485). Counts of labelled sensory neuron cell bodies in the 
L4 DRG further showed no significant difference between vehicle and TMX mice 
(Figure 5.6 C) (p=0.59).   
These results demonstrate that increasing c-Jun expression following chronic 
denervation does not restore the regenerative capacity of the peripheral nerve. c-Jun 
expression must be maintained from the initial injury during chronic denervation to 














Figure 5.6 | The regenerative capacity of a chronically denervated nerve cannot be restored by 
c-Jun activation 
(A) A summary diagram of the experimental timeline. 6-10 week old mice underwent a tibial nerve 
cut. 8 weeks later mice received 170mg/kg of tamoxifen or vehicle for 5 days. 10 weeks after the 
initial cut the tibial nerve was repaired using the proximal stump of the freshly cut common peroneal 
nerve. After 2 weeks of regeneration, the repaired tibial nerve was cut 4mm from the repair site and 
exposed to fluorogold. After 1 week the mice were perfused. (B) Counts of labelled motor neurons in 
the spine showed that there was no difference between vehicle and tamoxifen injected mice 
(p=0.9485). Veh n= 5, TMX n=6. (C) Counts of labelled sensory neuron cell bodies in the L4 DRG 
count showed no difference between vehicle and tamoxifen injected mice (p=0.59). Veh n= 6, TMX 
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The results described in previous chapters of this thesis have shown the ability of 
OE/+ Schwann cells to maintain c-Jun during chronic denervation. This chapter 
therefore aimed to determine whether c-Jun maintenance equated to maintenance of 
regenerative capacity.  
This was examined with nerve cross-suturing, the method of suturing a proximal 
stump of one nerve to the distal nerve stump of another. Here, as described 
previously, the denervated distal tibial nerve was sutured to the proximal stump of 
the common peroneal nerve (Holmes & Young, 1942; Sadr, 1946; Fu & Gordon, 
1995; Sulaiman & Gordon, 2000; Boyd & Gordon, 2001; Bain et al., 2001; Willand 
et al., 2016). 
Regeneration into distal nerve stumps was then examined by retrograde labelling 
using fluorogold as described previously. The repaired nerve was transected 4mm 
from the repair site and exposed to a reservoir of fluorogold as described by 
(Catapano et al., 2016) This method was selected, as although time consuming, it is 
reliable and commonly used (Gordon et al., 1991; Richmond et al., 1994; Garrett et 
al., 1991; Schmued & Fallon, 1986; Catapano et al., 2016). Injecting dyes can 
produce variable results. If dye is injected into muscle, the exact location of the 
injection is very important. If injections are done incorrectly, the dye can leak, 
producing non-specific results (Janjua & Leong, 1981; Tosolini et al., 2013). 
Therefore fluorogold solution was applied directly to the sutured tibial nerve stump 
as described in the materials and methods section (Chapter 2). Although it has been 
suspected that fluorogold may be toxic in long-term studies (Garrett et al., 1991), 
these claims are not widely reported (Novikova et al., 1997) and here tissue was 
harvested 1 week after labelling so would not be affected by this.  
Before experiments into the regenerative capacity of chronically denervated nerves 
could commence, an acute denervation time point had to be selected. When time 
points of immediate repair and repair following 1 week denervation were examined, 
no difference was found between the two. Repairing the nerve after 1 week might be 
expected to result in increased regeneration compared with immediate suture since 
during this time myelin clearance and repair cell activation occurs (Perry et al., 1995; 
Arthur-Farraj et al., 2012), although in previous studies no differences between 
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immediate and short term repair were seen (Holmes & Young, 1942; Bignotti et al., 
1986; Gattuso et al., 1989). This finding was confirmed here since no differences 
between the time points chosen were found in my experiments, and therefore to 
reduce the number of surgeries and thus post-operative pain experienced by the 
mice, immediate repair was selected as the acute denervation model.  
Results in this chapter showed no difference in the regenerative capacity WT and 
OE/+ nerves during acute denervation. It was hypothesized in Chapter 4 that due to 
the increased number of macrophages attracted to the injury site in OE/+ nerves, an 
increased rate of regeneration might be observed. However, these macrophages 
counts were performed 3 days after crush and EM counts found no difference in 
macrophage numbers between genotypes at 1 week. It is likely, as in c-Jun cKO  
nerves, the difference observed in initial macrophage recruitment may not be 
observed at later time points and may be seen only close to the injury site (Arthur-
Farraj et al., 2012). WT and OE/+ nerves also express similar levels of c-Jun 1 week 
after injury. A difference in regeneration is therefore only likely to be seen when 
differences in c-Jun expression are seen between the 2 genotypes, such as following 
chronic denervation (Figure 4.5-6).  
The reduced regenerative capacity of the nerve during chronic denervation is well 
established (Holmes & Young, 1942; Bolesta et al., 1988; Fu & Gordon, 1995; 
Sulaiman & Gordon, 2000). Here, when WT nerve regeneration was compared 
between acute and chronic denervation, a significant decline was observed. This was 
not conserved between genotypes, since OE/+ nerves showed significantly more 
motor and sensory neuron regeneration than WT nerves following chronic 
denervation. This suggests that maintaining c-Jun during chronic denervation also 
maintains the regenerative capacity of the nerve. The mechanism behind this 
however may not be as simple as previously hypothesized.  
In Chapter 4 it was shown that OE/+ tibial nerves have significantly more Schwann 
cells present in the nerve following chronic denervation (Figure 4.9). It could 
therefore be argued that the maintained regenerative capacity of the nerve is due to 
the increased Schwann cell number in OE/+ nerves compared to WT following 
chronic denervation. OE/+ nerves also contain a higher number of macrophages 
following chronic denervation which could also contribute to enhanced regeneration. 
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Despite OE/+ nerves containing more Schwann cells and maintaining c-Jun, trophic 
factor expression is not maintained. Therefore despite an increase in the quantity of 
Schwann cells in OE/+ nerves, the quality of the cells are similar to WT. In order to 
elucidate the mechanism behind the enhanced regeneration observed in OE/+ nerves, 
an inducible mouse line is required.  
Despite the temporal up-regulation of c-Jun in the chronically denervated nerves of 
TMX mice, no improvements in nerve regeneration were seen. This could be due to 
various factors. Firstly, as the tamoxifen has to be administered for 5 days to take 
effect, c-Jun is only fully elevated for 9 days before the nerve repair is performed. It 
is unknown if other repair cell markers are also elevated in this time as no RNA has 
been extracted from these nerves. Although it is unlikely that trophic factors will be 
elevated, based on the experiments in Chapter 4.8, Shh elevation may be observed. It 
is likely that 9 days does not allow sufficient time to restore the regenerative capacity 
of the nerve. Future work could examine nerve regeneration at later time points from 
tamoxifen administration. However, it could be argued that this work demonstrates 
that elevation of c-Jun is not solely responsible for the effects seen in OE/+ nerves.  
The number of cells present in TMX and vehicle treated mouse nerves was not 
determined. Schwann cell proliferation may or may not occur following tamoxifen 
injection and macrophages may not be recruited to the nerve. If counts of these cell 
types were performed it may be possible to determine if the enhanced regeneration 
observed when c-Jun is maintained is due to the number of Schwann cells and 
macrophages present in the nerve. 
It is important to examine all the factors that may have contributed to the enhanced 
regeneration. The fact that OE/+ nerves have a larger area following chronic 
denervation may have contributed to this result. It may improve size matching with 
the common peroneal. When selecting nerves for graft repairs, the diameter of nerve 
is one of the considerations with nerves of a similar diameter being preferable 
(Sunderland & Ray, 1947). For example, in humans, repairs of the inferior alveolar 
nerve (diameter: 2.4 mm) are performed with nerve graphs from the sural nerve 
(diameter: 2.1 mm) (Svane et al., 1986; Brammer & Epker, 1988). However, as the 




It has previously been reported that the longer a nerve is denervated, the worse the 
union with another nerve upon its repair. It was noted that this may be due to the 
surgical technique. As the nerve is known to decrease in size post-injury, it is 
implied that larger nerves are easier to suture (Holmes & Young, 1942; Abercrombie 
& Johnson, 1946). The improved regenerative capacity of the nerve measured here 
could therefore be due to improved surgical technique in these samples. As surgeries 
were performed blind, this cannot be confirmed, however no difference was noted at 
the time of surgery in the ease of some surgical procedures compared to others. 
It is important to note that regeneration was only assessed in this chapter by one 
technique. Although retrograde labelling is a very reliable method for examining 
regeneration, the other hypotheses of this thesis have been tested using a variety of 
techniques to fully establish the result. Neurofilament staining can be used to 
examine regenerating axons. Cutting longitudinal sections of the repaired nerves was 
found to be very difficult due to the formation of fibrotic tissue around the nerves 
and repair site. This made embedding the nerve flat extremely difficult. Transverse 
sections taken at various distances from the repair site could overcome this issue and 
potentially enforce the findings observed here.  
 
Although it is has not been fully determined how the maintenance of c-Jun restores 
the regenerative capacity of the nerve, the results presented in this chapter 
demonstrate the importance of c-Jun in the regeneration deficit observed following 










6. Restoring the regenerative capacity of aged nerves with increased c-Jun up-
regulation 
This thesis has thus far demonstrated that the maintenance of Schwann cell c-Jun 
prevents the regeneration deficit observed in chronically denervated distal nerve 
stumps. It was therefore decided to examine if regeneration deficits observed in other 
systems could be restored through the over-expression of c-Jun.  
It is well established that the regenerative capacity of peripheral nerves declines with 
age (Pestronk et al., 1980; Tanaka & Webster, 1991; Tanaka et al., 1992; Vaughan, 
1992; Verdú et al., 1995; Graciarena et al., 2014).  
The slow rate of regeneration has been believed to be in part due the diminished 
regenerative capacity of the neurons. Aged regenerating axons for example have a 
reduced ability to transport cytoskeletal proteins and to respond to tropic support 
(Brunetti et al., 1987; Uchida & Tomonaga, 1987; Tashiro & Komiya, 1994). 
However, as described in the introduction, recent work suggests that it is not the 
axon’s response to injury that is impaired with age. Painter et al (2014) performed a 
detailed study into the regeneration differences between young and aged mice and 
the potential causes of these disparities.  Transcriptional profiling of DRGs from 
young and old mice found no difference in the expression in regeneration associated 
genes and cultures of dissociated DRGs displayed no differences in neurite 
outgrowth. These findings were further backed up through transplantation studies in 
which young mice received a nerve graft from old mouse and vice versa. Analysis of 
axon regeneration through these grafts found that young mice with old grafts 
regenerated at the same rate as old nerves and that the regeneration deficit observed 
in old mice could be restored with a young graft. These findings suggest that the 
regeneration deficit observed in age is not due to the axons diminished regenerative 
capacity. Painter et al (2014) go on to confirm that it is the Schwann cells response 
to injury that is impaired with age. Aged nerves have disrupted activation of markers 
of the repair cell phenotype and reduced c-Jun activation in the days immediately 
following injury (Painter et al., 2014). Together, the findings of this study 
demonstrate that the regeneration deficits observed with age are largely due to the 
Schwann cells inability to activate the repair cell phenotype.  
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Based in these findings, it was hypothesized that the regeneration deficit observed 
with age could be ameliorated through the increased activation of c-Jun. 
  
 
The aims of the chapter are: 
- To demonstrate that the reduced c-Jun activation observed previously is 
Schwann cell specific.  
- To examine c-Jun expression in injured old OE/+ Schwann cells.  
- To determine if improved c-Jun activation restores the regenerative capacity 
of aged nerves.  
 
In this chapter, 6-10 week old mice are referred to as young mice whereas old mice 















6.1 Reduced c-Jun expression is Schwann cell specific and is not observed in 
aged OE/+ nerves  
To determine the c-Jun levels in young and old Schwann cells following injury, 
young and old WT and old OE/+ mice underwent a 3.5 day sciatic nerve cut. 
Transverse sections of the nerves 2 mm from the injury site were dual 
immunolabelled with antibodies for Schwann cell marker Sox 10 and c-Jun (Figure 
6.1). Labelling showed a decrease in Sox 10 positive c-Jun positive cells between 
young and old WT nerves despite the many Sox 10 positive cells present in the 
nerves of old WT mice (Figure 6.1 A). The majority of young Sox 10 positive cells 
expressed c-Jun. However, no such difference was observed between the young WT 
nerves and old OE/+ nerves. Bright c-Jun labelling was observed in aged OE/+ 
nerves which was almost indistinguishable from that seen in young WT samples. 
Counts of Sox 10 positive c-Jun positive cells were performed and the % of c-Jun 
Sox 10 positive cells was calculated (Figure 6.1 B). Calculations showed that, after 
injury, 86% of Schwann cells in young WT nerves expressed c-Jun. However, only 
35.23% of Schwann cells in old WT nerves expressed detectable levels of c-Jun, 
demonstrating impaired activation in response to injury. This confirms the previous 
findings that old nerves activate lower levels of c-Jun following injury (Painter et al., 
2014). These observations were not conserved in old OE/+ nerves. 82.36% of 
Schwann cells in these nerves up-regulated c-Jun following injury. This was seen to 
be a significant increase relative to old WT Schwann cells. No difference however 
was observed between young WT and old OE/+ Schwann cells, demonstrating that 
c-Jun activation in these Schwann cells is equal. OE/+ Schwann cells are therefore 

















Figure 6.1 | c-Jun activation is impaired in old WT but not OE/+ Schwann cells following injury 
(A) c-Jun Sox 10 dual immunolabelling of transverse sections of distal tibial nerve 3.5 days after cut 
injury. The majority of Schwann cells were c-Jun positive in young mice.  In contrast, very low c-Jun 
expression was observed in aged WT nerves. OE/+ Schwann cells in aged nerves were predominately 
brightly labelled with c-Jun. (B) Counts of the total number of Sox 10 positive cells and the number 
of those cells that were c-Jun positive were used to calculate the percentage of c-Jun positive 
Schwann cells (c-Jun Sox 10 positive). A significant reduction in c-Jun activation in response to 
injury was observed in old WT Schwann cells compared to young. No difference however was 
observed in c-Jun activation between young and old OE/+ Schwann cells with old OE/+ Schwann 
cells demonstrating a significant increased response to injury compared to old WT Schwann cells. 
Graph of means ± SEMs, n=3, two-way ANOVA with Tukey’s test. Scale bar: 100µm.  
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6.2 Young WT and OE/+ nerves regenerate equally well following crush injury  
Work in Chapter 5 (Figure 5.3) demonstrated that during acute injury, WT and OE/+ 
nerves were equal in their regenerative capacity. This however was demonstrated 
using nerve cross suture as a model to study regeneration. As the nerves examined in 
this chapter are not chronically denervated, a single crush injury can be used to 
examine axon regeneration. It is therefore important to determine if any differences 
in regeneration are observed between these two genotypes using this model. To 
examine this, young WT and OE/+ mice underwent a sciatic nerve crush at the 
location of the sciatic notch. 5 days thereafter, the whole nerve was cut 10mm away 
from the crush site and exposed to a reservoir of fluorogold for 1 hour. A week later 
the mice were sacrificed and the tissue harvested. Counts of labelled motor neurons 
in the spinal cord found no difference in the number of regenerating motor neurons 
between the two genotypes (Figure 6.2). It was therefore concluded that at least 









Figure 6.2 | Young WT and OE/+ nerves display equal numbers of regenerating motor neurons 
following crush injury 
Counts of labelled motor neurons in the spinal cord showed no significant difference between the 2 
genotypes 5 days after crush (p=0.3128). Graph of means ± SEMs, WT n=5, OE/+ n=4, unpaired 





6.3 Enhanced c-Jun expression restores the age-related regeneration deficit 
To examine the effect of increasing c-Jun expression in old Schwann cells on 
peripheral nerve regeneration, young and old WT and old OE/+ mice underwent a 
whole sciatic nerve crush. Nerves were backfilled after 4 days to examine the 
number of regenerating axons 7mm from the crush site (Figure 6.3.1 A).  
To examine motor neuron regeneration 4 days after crush, labelled cell bodies in the 
spinal cord were examined (Figure 6.3.1 B). Young WT mice were found to have 
high numbers of labelled cells suggesting a high rate of axon regeneration. Old WT 
mice however had low numbers of labelled cell bodies in line with the poor 
regeneration reported previously with age (Painter et al., 2014). In contrast, OE/+ 
mice were found to have higher numbers of labelled cells suggesting regeneration in 
these mice is enhanced compared to that seen in old WT mice. Counts of these cell 
bodies confirmed these observations (Figure 6.3.1 C). A significant decrease in 
labelled motor neuron cell numbers was observed between young and old WT mice. 
Old mice had 50.37% fewer motor neurons regenerating after crush injury. Old OE/+ 
mice motor neuron regeneration only decreased by 15.7% which was found not to be 
significantly different to young mice. These mice had a significantly higher number 
of motor neurons regenerating post crush injury compared to old WT mice.  
To further examine the decline in regenerative capacity of WT nerves with age, 
sensory neuron cell bodies labelled in the L4 DRG were counted 4 days after crush 
(Figure 6.3.2 B). Counts showed that there was a significant difference in sensory 
neuron regeneration between young and old nerves (p=0.0309). Age decreased the 
number of regenerating sensory neurons by 43%. When this data was compared to 
the number of sensory neurons regenerating in old OE/+ nerves, no decline in 
regeneration was observed with old OE/+ and young nerves supporting the growth of 
equal numbers of sensory neurons (Figure 6.3.2 C). Old OE/+ nerves showed double 
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Figure 6.3.1 | The age-associated regeneration deficit is not observed in motor neuron 
regeneration in OE/+ nerves  
(A) Summary diagram of surgery timeline. Young and old mice underwent a 4 day sciatic nerve 
crush. The nerve was then cut 7mm from the injury site and backfilled with fluorogold. The mice 
were perfused and the tissue harvested after 1 week. (B) Motor neurons labelled in the spinal cord. 
Many bright cells were observed in young WT mice compared to old WT mice, which had few, 
faintly labelled cells. OE/+ spinal cords however contained many brightly labelled cell bodies 
(arrows). (C) Counts of motor neuron cell bodies labelled in the spinal cord showed a reduction in 
regenerative capacity between young and old WT nerves. With age, the number of regenerating 
neurons growing past 7mm from the crush site, was half of that in young nerves (p<0.001). There was 
no age-related decline in regeneration observed however in OE/+ nerves with no significant 
difference in the number of regenerating motor neurons between young WT and old OE/+ nerves. 
OE/+ nerves had significantly more motor neurons regenerating past 7mm compared to old WT 





























Figure 6.3.2 | The age-associated regeneration deficit is not observed in sensory neuron 
regeneration in OE/+ nerves  
(A) Sensory neuron cell bodies labelled in the L4 DRG of young WT and old WT and OE/+ mice.  
(B) Counts of labelled sensory neuron cell bodies highlighted a significant decrease in the 
regenerative capacity of nerves with age (p=0.0309), unpaired Student’s T-test. (C) When the data 
from (B) was compared with sensory neuron regeneration in OE/+ nerves, OE/+ nerves were found to 
support regeneration in significantly more sensory neurons than old WT nerves. No difference in the 
number of regenerating sensory neurons was observed between young WT and old OE/+ suggesting 
these nerves maintain their regenerative capacity throughout life. One-way ANOVA with Tukey’s 
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6.4 Discussion  
The reduced regenerative capacity of the peripheral nervous system with advancing 
age has been well documented (Pestronk et al., 1980; Tanaka & Webster, 1991; 
Tanaka et al., 1992; Vaughan, 1992; Verdú et al., 1995; Graciarena et al., 2014). 
However, it is only recent work that is establishing the role of Schwann cells in this 
deficit. A recent study has highlighted the role of Schwann cell c-Jun and the repair 
cell phenotype. It was demonstrated that in the immediate days after injury, 
activation of c-Jun and other markers of the repair cell phenotype was reduced 
(Painter et al., 2014). It was therefore hypothesized here that restoring the injury 
induced activation of c-Jun in aged nerves would reverse the effects of aging on 
regeneration. This could be examined using nerves from old OE/+ mice, where it is 
known that at 1 year old, normal myelin sheaths are maintained, with no tumour 
development and stereotypical nerve architecture (Fazal et al., 2017).  
To confirm the previous findings that c-Jun activation is repressed in old mice 
following injury and that this is a Schwann cell specific response, c-Jun Sox 10 dual 
labelling was performed on transverse sections of young and old WT nerves 3.5 days 
after nerve transection. The percentage of c-Jun expressing Schwann cells was 
calculated, showing a significant decline in c-Jun activation in aged nerves, 
confirming previous findings. This observation was in contrast to that shown in 
OE/+ nerves, the Schwann cells in which expressed c-Jun to the same extent as 
young nerves. These mice could therefore be used to examine the effect of restored 
c-Jun expression in aged nerves on nerve regeneration. Further work could confirm 
these findings with Western blot analysis and examine c-Jun phosphorylation to 
determine changes in the activation as well as expression of c-Jun with age and in 
these mutants.  
Regeneration was examined by retrograde labelling with fluorogold which has been 
utilised to study regeneration throughout this thesis. Axon regeneration 4 days after 
crush was compared between old WT and OE/+ and young WT nerves. The age 
associated decline in regeneration was observed between young and old WT nerves 
with a 51% and 43% reduction in motor and sensory neuron regeneration 
respectively. However, no decrease in regenerative capacity was observed in OE/+ 
nerves with age with motor and sensory neuron regeneration equalling that seen in 
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young nerves. Although previous studies have reported no major differences in 
regeneration between young and old mice in the first few days following injury 
(Black & Lasek, 1979; Pestronk et al., 1980), a significant difference was reported 
here. This is likely to be due to a difference in techniques used to estimate 
regeneration. Neuron backfilling is a reliable technique for studying regeneration as 
it labels cell bodies. Examining axons alone could report different results due to 
variations in nerve sprouting. This work demonstrates using backfilling with 
fluorogold, that the age associated decline in regenerative capacity of peripheral 
nerves can be reversed when injury induced c-Jun expression is restored.  
It is important to note that although the mice here are referred to as old for 
simplicity, they are not really so. Many other studies into the age associated decline 
use 24 month old mice. 12 month old mice are classified as ‘middle aged’ however 
there is little difference in the functional recovery between these two ages, despite 12 
and 24 months being the equivalent of 35-40 and 60 human years respectively  
(Kang & Lichtman, 2013; Painter et al., 2014; Dutta & Sengupta, 2016). Therefore, 
although the mice used in this study are ‘middle aged’, they are unlikely to differ 
from older mice, producing similar results.  
It is important to consider the other effectors of c-Jun, not just the repair cell 
phenotype, that could improve axon regeneration. Myelin debris is a known inhibitor 
of PNS regeneration (Mukhopadhyay et al., 1994; Schäfer et al., 1996). As 
previously discussed, although myelin clearance is heavily mediated by Schwann 
cells in the days immediately following injury, macrophages are recruited to the 
nerve after 2-3 days. It has been shown that old nerves have reduced myelin 
clearance following injury. It has been demonstrated that this may be due not only to 
a failure to recruit macrophages to the nerve but also to the aged Schwann cells 
inability to break-down myelin (Kang & Lichtman, 2013; Painter et al., 2014). 
Results in Chapter 4 (Figure 4.9) demonstrated, 3 days after crush, OE/+ nerves 
recruit more macrophages to the injury site. It is therefore likely that old OE/+ 
nerves may be able to recruit more macrophages following injury compared to WT 
counterparts. This could increase the rate of myelin breakdown and aid regeneration. 
The rate of myelin breakdown could also be restored due to the enhanced activation 
of myelinophagy. Schwann cells breakdown myelin debris by autophagy, referred to as 
myelinophagy, which is controlled by c-Jun through the JNK signalling pathway (Gomez-
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Sanchez et al., 2015). Although it has been found that young OE/+ nerves do not 
demonstrate increased autophagic activity (J.A Gomez-Sanchez, unpublished 
observations), activity may be higher in old OE/+ nerves compared to old WT nerves. 
Future work into myelin clearance of old WT and OE/+ nerves would confirm if enhanced 
debris clearance contributes to the enhanced regeneration in OE/+ nerves.  
It has further been suggested that old Schwann cells may have a reduced rate of 
proliferation due to younger nerves highly up-regulating genes associated with the 
cell cycle, DNA replication, lipid biosynthesis and the extracellular matrix (Painter 
et al., 2014). Although an age-related decline in proliferation have been documented, 
this has not been studied in detail in aged mice  (Komiyama & Suzuki, 1991, 1992). 
If old Schwann cell do in fact have a reduced proliferative capacity, old OE/+ 
Schwann cells are likely to overcome this and proliferate at rate similar to that of 
young Schwann cells. However this is unlikely to contribute to improved initial 
axonal growth examined in this chapter because Schwann cell proliferation is not 
required for axon regeneration (Kim et al., 2000; Yang et al., 2008). The transverse 
sections taken 3.5 days after cut however could be used to confirm the effect of age 
on Schwann cell proliferation. Ki-67 is a marker of proliferation, labelling cells 
during all stages of the cell cycle except G0. (Gerdes et al., 1984, 1983). Our 
laboratory has successfully used Ki-67 as a marker for Schwann cell proliferation in 
transverse nerve sections (Benito et al., 2017). This method could be applied here to 
examine proliferation in young and aged nerves of both genotypes.  
No experiments were performed to examine the expression of repair cell markers in 
aged mice. As older mice show reduced activation of repair cell markers such as 
GDNF (Painter et al., 2014), old OE/+ mice may overcome this and activate the 
repair cell phenotype as efficiently as young animals do. This work is required to 
demonstrate that not only c-Jun but improved repair cell activation results in 
restoration of neuron regeneration in old mice. Samples for this work are in 
preparation and will undergo RNA sequencing to determine the differences in gene 
expression in old WT and OE/+ nerves 3.5 days post injury.  
Overall, the work in this chapter confirms that Schwann cells from old mice fail to 
up-regulate c-Jun as efficiently as Schwann cells from young mice. This observation 
is different from that seen in OE/+ Schwann cells from old mice, which up-regulate 
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c-Jun to a similar level as young Schwann cells. The enhanced expression of c-Jun 
restores the age-related deficit in regeneration with old OE/+ and young nerves 
























7. The role of hedgehog signalling in c-Jun activation  
Thus far, the results of this thesis have demonstrated the importance of c-Jun 
activation and maintenance in restoring regeneration deficits of the PNS observed 
during chronic denervation and advanced aging. These results have highlighted c-Jun 
as a pharmaceutical target for peripheral nerve repair.  
The role of hedgehog signalling in the PNS has been previously established. Desert 
hedgehog (Dhh) signalling is involved in the development and maintenance of 
peripheral nerves. When Dhh is conditionally knocked out from Schwann cells 
abnormalities are observed in the nerve structure. Changes in epi-, peri-, and 
endoneurial structures are observed (Parmantier et al., 1999; Sepideh N Bajestan et 
al., 2006). Humans carrying mutations in the Dhh gene present with minifascicular 
neuropathy, in which many small fascicles are present in the peripheral nerves 
(Umehara et al., 2002; Sato et al., 2017). Dhh and its receptor patched 2 are rapidly 
down-regulated following peripheral nerve injury (S N Bajestan et al., 2006) and 
sonic hedgehog (Shh), is up-regulated by Schwann cells in the distal nerve stump, 
however its function is unknown (Arthur-Farraj et al., 2012).  
It has been suggested that activation of Shh promotes nerve regeneration. Mice given 
injections of Shh that has undergone polyethylene glycol modification, have 
increased levels of Shh in their bloodstream (normal Shh has a short half-life). These 
mice showed improved functional recovery following sciatic nerve crush (Pepinsky 
et al., 2002). Studies have also suggested that application of Shh can be 
neuroprotective following crush injury to the cavernous nerve (Bond et al., 2013; 
Angeloni et al., 2013). In contrast, when the sciatic nerve is continuously exposed to 
cyclopamine following crush injury, motor neuron survival is impaired (Hashimoto 
et al., 2008). 
Here, it was hypothesized that Shh signalling could play a role in the activation of c-
Jun and that this is the reason for the enhanced regeneration previously observed in 
the literature. Laner-Plamberger et al (2009) have previously demonstrated the link 
between Hh signalling and Jun. When HaCat cells (an immortal human keratinocyte 
cell line) were modified to express activated forms of Gli1 and Gli2, Jun mRNA and 
protein expression increased (Laner-Plamberger et al., 2009). Kudo et al (2012) 
contributed to our understanding of this connection by transfecting human ovarian 
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cancer cells with anti-Gli1 shRNA. This was found to reduce c-Jun protein and 
inhibited phosphorylation of c-Jun at serine 63. A similar result was observed when 
the cells were incubated with cyclopamine (Kudo et al., 2012). Laner-Plamberger et 
al (2009) explained these results by investigating the presence of Gli binding sites on 
the Jun promoter. They found 6 potential Gli binding sites, five clustered upstream 
of the transcription start site and one downstream. The area of the promoter 
containing these sites and the AP-1 binding sites were cloned into a luciferase 
reporter vector (Figure 7.0 A). Each potential binding site was then inactivated by 
mutation. Only the inactivation of the binding site at -712 base pairs upstream of the 
transcription start site affected luciferase reporter activity, confirming this site to be 
the Gli binding site (Figure 7.0 B). They further found that Jun promoter activity was 
strongly enhanced by the dual binding of Gli and Jun, suggesting Gli binding is 










Figure 7.0 | The Jun promoter contains Gli binding sites 
(A) The Jun promoter was proposed to have 6 potential Gli binding sites. 5 were located upstream of 
the transcriptional start site and a single site was positioned downstream. This fragment was cloned 
into a luciferase reporter vector. (B) Mutating each binding site demonstrated that only inactivation of 
the site at -712 affected reporter activity confirming this to be the Gli binding site on the Jun 






















































In Schwann cells however, no direct link has been made between Hh signally and c-
Jun activation. Shh has however been shown to regulate BDNF in cultured Schwann 
cells. When Hh signalling is inhibited in cultured Schwann cells with cyclopamine, 
BDNF expression is decreased. Incubation with the recombinant N-terminal peptide 
of Shh results in increased BDNF expression. GDNF expression however is 
unaffected by Hh signalling (Hashimoto et al., 2008). As BDNF expression have 
previously been shown to be regulated by c-Jun (Arthur-Farraj et al., 2012; Huang et 
al., 2015), this activation may be a c-Jun mediated response.  
This chapter therefore aimed to examine the relationship between Hh signalling and 
c-Jun activation. If a link between these pathways is established, the effect of Hh 
signalling on the markers of the repair cell phenotype will also be investigated.  
These investigations will utilise: 
- A mouse line in which Shh has been specifically knocked out in Schwann 
cells (Shh cKO), the tissue from which was gifted from the laboratory of 
John Svaren (USA).  















7.1 c-Jun activation and p75 are reduced in Shh cKO nerves 7 days post injury 
To examine the role of Shh in Schwann cells after injury, 3 and 7 day cut distal 
nerves stumps from Shh cKO mice were sent from the laboratory of John Svaren. 
These mice have Shh specifically knocked out in Schwann cells, much like the c-Jun 
cKO mouse. Western blots of these nerves were run to examine c-Jun expression 
levels after injury (Figure 7.1.1). Results indicated that 3 days after injury, there was 
no difference in the level of c-Jun expression between WT and Shh cKO nerves 
(Figure 7.1.1 A). However, 7 days after injury Shh cKO nerves expressed lower 
levels of c-Jun compared to WT nerves, with levels similar to those observed at 3 
days post injury. Quantification of the data demonstrated that there was no 
significant difference in c-Jun expression between WT and Shh cKO nerves 3 days 
after injury, suggesting that initial c-Jun activation is not impaired (Figure 7.1.1 B). 
However, Shh cKO nerves express significantly lower levels of c-Jun at 7 days. WT 
c-Jun expression increased 4-fold between 3 and 7 days after injury. Shh cKO c-Jun 
expression however only doubled during this time. These results suggests that Shh 
plays a role in the partial activation of c-Jun during the early stages of injury.  
To examine the effect on Shh on c-Jun activation further, phosphorylation of c-Jun at 
serine 63 was examined (p-c-Jun). As no difference in c-Jun expression was 
observed 3 days after injury, c-Jun phosphorylation was only observed 7 days after 
injury (Figure 7.1.2). Consistent with previous blots (Figure 7.1.1), total c-Jun 
expression was lower in Shh cKO nerves. Levels of phosphorylated c-Jun were even 
lower (Figure 7.1.2A). To quantify this observation, phosphorylated c-Jun was 
divided by total c-Jun protein demonstrating a 25% difference in c-Jun 
phosphorylation between WT and Shh cKO nerves (Figure 7.1.2 B).  This data 




















Figure 7.1.1 | c-Jun activation is impaired in Shh cKO nerves 7 days after injury  
(A) Western blots of WT and Shh cKO distal nerve extracts 3 and 7 days after injury. No difference in 
initial c-Jun activation was observed, however 7 days after injury, Shh cKO nerves expressed lower 
levels of c-Jun. (B) Blots were analysed by dividing c-Jun by the house keeping protein calnexin. All 
data was normalised to 3 day WT. Although no difference in initial c-Jun activation was observed 
between the 2 genotypes, after 7 days  Shh cKO nerves failed to activate c-Jun to the levels observed 
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Figure 7.1.2 | c-Jun phosphorylation at serine 63 is reduced in Shh cKO nerves  
(A) Shh cKO distal nerve extracts were Western blotted for c-Jun and c-Jun phosphorylated (p-c-Jun) 
at serine 63 (Ser 63). c-Jun activation was decreased in these nerves in line with previous 
observations. Phosphorylation of c-Jun was also visibly reduced. (B) Blots were quantified by 
dividing p-c-Jun by total c-Jun protein. Phosphorylation of c-Jun was significantly impaired in Shh 
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Since c-Jun activation is reduced in the nerves of cKO mice, activation of other 
markers of the repair cell phenotype might also be impaired. Reduced Schwann cell 
c-Jun has been previously demonstrated to decrease p75 NTR protein expression 
(Arthur-Farraj et al., 2012). p75 NTR activation in Shh cKO nerves was therefore 
examined. As has been previously shown here (Figure 3.4) as well as in the 
literature, p75 NTR expression is low in the early days of injury but high levels are 
observed 1 week after injury (Taniuchi et al., 1986; Heumann et al., 1987). WT 
nerves, as expected, followed this expression pattern (Figure 7.1.3 A). Shh cKO 
nerves, although expressing similar levels of p75 NTR at 3 days compared to WT, 
displayed lower elevation 7 days after injury. Similarly to c-Jun activation, WT 
nerves increased p75 NTR expression 6 fold between 3 and 7 days (Figure 7.1.3 B). 
Shh cKO distal nerves however, only doubled p75 NTR expression between 3 and 7 
days, a trend similar to that observed in the activation of c-Jun in these nerves. These 
results demonstrated that Shh signalling in Schwann cells is not only a marker of the 




























Figure 7.1.3 | p75 NTR protein expression is decreased in Shh cKO nerves 7 days after injury  
(A) Western blots of Shh cKO and WT distal nerves 3 and 7 days after injury showed no difference in 
p75 NTR expression 3 days after injury. Expression was initially very low 3 days after injury but then 
became elevated after 7 days in WT nerves. Elevation was reduced in Shh cKO nerves at 7 days. (B) 
Blots were quantified by dividing levels of p75 NTR expression by levels of the house keeping 
protein calnexin. All data was normalised to 3 day WT. Quantification of blots showed no significant 
difference in the activation of p75 NTR between genotypes. The elevation of p75 NTR was 
significantly impaired in Shh cKO nerves at 7 days after injury. Graph of means ± SEMs, n=5, two-
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7.2 In vitro modelling of chronically denervated Schwann cells  
The results from 7.1 demonstrate the role of Shh signalling in c-Jun and possibly in 
repair cell phenotype activation. This works highlights the Shh pathway as a 
potential pharmacological target for c-Jun activation in chronically denervated 
Schwann cells. However, before this can be examined, it is important to first 
establish an in vitro model of chronically denervated Schwann cells. Although 
Schwann cell cultures from chronically denervated nerves have been performed in 
the past, attempts at culturing adult Schwann cells from chronically denervated 
mouse nerves did not produce high cell yields or pure cultures in my hands. The idea 
of cell sorting was proposed, however the physical pressures to the cells during this 
process might lead to the reactivation of c-Jun, invalidating the model. Furthermore, 
cell surface markers that could be used to identify Schwann cells for cell sorting, 
such as p75 NTR, are down regulated during chronic denervation (Figure 3.4) (You 
et al., 1997). When Schwann cells are in culture, they are without axon contact from 
prolonged periods of time, a situation similar to that seen in chronic denervation. It 
was therefore hypothesized that long-term cultured Schwann cells might down-
regulate c-Jun and not maintain the repair cell phenotype.  
To examine this, rat Schwann cells were cultured. At every passage, 1 million cells 
were removed and cultured separately in DM for 48 hours. Protein was then 
extracted and stored until all the samples were collected (Figure 7.2.1). Cells 
underwent a total of 9 passages and were in culture for 6 weeks. A Western blot was 
run once samples from all 9 passages had been collected (Figure 7.2.1 A). This pilot 
study showed that c-Jun was activated in Schwann cells by the first passage. Levels 
increased and remained high during the first 4 passages, equivalent to between 2-3 
weeks in culture.  c-Jun began to decline however with increasing time in culture. c-
Jun levels were found to be lowest at passage 9 where c-Jun decreased 62% relative 
to passage 4 where c-Jun expression peaked (Figure 7.2.1 B). c-Jun protein levels at 
passage 9 however were almost half compared to the elevation observed at passage 
2, a similar trend that is observed in the nerve between 1 and 10 weeks denervation. 
It was therefore decided to examine the differences between Schwann cells during 
















Figure 7.2.1 | c-Jun protein expression decreases during long-term culture of rat Schwann cells 
(A) Rat Schwann cells were cultured for 6 weeks. During this time, after each passage, 1,000,000 
cells were removed and cultured separately in DM for 48 hours. c-Jun protein levels in these cultures 
were then examined by Western blot and quantified. (B) c-Jun levels increased and remained high 
during the early passages. c-Jun expression then began to decrease with increasing passage number 
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To confirm the results of the pilot study, c-Jun expression was analysed between 
Schwann cells at passage 2 and 9 (Figure 7.2.2). Western blots confirmed the 
previous finding with c-Jun expression found to be lower in passage 9 cells 
compared to passage 2 (Figure 7.2.2 A). As previously observed, this difference in 
expression in passage 9 cells was found to be half of that at passage 2 (Figure 7.2.2 
B).  
It was observed that the purity of the cultures decreased with time. Increasing 
numbers of fibroblasts were present in the cultures. To therefore confirm that the 
Schwann cells are down-regulating c-Jun, producing these results, instead of the 
reduction in c-Jun being due to the increasing number of fibroblasts in the culture, a 
Sox 10 c-Jun dual immunolabelling was performed (Figure 7.2.2 D). Both cultures 
highly expressed Sox 10, however differences were observed in c-Jun levels. 
Passage 2 cells expressed high levels of c-Jun with cells brightly labelled. Passage 9 
cells however were faintly labelled for c-Jun. The stark contrast in the labelling of c-
Jun between these two cultures confirms that Schwann cells down-regulate c-Jun 
with increasing time in culture.    
It was previously found in vivo, that decreasing levels of c-Jun lead to a decline in 
the repair cell phenotype, demonstrated by decreasing levels of phenotypic markers. 
To examine this phenomenon in vitro, markers of the repair cell phenotype were 
examined. p75 NTR protein expression was examined first (Figure 7.2.2 A).  
Expression was greatly reduced in long-term cultured cells in comparison to the high 
levels observed in passage 2 cells (Figure 7.2.2 C). This was a highly significant 
(p=0.0007) decrease, with passage 9 cells expressing half the level of p75 NTR 
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Figure 7.2.2 | c-Jun and p75 expression decreases in long-term cultured rat Schwann cells 
(A) Western blots of c-Jun and p75 NTR after 2 or 9 passages. Both c-Jun and p75 NTR protein 
levels decreased with time and increasing number of passages. (B) Quantification of c-Jun Western 
blots. The decrease in c-Jun expression observed between short (passage 2) and long (passage 9) term 
culture was found to be significant (p=0.0023). (C) Quantification of p75 NTR Western blots showed 
that the decrease in p75 NTR levels over time was significant (p=0.0007). (D) Immunofluorescence 
of c-Jun levels in passage 2 and passage 9 cultures with Sox10 as a Schwann cell marker. Graph of 






















To examine the other markers of the repair cell phenotype such as c-Jun, GDNF, 
BDNF, Olig1 and Shh, RNA was extracted from passage 2 and 9 cultures. 
Subsequent qPCR results demonstrated a significant decrease in c-Jun mRNA levels, 
in line with protein levels (Figure 7.2.3 A). Trophic factor BDNF was also 
significantly reduced in passage 9 cultures (Figure 7.2.3 B). GDNF expression was 
reduced following long-term culture, although this was not found to be significant  
(p= 0.0889) (Figure 7.2.3  C). A reduction in Olig1 was also observed but was 
similarly found to be insignificant (p=0.2748) (Figure 7.2.3  D). Shh however was 
elevated following long-term culture (Figure 7.2.3 E). As Shh has been previously 
shown to play a role in c-Jun activation (Figure 7.1.1), this may be a compensatory 
method to elevate or maintain remaining c-Jun levels. This elevation however is not 
significant (p=0.4888).  
From these results it can be concluded that c-Jun decreases in long-term cultured 
Schwann cells, a phenomenon similar to the events in chronic denervation. Some of 
the markers of the repair cell phenotype also decrease with prolonged culture such as 
p75 NTR and BDNF. p75 NTR decreases in chronically denervated Schwann cells 
(Figure 3.4) (You et al., 1997) BDNF has also previously been to decline in 
chronically denervated nerves (Michalski et al., 2008). Long-term cultured Schwann 
cells may therefore be a useful in vitro model of chronic denervation and for 


























Figure 7.2.3 | mRNA expression of c-Jun and BDNF decreases in long-term rat Schwann cells 
cultures 
qPCR was used to examine fold changes in RNA expression of repair cell markers in passage 9 cells 
relative to passage 2 cell cultures. Significant decreases were observed during long-term culture in 
(A) c-Jun (p=0.0299) and (B) BDNF levels (p=0.0105). (C) GDNF (p=0.0889), (D) Olig1 (p=0.2748) 










7.3 Decreases in c-Jun levels during long-term culture are not associated with 
cAMP accumulation  
cAMP has previously found to be elevated in Schwann cells after prolonged time in 
vitro (Stewart et al., 1991) . This can lead to activation of genes associated with 
myelin Schwann cells. cAMP is also known to inhibit c-Jun and promote the myelin 
phenotype (Morgan et al., 1991; Arthur-Farraj et al., 2011; Parkinson et al., 2008). It 
could therefore be possible that the reduction in c-Jun is due to cAMP accumulation 
and adoption of the myelin phenotype. This is important to establish to ensure this 
model is characteristic of chronically denervated Schwann cell as opposed to myelin 
Schwann cells.  
cAMP levels in passage 2 and 9 cultures was measured by ELISA (Figure 7.3). 
When the concentration (pMol) of cAMP measured in each sample was compared 
relative to the protein concentration in each sample (mg) as an internal control, it 
was found that there was no difference in the level of cAMP expressed between the 
two cultures (p=0.8925). It was therefore concluded that the decrease in c-Jun was 
not due activation of the myelin phenotype but more likely due to fading of the 








Figure 7.3 | Long-term cultured Schwann cells do not accumulate cAMP 
cAMP levels in passage 2 and 9 Schwann cell cultures by ELISA. No difference in cAMP levels were 
observed following short or long-term culture (p=0.8925). Graph of means ± SEM, n=3, unpaired 




7.4 Agonists of the hedgehog pathway activate c-Jun in long-term cultured 
Schwann cells 
Now that a model for studying chronically denervated Schwann cells in vitro has 
been established, methods of activating c-Jun can be determined. As described 
earlier in this chapter, Shh signalling may play a role in the partial activation of c-
Jun. The Shh signalling pathway could therefore be utilised to activate c-Jun in 
Schwann cells. To examine this Shh agonists can be incubated with Schwann cell 
cultures that have undergone 9 passages.  
Purmorphamine is an agonist of the hedgehog (Hh) pathway directly targeting 
smoothened, leading to activation of down-stream targets of the hedgehog pathway 
such as Gli (Wu et al., 2004; Sinha & Chen, 2006). To examine the effect of 
stimulating the hedgehog pathway on c-Jun in Schwann cells, rat Schwann cells 
underwent 9 passages to lower their c-Jun levels. Passage 9 cells were incubated 
with increasing concentrations of purmorphamine (1, 2.5, 5 or 10µM) (Figure 7.4.1 
A). Two controls were established: untreated cells (UT) incubated in DM only and 
cells incubated with DMSO (Veh). The volume of DMSO added to these was the 
same as the volume present in cells incubated with 5µM purmorphamine. No 
difference in c-Jun expression was observed between the controls demonstrating that 
any changes in c-Jun expression observed are due to Hh signalling. c-Jun was found 
to increase in cultured cell with increasing concentration of purmorphamine. 
Although all concentrations of purmorphamine lead to c-Jun activation, only 2.5µM, 
























Figure 7.4.1 | Hh agonist purmorphamine activates c-Jun in long-term cultured rat Schwann 
cells  
(A) Western blots of protein lysates showed that all concentrations of purmorphamine activated c-Jun. 
(B) Blots were quantified by dividing c-Jun levels by levels of house keeping protein GAPDH. All 
blots were normalised to the UT cells and the fold change observed. Although c-Jun was elevated by 
all concentrations of purmorphamine, 2.5µM was the only one to elicit a significant increase. A 
decline in cJun expression observed following incubation with 10µM suggests toxicity. Graph of 
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To confirm the activation of c-Jun through activation of the Hh pathway, passage 9 
Schwann cell cultures were also incubated with smoothened agonist (SAG) for 48 
hours. SAG activates the Hh pathway by directly binding to smoothened (Chen, 
Taipale, Young, et al., 2002).   
As it was previously found that DMSO did not activate c-Jun in cultured Schwann 
cells at the low volumes previously used, only a vehicle control was used in these 
experiments. The volume of DMSO used was equal to that of cells incubated with 
2.5µM SAG. Cells were incubated with 1 or 2.5µM SAG for 48 hours (Figure 7.4.2 
A). Both concentrations of SAG were found to significantly elevate c-Jun levels 
compared to the control (Figure 7.4.2  B).   
It was previously observed that long-term cultures decreased in purity. In order to 
confirm that the changes in c-Jun expression observed were Schwann cell specific, 
cultures were dual immunolabelled for c-Jun and Sox 10 after 48 hour 2.5µM SAG 
or DMSO incubation (Figure 7.4.2  C). c-Jun labelling was brighter in the SAG 
incubated cultures compared to the control. Sox 10 staining demonstrated that this 
was observed in Schwann cells.  
The results from this set of experiments showed that incubation with Hh agonists 
leads to an increase in c-Jun protein. However to validate these results, the Hh 






























Figure 7.4.2 | Hh agonist SAG activates c-Jun in long-term cultured rat Schwann cells 
(A) Passage 9 Schwann cells were incubated with SAG or DMSO (veh) for 48 hours. Western blots 
of protein lysates show that c-Jun increased with increasing concentration of SAG. (B) Blots were 
quantified and normalised to the vehicle to determine fold change in c-Jun expression. c-Jun was 
significantly elevated following incubation with SAG with levels increasing with increasing drug 
concentration. To increase n numbers, 2 data sets obtained from blots run by Liam Wong, a student 
under the author’s supervision, were added to the analysis performed here. (C) Dual immunolabelling 
with c-Jun and Sox 10 antibodies of passage 9 cultures incubated with vehicle or 2.5µM SAG for 48 
hours. SAG incubated cells are brightly labelled for c-Jun compared to vehicle control cells. Graph of 
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7.5 Cyclopamine decreases c-Jun and p-c-Jun in short term cultured Schwann 
cells  
Cyclopamine inhibits the Hh pathway through direct binding with smoothened 
(Cooper et al., 1998; Incardona et al., 1998; Chen, Taipale, Cooper, et al., 2002).  
Cyclopamine can therefore be used to examine the effect on c-Jun of inhibiting the 
Hh pathway. As Shh cKO nerves exhibit impaired c-Jun activation (Figure 7.1.1), 
cyclopamine is likely to decrease c-Jun expression.  
As c-Jun is already low in passage 9 cells, any attempt to lower it further may only 
be slight and could even result in cell death. Hh inhibition must therefore be 
examined in conditions were c-Jun is highly elevated, such as during the early stages 
of culture. Passage 2 Schwann cells were therefore used. Cells were incubated with 
increasing concentrations of cyclopamine (10-50µM). As higher volumes of DMSO 
are required for the control cultures under these conditions (DMSO volume = 
volume for 30µM), the two controls of untreated cells in DM (UT) or DMSO (Veh) 
where reintroduced in this experiment. No difference was observed between the 
controls while c-Jun expression decreased with increasing concentrations of 
cyclopamine (Figure 7.5 A) The higher concentrations of cyclopamine, 40 and 
50µM, significantly decreased c-Jun expression by 47% and 52% respectively 
(Figure 7.5 B).  
It was previously found that Shh cKO Schwann cells, as well as having decreased 
levels of total c-Jun protein, also showed decreased levels of c-Jun phosphorylation 
(Figure 7.1.1 and 7.1.2). Cyclopamine has previously been shown to decrease 
phosphorylation of c-Jun at Ser63 (Kudo et al., 2012). The effect of inhibiting Hh 
signalling on c-Jun phosphorylation in Schwann cells was therefore examined. All 
concentrations of cyclopamine reduced the phosphorylation of c-Jun at Ser63 (Figure 
7.5 A). All concentrations of cyclopamaine halved the levels of phosphorylated c-
Jun, with the highest concentrations reducing phosphorylation by two thirds (Figure 
7.5 C). The phosphorylation of c-Jun may therefore be a downstream target of Hh 

























Figure 7.5 | Cyclopamine reduces c-Jun and p-c-Jun expression in cultured rat Schwann cells  
(A) Passage 2 Schwann cells were incubated with increasing concentrations of cyclopamine for 48 
hours. c-Jun expression gradually decreased with increasing concentration of drug. Cyclopamine 
dramatically reduced phosphorylation of c-Jun at all concentrations. (B) Blot quantification showed 
that total c-Jun protein is significantly reduced by 40-50µM cyclopamine. (C) Cyclopamine inhibits 
the phosphorylation of c-Jun. Incubation with all applied concentrations of cyclopamine lead to a 
significant down-regulation of p-c-Jun. Graphs of means ± SEM, n=3, one-way ANOVA with 
Dunnett’s test.  
Con      Veh      10       20      30        40       50 
c-Jun 
GAPDH 
p-c-Jun (Ser 63) 
35 kD - 
43 kD - 
Cyclopamine  
(µM) 






7.6 Hh agonists increase trophic factor expression in long-term cultured 
Schwann cells  
Since it has been shown that the Hh agonists activate c-Jun in vitro it is possible Hh 
signalling is also able to restore the repair cell markers which decrease in long-term 
cultured Schwann cells. As with previous experiments, passage 9 cultured rat 
Schwann cells were incubated with 5µM purmorphamine or an equal volume of 
DMSO and RNA was extracted after 48 hours. The subsequent qPCRs showed that 
c-Jun was highly elevated in cells incubated with purmorphamine (Figure 7.6.1 A). 
Despite the reduction in BDNF expression reported in long-term cultured cells 
previously (Figure 7.2.3 B), purmorphamine was unable to elevate expression further 
(Figure 7.6.1 C). GDNF however was significantly elevated after incubation with 
purmorphamine (Figure 7.6.1 B). GDNF expression declined during long-term 
culture (Figure 7.2.3 C). Although this was not significant, incubation with 
purmorpahmine resulted in a significant 2-fold increase in the trophic factor 
expression. Olig1 and Shh expression remained unchanged following 
purmorphamine incubation (Figure 7.6.1 D and E). Neither of these were altered by 
long-term culturing of Schwann cells and purmorphamine is unlikely to further 
elevate Shh expression as the Hh pathway is already active.  
To further examine the increase in trophic factor expression caused by activation on 
the Hh pathway, passage 9 cultured rat Schwann cells were incubated with 2.5µM 
SAG for 48 hours. qPCRs of the extracted RNA found that both GDNF and BDNF 
significantly increased in these cultures relative to the control (Figure 7.6.2 A and 
B).  
p75 NTR expression was found to decrease in Schwann cells with increasing time in 
vitro (Figure 7.2.2). Due to Hh signalling increasing other markers of the repair cell 
phenotype, p75 NTR may also be restored by Hh agonist incubation. Western blots 
of Schwann cells incubated with SAG for 48 hours were run. Despite the decrease 
previously observed, p75 NTR expression remained unchanged (Figure 7.6.2 C). 




Together these results demonstrate that activation of the Hh signalling pathway 
activates c-Jun and some markers of the repair cell phenotype, namely trophic 










































Figure 7.6.1 | Purmorphamine increases mRNA expression of c-Jun and GDNF in long-term 
cultured rat Schwann cells 
RNA was extracted from passage 9 Schwann cells that were incubated with DMSO (Veh) or 5µM 
purmorphamine for 48 hours. qPCR results found that (A) c-Jun was significantly elevated by 
purmorphamine (p=< 0.0001). (B) GDNF expression increased 2-fold following purmorphamine 
incubation (p=0.0116), however no change in expression was observed in (C) BDNF (p=0.3344), (D) 



























Figure 7.6.2 | SAG elevates trophic factors in long-term cultured rat Schwann cells but not p75 
NTR protein expression 
RNA was extracted from passage 9 Schwann cells following 48 hours of incubation with 2.5µM 
SAG. qPCRs found significant increases in both (A) GDNF (p=0.0382) and (B) BDNF (p=0.0314) 
expression. Unpaired Student’s T-test. (C) Western blots showed no change in p75 NTR expression. 
(D) Quantification of blots even demonstrated a slight decline in levels when cells were incubated 
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7.8 Discussion  
Shh is up-regulated by Schwann cells in response to injury. Previous studies have 
suggested that this provides a neuroprotective effect through the activation of BDNF 
(Pepinsky et al., 2002; Hashimoto et al., 2008; Bond et al., 2013; Angeloni et al., 
2013). Although a link between Hh signalling and Jun activation has been 
established in various cell lines, this has not previously been established in Schwann 
cells (Laner-Plamberger et al., 2009; Kudo et al., 2012). Here, the activation of c-Jun 
in Schwann cells through hedgehog signalling is shown using in vitro and in vivo 
models.  
To examine the role of Shh signalling in c-Jun activation in vivo, sciatic nerves from 
Shh cKO mice that had undergone a 3 or 7 day cut were gifted from the laboratory of 
John Svaren (USA). Although c-Jun was expressed equally in WT and Shh cKO 
nerves 3 days after injury, the mutant displayed reduced levels at 7 days. This 
suggests Shh signalling, although not responsible for initial activation of c-Jun, is 
required for its further elevation. This enforces findings previously described in this 
Chapter that Gli is required for the enhanced activation of Jun (Laner-Plamberger et 
al., 2009). As previous studies have demonstrated inhibition of Shh signalling 
reduces phosphorylation of c-Jun at serine 63 (Kudo et al., 2012), it was 
hypothesised that this might lead to the reduced activation of c-Jun. The 
phosphorylation of c-Jun at serine 63 was found to be reduced at 7 days after injury. 
Due to the reduced c-Jun activation observed in Shh cKO nerves, it was considered  
likely that induction of the repair cell phenotype might also be impaired. To examine 
this, nerves were extracted and Western blotted for p75 NTR at 3 and 7 days after 
injury. p75 NTR activation following injury is gradual with levels peaking 1 week 
after injury (Heumann et al., 1987). It was therefore expected that no difference 
would be observed between the 2 genotypes at this time. At 7 days however, in line 
with c-Jun, p75 NTR activation is impaired. Overall these findings demonstrate that 
Shh signalling in Schwann cells participates in the partial elevation of c-Jun and the 
repair cell phenotype. 
In order to truly establish the impaired induction of the repair cell phenotype, further 
experiments would be required. qPCRs of repair cell markers could be performed on 
these nerves at 7 days after injury. Although experiments of this nature have been 
218 
 
performed throughout this thesis, limitations in the amount of tissue supplied 
prevented these investigations. It would be of further interest to examine the 
functional implications of Shh inhibition. Although studies described here have 
examined this, a thorough analysis of regeneration has never been undertaken. These 
investigations were clearly limited by time considerations and the lack of an 
established Shh cKO mouse colony in the UK, however if this were not the case 
many aspects of nerve regeneration could be tested. Retrograde labelling of 
regenerating motor and sensory neurons could be performed. Work is this thesis has 
demonstrated a reliable method for this already established in our laboratory. Axon 
regeneration could further be examined for by immunolabelling transverse sections 
with calcitonin gene-related peptide (CGRP) or neurofilament (Streit et al., 1989; 
Dumoulin et al., 1992). 
Based on the findings from Shh cKO nerves, the Hh pathway could be activated to 
maintain c-Jun during chronic denervation or to enhance c-Jun activation in aged 
Schwann cells. It order to examine this however, it was first important to establish an 
in vitro model in which c-Jun is lowered. As c-Jun is highly elevated in cultured 
Schwann cells, further elevation might not be possible. It was found that Schwann 
cells down-regulate c-Jun with increased time in vitro similar to during chronic 
denervation. Markers of the repair cell phenotype such as p75 NTR and BDNF were 
also shown to decrease. It would have been interesting to establish the functional 
implications of these results on neurite outgrowth and survival of co-cultures with 
dissociated DRGs. A previous study examining the effect on long-term culturing of 
Schwann cells found that Schwann cell growth and proliferation and neurite growth 
in co-cultures increased with prolonged time in vitro. Their classification of short 
term culture however was 5-11 passages comparing with cells that had undergone at 
least 20 passages and some of their representative images do not match the 
quantification in the graphs. Schwann cells that are claimed to be growing well are 
imaged with short outgrowths and do not display classic Schwann cell bipolar 
morphology. It was however suggested that the long-term cultured Schwann cells 
had become tumorigenic (Funk et al., 2007). As many studies have been able to 
maintain Schwann cell cultures for even longer periods and no difference in the 
proliferation during prolonged culture has been demonstrated, the results from Funk 
et al should be viewed with caution (Porter et al., 1987; Mathon et al., 2001).  
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Application of Hh agonists to long-term cultured Schwann cells significantly 
elevated c-Jun and trophic factor expression. As with the model, it would be of 
interest to examine the effect of this elevation on neurite outgrowth and survival in 
co-cultures with dissociated DRGs. Interestingly, purmorphamine was unable to 
elicit an elevation in BDNF, only in GDNF. This is the reverse observation of 
previous findings which claim Shh activates BDNF but not GDNF in vitro 
(Hashimoto et al., 2008). Incubation with SAG however activated both trophic 
factors. Previous work has demonstrated that the application of both GDNF and 
BDNF can be more beneficial than activation of a single trophic factor (Boyd & 
Gordon, 2003). It is possible that the activation of repair cell markers may increase 
with prolonged exposure to Hh agonists or that their activation occurs only following 
immediate exposure to the agonist. RNA could be extracted at early and later time 
points to examine this further.  
Although the expression of repair cell markers was examined following incubation 
with both agonists, it was not examined following inhibition of Hh signalling with 
cyclopamine. Cyclopamine was found to reduce c-Jun expression and partially 
inhibit phosphorylation of Ser 63. It is unknown if these reductions are enough to 
down-regulate the repair cell phenotype or effect the Schwann cells ability to support 
axonal growth. qPCRs for repair cell markers and Western blots for p75 NTR could 
examine this as well as co-cultures with dissociated DRGs. Performing neurite 
outgrowth studies on dissociated DRG cultures would have to be carefully planned. 
When Shh signalling is knocked out in these cultures, reductions in neurite 
outgrowth and branching are observed (Martinez et al., 2015). Therefore any 
alterations in DRG activity as a result of the manipulation of Hh signalling may 
simply be due to neuronal activation/inhibition of Hh. If activation of Hh improves 
axon regeneration, it may not be of concern if this is due to a Schwann cell or 
neuronal activation, the goal is still achieved. However to ultimately examine the 
effect of Hh and specifically Shh in vitro, genetic manipulation is required. For in 
vivo experiments, the Shh cKO mouse could be examined but this mouse can also be 
used for in vitro work. Schwann cells cultured from Shh cKO nerves could be co-
cultured with DRGs. To examine activation of Shh expression, a mouse similar to 
the OE/+ mouse could be created that can over express Shh. It is likely this would be 
a fl/fl mouse to prevent developmental abnormalities, but Schwann cells cultured 
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from this mouse, infected with a cre recombinase adenovirus could be used to 
examine the effect of over-expressing Shh on neurite outgrowth.  
Although this chapter has demonstrated the relationship between Hh and c-Jun, this 
chapter does not demonstrate that that Hh agonists can be used to overcome the 
effects of Hh inhibition, a crucial experiment in confirming the effects of Hh 
signalling in Schwann cells. Short term cultured Schwann cells should be incubated 
with both cyclopamine and a smoothened agonists to confirm this. 
Overall the results of this chapter have demonstrated that Shh signalling in Schwann 
cells plays a role in the elevation of c-Jun. Hh agonists and antagonists were further 
shown to activate and inhibit c-Jun in Schwann cells in vitro. Hh agonists were also 
shown to increase the activation of trophic factors. This work highlights the Shh 
pathway as a pharmaceutical target for c-Jun activation and maintenance during 
times of poor peripheral nerve regeneration such as chronic denervation and 















8. General discussion  
As has been stated previously, the PNS has a remarkable capacity for regeneration. 
Following nerve injury, myelin and Remak Schwann cells convert to a repair cell 
phenotype that facilitates axon regeneration. These cells promote axon guidance and 
regeneration by breaking down myelin through external macrophage recruitment and 
Schwann cell autophagy. Trophic factors, cell adhesion molecules and cytokines are 
up-regulated and cells proliferate, elongate, branch and align with each other to form 
the Bands of Büngner that facilitate axon guidance. c-Jun is a major regulator of this 
repair phenotype (Arthur-Farraj et al., 2012; Fontana et al., 2012).  
Despite the activation of this repair cell phenotype, peripheral nerve regeneration in 
humans is poor. This is due to a variety of factors, one of which is the deterioration 
of the distal nerve stump which occurs during chronic denervation. The deterioration 
of the distal nerve stump is defined by two factors: the gradual decrease of trophic 
factor expression and a decline in Schwann cell numbers (Abercrombie & Johnson, 
1946; Weinberg & Spencer, 1978; Siironen et al., 1994; You et al., 1997; Hall, 1999; 
Höke et al., 2002; Michalski et al., 2008; Eggers et al., 2010; Benito et al., 2017). 
This thesis investigated the hypothesis that c-Jun and thus the repair cell phenotype 
was not maintained during chronic denervation. 
Results in Chapter 3 confirmed aspects of this idea. c-Jun protein levels were not 
maintained in Schwann cells following chronic denervation. p75 NTR protein was 
similarly found not to be maintained, confirming previous findings (You et al., 
1997). qPCR results in Chapter 4 further demonstrated that c-Jun, GDNF and Shh all 
significantly decline during chronic denervation (Figure 4.8). BDNF expression was 
also reduced, however this was not a significant finding. GDNF and BDNF have 
previously been demonstrated to decline in rat models of chronic denervation (Höke 
et al., 2002; Michalski et al., 2008; Eggers et al., 2010). BDNF elevation is gradual 
in Schwann cells after injury (Meyer et al., 1992; Funakoshi et al., 1993; Michalski 
et al., 2008). It may be that no significant decrease is observed in BDNF expression 
as the qPCR only examines two time points. Examining expression at 4 weeks may 
provide results more in line with the literature. Furthermore, increasing the number 
of experimental repeats is likely to be beneficial and contribute to these findings. 
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Overall these data provide strong evidence that c-Jun and the repair cell phenotype 
are not maintained during chronic denervation.  
It was hypothesized that maintaining c-Jun during chronic denervation might 
maintain the repair cell phenotype, preventing the deterioration of the distal nerve 
stump. The OE/+ mouse was generated, a heterozygote mouse which over-expresses 
c-Jun specifically in Schwann cells.  During chronic denervation, c-Jun is maintained 
in the Schwann cells of this mouse (Figures 4.5-6). However, despite the 
maintenance of Schwann cell c-Jun, the present experiments failed to detect 
elevation in GDNF and BDNF in OE/+ nerves. Levels of GDNF were even lower 
than those expressed by WT nerves (Figure 4.8). This is an unusual finding as c-Jun 
has previously been demonstrated to directly regulate GDNF expression (Fontana et 
al., 2012). Nevertheless, the regenerative capacity of nerves in OE/+ mice is 
maintained. Motor and sensory neuron regeneration in these mice is equal to that in 
nerves that have been immediately repaired (Figure 5.4). What therefore, are the 
possible mechanisms behind this finding?  
The reasons for the restoration of regeneration could be complex. c-Jun controls 
expression of many different genes besides the two trophic factors examined here. c-
Jun cKO Schwann cells demonstrate changes in the expression of 172 different 
genes (Arthur-Farraj et al., 2012). Some of these genes may be maintained by OE/+ 
Schwann cells during chronic denervation. Furthermore, GDNF and BDNF protein 
levels were not examined here. It may be possible that maintenance is observed at 
the protein level. c-Jun protein is maintained by OE/+ nerves during chronic 
denervation, yet c-Jun mRNA expression decreases by half. Discrepancies may 
therefore also be observed between GDNF and BDNF mRNA and protein levels. 
More in depth analysis such as whole genome RNA sequencing and proteomic 
analysis may further explain this result and highlight other Schwann cell genes and 
proteins, such as other trophic factors and cell adhesion molecules, that might aid 






Counts of Schwann cells in the distal nerve stump 1 and 10 weeks after injury 
showed that OE/+ nerves have an increased number of Schwann cells compared to 
WT (Figure 4.9). This raises the question of whether cell quality or quantity is an 
important factor in regeneration. Although the OE/+ nerves do contain more 
Schwann cells following chronic denervation, and c-Jun protein expression in 
individual cells is maintained, as demonstrated by immunolabelling (Figure 4.6,) 
these cells as previously discussed, do not express high levels of  trophic factors 
GDNF and BDNF despite elevated c-Jun levels. Therefore, it could be concluded 
that by simply increasing the number of cells, regardless of their quality, is enough 
to enhance regeneration. However, it is been demonstrated that distal nerve stump 
Schwann cell proliferation is not required for axon regeneration. When proliferation 
is inhibited, axon regeneration is not impaired following crush injury (Yang et al., 
2008). This suggests that an increase in Schwann cell number is not required for 
axon regeneration which persists regardless.  
EM counts also showed that OE/+ nerves contain more macrophages during chronic 
denervation. It was shown that OE/+ nerves are able to attract more macrophages to 
the injury site following a short-term crush injury (Figure 4.10), although no 
difference was found between genotypes at 1 week (Figure 4.9). Therefore the 
differences between the two genotypes in acute denervation disappears with time, as 
is observed in the c-Jun cKO (Arthur-Farraj et al., 2012). It is possible however than 
macrophages do not leave the nerve during the time course usually described. They 
may even be unable to leave the nerve. A time course study would be needed to 
determine this. Because this information is not available, it cannot be determined if 
OE/+ nerves retain macrophages from the outset of denervation or if trafficking is 
simply increased. 
Either way, this increased number of macrophages might contribute to improving 
axon regeneration. As previously discussed, macrophages normally appear in the 
nerve 2-3 days after injury where their primary role is to facilitate the secondary 
stage of myelin clearance. If this process is impaired, axon regeneration is inhibited, 
partly through the continued presence of myelin debris. (Perry et al., 1987; Stoll et 
al., 1989; Raivich et al., 1991; Perry et al., 1995; Dailey et al., 1998; Kang & 
Lichtman, 2013). However, chronically denervated nerves will no longer contain 
myelin debris. Therefore, how can their presence enhance regeneration? A secondary 
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function of macrophages is to promote vascularization through secretion of VEGF-A 
(Cattin et al., 2015). Although this has been solely demonstrated after immediate 
nerve cut and regeneration across the nerve gap, macrophage retention is likely to 
result in increased vascularization of the distal nerve stump during chronic 
denervation, creating a more favourable environment for regeneration. VEGF-A has 
also been shown to enhance axon regeneration following axotomy (Hobson et al., 
2000). The vascularization of nerves from both genotypes following chronic 
denervation should therefore be examined. Macrophages also secret trophic factors 
and cytokines to promote axon regeneration (Brown et al., 1991; Reichert et al., 
1996; Shamash et al., 2002). Although no changes in trophic factor expression were 
observed in OE/+ nerves in this thesis, RNA sequencing may highlight the 
maintenance macrophage specific promoters of regeneration.  
The work presented here in aged mice however could contradict the importance of 
macrophages in regeneration. It was confirmed that up-regulation of c-Jun is 
impaired following injury in old mice (Figure 6.1) (Painter et al., 2014). This 
however was not observed in old OE/+ mice, the Schwann cells of which elevated c-
Jun to levels similar to those observed in young mice. With the restoration of c-Jun 
activation, the age-related regeneration deficit was not observed in old OE/+ mice. It 
is known that macrophage numbers are reduced in old nerves following injury, yet I 
did not examine if restored c-Jun activation repaired this. This is due to the fact that 
the regeneration deficit in old nerves was shown by Painter et al., (2014) to be of 
Schwann cell origin. Parabiosis experiments, in which old nerves are infiltrated with 
young macrophages following injury, do not restore the age associated regeneration 
deficit (Painter et al., 2014). This suggests even if old OE/+ nerves recruited more 
macrophages, this is unlikely to be the cause of the enhanced regeneration observed. 
It is likely associated with the adoption of the repair cell phenotype, which is 
inhibited in aged Schwann cells (Painter et al., 2014). To confirm this, qPCR 
experiments of repair cell markers are required in old WT and OE/+ nerves after 
injury. 
Further work is needed to truly determine the importance cell quality or quantity and 
cell type in chronic denervation. This issue could be further explored using the c-Jun 
OE/+ inducible mouse line. The nerves of these mice were allowed to deteriorate for 
8 weeks before c-Jun over-expression was induced with tamoxifen. Although the 
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distal nerve stumps expressed higher levels of c-Jun as a result of this (Appendix 1), 
2 weeks later, regeneration was not restored. This suggests that the consequences of 
c-Jun reduction during chronic denervation are not reversible. Alternatively, this 
enhances the idea that factors other than c-Jun elevation are required for nerve 
regeneration in chronically denervated tissue. Nerves from these mice and vehicle 
controls could be processed for EM and the number of Schwann cell and 
macrophages counted. Cell quality could also be examined by evaluating repair cell 
markers by qPCR or RNA sequencing. This could contribute to our understanding of 
the role of cell numbers in axon regeneration into chronically denervated nerves.  
Further experiments with the OE/+ mice are also needed. As previously described in 
Chapter 4, a decrease in Schwann cell numbers was not observed 10 weeks after 
injury. It was noted that the numbers counted at 1 week were lower than those 
previously documented and should therefore be re-examined (Arthur-Farraj et al., 
2012). However, as discussed previously in Chaper 4, the difference in cell number 
could be accounted for by the differences in the mouse strains examined. The mice 
examined by Arthur-Farraj et al (2012) and those used in this work were generated 
from different backgrounds. Repeating these experiments may therefore not produce 
different results.  
Although the exact mechanism by which c-Jun maintenance and enhanced elevation 
restores the regeneration deficits observed following chronic denervation and 
advancing age is still debatable, these regeneration deficits were importantly both 
restored. This highlights c-Jun has a possible pharmaceutical target. In Chapter 7 it 
was demonstrated that Hh signalling, particularly Shh, affected c-Jun activation. The 
hedgehog pathway could therefore be targeted to activate c-Jun and aid peripheral 
nerve regeneration. The work in this thesis has demonstrated that, if a treatment were 
to be developed, it would have to be administered as soon as possible. During 
chronic denervation, the re-activation of c-Jun does not enhance regeneration and is 
it the early activation of c-Jun that restores the age related decline. Once 
administered however, the course of drug treatment would have to be very 
specifically defined. c-Jun is an inhibitor of myelination (Parkinson et al., 2008) and 
following a crush injury, functional recovery is impaired in young OE/+ mice (Fazal 
et al., 2017) no difference is observed in motor or sensory neuron regeneration 
between genotypes following acute injury (Figure 5.3, 6.2), mild and transient 
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deficits are observed in both motor and sensory function tests such as toe pinch and 
spread. This is due to a delay in remyelination of the regenerating fibres (Fazal et al., 
2017). Drugs would have to be administered long enough to promote axon 
regeneration then halted to allow for remyelination. However, if the drug was 
administered at a low dose, axonal signals may override the effects of the drug and 
promote remyelination.  
The over-expression of c-Jun would also have to be confined to the injured nerve. 
Work in this thesis and by Fazal et al (2017) has demonstrated that moderate 
expression of c-Jun does not have substantial effects on uninjured nerves. c-Jun 
however is an oncogene. c-Jun is highly expressed in breast cancer (Vleugel et al., 
2006) and over-expression of c-Jun in breast cancer cell lines promotes 
tumorigenesis and cell motility (Smith et al., 1999). c-Jun expression has also 
previously been observed in 31% of primary and metastatic lung tumours (Szabo et 
al., 1996). In liver cancer, it is proposed that c-Jun expression prevents apoptosis 
which is likely to contribute to tumour development (Eferl et al., 2003). The 
inhibition of c-Jun is now proposed as a potential target for the treatment of cancers 
(Gurzov et al., 2008). It is therefore unlikely that a treatment that would have effects 
outside the nerve would be approved.  
 
Overall, the work in this thesis has demonstrated that the maintenance of Schwann 
cell c-Jun during chronic denervation restores the regeneration deficit observed with 
increased time after injury. It has also been demonstrated that restoring the activation 
of c-Jun after injury in old Schwann cells prevents the regeneration deficit observed 
with advancing age. c-Jun has therefore been highlighted as a pharmaceutical target 
for improving peripheral nerve regeneration which could potentially be targeted 
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Appendix 1 | c-Jun protein expression is increased in chronically denervated distal nerve 
stumps of PLP-Cre mice following tamoxifen administration  
(A) A Western blot of c-Jun protein expression in chronically denervated distal nerve stumps of WT 
and PLP-Cre mice following tamoxifen administration. Tamoxifen had no effect on WT nerve c-Jun 
levels following chronic denervation, however PLP-Cre nerve c-Jun levels increased. Administration 
of the vehicle (VEH) did not elevate c-Jun expression in PLP-Cre nerves. (B) Tamoxifen 
administration significantly increased c-Jun protein expression in chronically denervated PLP-Cre 
nerves in comparison to WT. Administration of the vehicle (VEH) did not significantly alter c-Jun 
expression in these nerves Graphs of means ± SEM, Veh-PLP-Cre and 7 day cut n= 4, UI n= 3, WT 
and PLP-Cre n= 6, one-way ANOVA with Tukey’s test, p=<0.00001. This experiment was perfomed 
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